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ABSTRACT
Calcium ions (Ca2+) function as universal second messengers in most if not all eukaryotic 
cells, including the cells of the immunesystem. Ca2+ signals are required for the proper 
activation of lymphocytes, such as T-lymphocytes, their proliferation, differentiation and 
effector functions. In lymphocytes store-operated calcium entry (SOCE) through calcium 
release activated calcium (CRAC) channels in the plasma membrane is the major mechanism 
to increase cytosolic Ca2+ concentrations and is essential for the activation of T and B cells as 
well as induction of their cytokine gene production. How exactly store operated calcium entry 
operates in T cells has remained unclear. While one model, based on results obtained using a 
variety of F-actin-modulating drugs, involves the cortical actin cytoskeleton, the function of 
F-actin in SOCE has remained controversial during the last decade, since independent studies 
have found no effects of the same drugs on SOCE in other model systems such as the rat 
basophile leukemia (RBL) cell line. The first part of this thesis aims at defining the role of the 
actin cytoskeleton during SOCE in human T cells. 
The data presented in this thesis clearly demonstrate that the F-actin cytoskeleton in human T 
cells has no role in SOCE. These results therefore contribute to our understanding of calcium 
signaling in cells of the immunesystem.
The second part of this thesis focuses on coronin 1, a member of the conserved WD repeat 
containing protein family which is encoded in mice (and human) by the gene coro1a. Coronin 
1, which is specifically expressed in leukocytes, was originally identified as a protein that is 
maintained around phagosomes containing live mycobacteria, thereby preventing the fusion 
of the mycobacterial phagosome with lysosomes and mycobacterial destruction.
The aim of this part of the thesis was to define the function of coronin 1 in immune cells by 
characterizing coronin 1 deficient mice with a special focus on T cell development, T cell 
receptor signaling, migration and survival as well as the proposed regulatory role of coronin 1 
in F-actin dependent processes. We found, in contrast to the long held dogma of coronin 1 
being a major regulator of the F-actin cytoskeleton, that coronin 1 regulates cellular signaling 
rather that F-actin modulation.
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Coronin 1 was shown to interact with phospholipase C  (PLC  thereby being an
important regulator of inositol-1,4,5-trisphosphate (IP3) generation from phosphatidylinositol-
4,5-bisphosphate (PIP2). The absence of coronin 1, although not affecting T cell development, 
resulted in a profound defect in Ca2+ mobilization, interleukin-2 (IL-2) production, T cell 
proliferation and T cell survival in naïve T-cells.
Finally in the last part of this thesis we provide data showing that coronin 1 maintains the 
balance between survival and apoptosis in naive T cells independent of F-Actin via a 
calcium/calcineurin dependent pathway.
The data presented in part two and three of this thesis establish the leukocyte specific protein 
coronin 1 as an essential regulator of T cell receptor signaling as well as naïve T cell 
homeostasis and survival. This work refutes the proposed role of coronin 1 in the regulation 
of the F-actin cytoskeleton, instead providing evidence for coronin 1 being a central regulator 
of Ca2+-dependent signaling in T cells. The work described here further offers new 
possibilities for the development of compounds for the treatment of T cell mediated disorders 
of the immunesystem.
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1. INTRODUCTION
1.1. The immune system
The immune system is a network of cells, tissues and organs which work in concert to defend 
our body against foreign invaders such as viruses, bacteria, fungi and parasites. The human 
body offers nutrient rich niches with optimal growth conditions for many microbes, and 
therefore microbial organisms, including many pathogens, continuously try to breach the 
body’s defense system. 
In an optimal scenario, physical barriers such as the skin and mucosal membranes, prevent 
foreign microorganisms from entering our body. However, if this first line of defense fails,
the immunesystem needs to seek out the invaders and eliminate them. In doing so, the 
immunesystem has to ensure that it distinguishes between the body’s own cells -“self”- and 
foreign structures or cells -“nonself”-.
If the immunesystem mistakes self for nonself and launches an attack against the body’s own 
cells this often results in autoimmune diseases such as lupus erythematodes or diabetes.
Another example where the immune system fails us are responses against harmless foreign 
substances such as pollen allergen resulting in allergy. Anything that can induce an 
immunresponse is termed an antigen. This can be a virus, a microbe, a recombinant protein in 
a vaccine or tissue from another person (except for genetically identical individuals) in the 
case of an organ transplantation.
In the following sections different organs, cell populations and signaling mechanisms that are 
important for the proper functioning of the immunesystem and in particular T lymphocytes 
will be discussed.
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1.1.1. Physical barriers
Our first line of defense against invaders is a physical barrier, mainly comprised of the skin 
and the mucosal membranes. Skin acts as a mechanical barrier, that in addition is equipped 
with a low pH of 3-5, retarding microbial entry and growth. The normal flora of the mucous 
membranes competes with invading microbes for attachment and nutrients. It also entraps 
foreign microorganisms in the mucus which are then propelled out of the body by the cilia.
Normal body temperature already inhibits growth of some bacteria, whereas fever responses
block the growth of many invading pathogens. Furthermore, most pathogens that are ingested 
are killed by the acidic pH of the stomach [1].
1.1.2. The organs of the immunesystem
The organs of the immune system, referred to as lymphoid organs, are positioned throughout 
the body. There are primary as well as secondary lymphoid organs. The bone marrow, which 
is a primary lymphoid organ, is the ultimate source of all blood cells, including white blood 
cell precursors destined to mature into immune cells. The second primary lymphoid organ is 
the thymus in which lymphocytes known as T lymphocytes or T cells mature.
The secondary lymphoid organs, tonsils, lymph nodes, appendix, peyer’s patches and spleen 
are all locations where cells of the immune system can meet each other as well as get into 
contact with their cognate antigen. There are only few T and/or B cells, specific for a given 
antigen (a few thousand). The antigen in addition might not even be accessible for T and/or B 
cells as they often cannot enter the tissues or organs where the foreign antigens are to be 
found. The body therefore contains the so called lymphatic system. This system is not under 
pressure such as the vascular system, bur merely drains the fluid (lymph), which leaks from 
our blood vessels into the surrounding tissue. The collected lymph is transported mainly by 
muscle contraction and a series of one-way valves to the upper torso where it reenters the 
vascular system. On its way back to the blood the lymph passes through the lymph nodes 
(secondary lymphoid organs). Cells of the immunesystem are retained in the secondary 
lymphoid organs for a limited amount of time which allows them to get in contact with 
antigens presented on so called antigen presenting cells (APCs, these will be discussed in 
- 15 - 
 
more detail below) or antigens such as viruses and bacteria carried there by the lymph. 
Immune cells such as T cells, B cells and APCs accumulate in secondary lymphoid organs,
where they are brought in close contact with antigens to increase the probability that a 
particular (nonself) antigen is met by a T and/or B cell carrying its cognate receptor. In 
addition the stroma network in secondary lymphoid organs which is composed of cells and 
fibers generates an appropriate microenvironment for cell-cell interactions. The secondary 
lymphoid organs are thus an important integral part of the adaptive immunesystem and
essential for the generation of efficient immunresponses. A schematic outline of the 
distribution of some lymphoid organs is provided below (Figure 1).
 
Figure 1:
The distribution of lymphoid tissues in the body (Adapted and modified from [1])
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1.1.3. The innate immune system: an overview
As mentioned above, the first line of defense against invaders is comprised of the skin and the 
mucous membranes of the body. If this defense system is breached the second line of defense,
the so called innate immune system, takes over. The innate immune system, besides being
based on a number of relatively unspecific components that are effective against a variety of 
pathogenic organisms, such as the complement system, opsonins and other enzymatic
mediators, relies heavily on professional phagocytic cells, namely macrophages and 
neutrophils. These phagocytic cells can internalize almost any kind of antigen, including 
soluble as well as particulate forms via receptor mediated endocytosis, phagocytosis and 
macropinocytosis [2-4]. Expression of specific surface receptors, also known as pattern 
recognition receptors (PRR), allows them to recognize invading microorganisms. Pattern 
recognition receptors such as the toll-like receptor (TLR) recognize so called PAMPs 
(Pathogen-Associated Molecular Patterns). PAMPs are molecular structures, especially of 
prokaryotes, which are shared by many related pathogens. They are relatively invariable and 
are not present in the host organism [5, 6]. Examples are the flagellin of bacterial flagella, the 
peptidoglycan of gram-positive bacteria, the lipopolysaccharide (LPS) of gram-negative 
bacteria, double-stranded RNAs and unmethylated CpG DNA [7, 8].
PRRs can be subdivided in three groups; (i) Secreted molecules that circulate in blood and 
lymph. (ii) Surface receptors that bind pathogens, initiating a signal leading to the release of 
immunostimulatory molecules (cytokines) such as the previously mentioned toll-like 
receptors. (iii) Finally surface receptors on phagocytic cells that bind pathogens, resulting in 
their uptake and subsequent degradation in the microbacterial milieu of the lysosomes.
Some pathogens, however, have evolved sophisticated survival strategies allowing them to 
invade the host, despite the efficient inborn defense mechanisms of the innate immune 
system. This is probably the main reason why vertebrates do not only have an innate immune 
system, but during the long process of co-evolution with pathogens, have evolved defense 
mechanisms that constitute adaptive immunity. The key players of adaptive immunity will be 
discussed in the following sections.
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1.1.4. The adaptive immunesystem: an overview
Vertebrates depend on the innate immune system as a first line of defense, but they can also 
mount another type of defense, called adaptive immune responses. The adaptive immune 
responses provide the vertebrate immune system with the ability to recognize, eliminate and
remember essentially every pathogen derived antigen and to mount an effective attacks each 
time the pathogen is encountered. The innate immunesystem and in particular the professional 
phagocytic cells, which have the ability to present antigens to cells of the adaptive 
immunesystem and provide co-stimulatory signals, work in concert with the adaptive immune 
responses to eliminate the pathogens. Unlike the innate immune responses, that only 
recognizes general PAMPs, the adaptive responses are highly specific for the 
antigen/pathogen that induced them. Recognition of antigens by the adaptive immune system 
is based on membrane bound cell-surface receptors of the immunoglobulin super family. A 
large variety of receptor specificities that in principle are able to recognize almost every 
structure on foreign antigens, is generated by somatic rearrangements of germ line encoded 
gene segments that code for the antigen binding regions of those receptors [9]. This already 
huge diversity becomes even more diverse in B cells and the antibodies they secrete during 
affinity maturation of effector B cells by a process termed somatic hypermutation [10].
Somatic hypermutations are only generated in the hypervariable regions of the antigen 
receptors which directly bind the antigen. This whole maturation process is termed clonal 
selection. During clonal selection, cells which display the highest affinity towards an antigen 
are selected and proliferate in order to mount an immune response against the pathogen 
carrying this antigen. This necessity of selection, proliferation and maturation causes a lag 
phase of several days, only after which the pathogen specific cells of the adaptive 
immunesystem can participate in the elimination of the pathogen. Until then it is up to the 
innate immune system to either already eliminate the intruder or at least keep it under control
until the adaptive immune cells have multiplied and matured into effector cells. In contrast to 
the innate immune system, the adaptive immune system has a long term memory in the form 
of memory cells that can be reactivated if the same pathogen attacks again. In this case the 
immune response is faster and more efficient than during the initial infection.
Because the responses of the adaptive immunesystem are destructive and can be detrimental 
for the vertebrates body it is crucial that they be made only in response to antigens that are 
foreign to the host. The ability to distinguish between foreign and self is a fundamental 
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feature of the adaptive immunesystem. Occasionally, the system fails to make this distinction 
and reacts against the host’s own antigens, resulting in the potentially fatal condition of 
autoimmunity. The immunesystem thus has evolved mechanisms to either destroy potentially 
auto reactive cells of the adaptive immunesystem or render them non responsive, a state 
which is also referred to as anergy. Such inappropriate responses are normally avoided as the 
innate immunesystem only calls into action the adaptive immune cells when it recognizes 
molecules characteristic of invading pathogens, such as PAMPs. 
Lymphocytes, the cells of the adaptive immune system, are subdivided into B and T cells. B
cells are able to secrete a soluble version of their otherwise membrane bound antigen receptor, 
which is antigen specific and in its soluble from referred to as antibody. Antibodies are the 
major effectors of the adaptive, humoral immune responses. They recognize the antigen for 
which they are specific, in its native, three dimensional structure. Antibodies can either 
neutralize the antigen as in the case of toxins, opsonized antigen and as such mark it for 
phagocytosis, activate the complement system or induce ADCC (Antibody-Dependent Cell-
Mediated Cytotoxicity) [11, 12].
Antigen recognition by T cells is central to the generation and regulation of effective adaptive 
immune responses. Unlike B cells or soluble, circulating antibodies, T cells are not able to 
recognize free antigens. They can only recognize antigenic peptides which are bound and 
presented by specialized antigen presenting molecules. The most important group of those 
molecules is represented by the MHC (Major Histocompatibility Complex) class  and 
molecules that present polypeptides to different subsets of T cells, depending on the origin of 
the polypeptide. Other classes of antigen presenting molecules exist, such as the CD1
molecules involved in the presentation of lipids and glycolipid antigens [13, 14].
T cells are subdivided into two functionally distinct populations, the CD8 and the CD4 
expressing T cells which recognize antigenic peptides presented on MHC class I respective 
MHC class II. Antigen recognition on MHC class I induces effector CD8+ T cells to rapidly 
kill the antigen presenting cell by either secretion of perforin and granzym or surface 
expression of apoptosis inducing molecules such as the Fas-ligand [15]. In the case of an 
infection, pathogens residing within in the cytosol are thereby either directly killed alongside 
with the infected cell or released into the extracellular space, where they can be targeted by
the complement system and other humoral defense systems or opsonized by anybodies which
render infectious agents non infectious and/or mark them for destruction by phagocytes [16].
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derived from pathogens taken up and processed via the endocytic system. Activated CD4+ T
cells produce cytokines that activate cells such as macrophages, helping these to kill 
phagocytosed or intracellular pathogens [17]. CD4+ T cells further help B cells to differentiate 
into plasma cells and produce antigen specific antibodies, and hence are referred to as T 
helper cells [18]. In the following section the different antigen processing and presentation 
pathways will be discussed in more detail.
1.1.5. MHC molecules and antigen presentation
T cells can only recognize antigen in form of antigen derived fragments (peptides) that are 
bound and presented by MHC (Major Histocompatibility Complex) class  and  molecules. 
As a rule MHC class I molecules display intracellularly derived peptides, whereas MHC class 
II molecules present peptides originating from extracellularly present antigens. MHC class I 
molecules are expressed on all nucleated cells, whereas MHC class II molecules are restricted 
to a set of specialized cells, termed antigen-presenting cells (APCs). APCs, which will be 
discussed in detail later, comprise a subset of cells such as dendritic cells, macrophages and 
activated B cells. Depending on the source of the antigen two different antigen processing 
pathways are employed to load antigenic peptides onto the two classes of MHC molecules. 
This loading process determines to which T cell subsets an antigen will be presented as well 
as the type of the immunresponse that will be mounted against the antigen.
1.1.5.1. Class I MHC molecules
The two classes of MHC molecules serve different functions in antigen presentation, binding 
peptides from different intracellular sources and activating different T cell subsets. These 
functional differences are reflected by their differential distribution on the body’s cells as well
as in their structure.
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Figure 2 
The structure of the MHC class I molecule. A) Computer graphic of the human MHC class I X-ray structure 
without the transmembrane domain. B) and C) show a ribbon diagram of the structure whereas panel D) shows a 
schematic outline of the MHC I molecule. The molecule is displayed as a membrane spanning heterodimer with 
#
 
$	
 			% & chain (43 kDa) and the non covalently bound '2-microglobulin chain (12 kDa).
(Adapted and modified from [1])
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The structure of the MHC class I molecule is outlined in Figure 2. The MHC class I molecule 
is composed of (
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 &1 	 &2 domains form the peptide binding cleft on the 
surface of the MHC class I molecule [19-21]. They are also sites of polymorphisms which 
determine T cell antigen recognition.
1.1.5.2. Class II MHC molecules
The MHC class 
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made up of two domains, one being a transmembrane domain. Both chains are encoded in the 
MHC locus. The overall folding of the MHC class II molecules resembles that of the above
described MHC I molecule. The major difference lies at the end of the peptide binding cleft 


#
&1 	'1 domains in case of the MHC class II molecule (Figure 3) [22-24].
The cleft is more open in the MHC class II molecule compared with the MHC class I
molecule. As a consequence, the ends of a peptide presented on MHC class I are mostly 
buried within the molecule whereas this is not the case for peptides presented on MHC class 
II. Another consequence is the maximal length of the bound peptide. MHC class I binds short 
peptides of 8-10 amino acids, whereas peptides which are bound to MHC class II are at least 
13 amino acids long, but can be much longer and contain anchoring sites at various distances 
from the end of the peptide. These differences in peptide binding properties and peptide 
length reflect the different antigen processing pathway by which peptides are generated and 
loaded on MHC class I respectively MHC class II molecules. Antigen processing and MHC 
loading will be discussed in the following section.
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Figure 3:  
The structure of the MHC class II molecule. A) Computer graphic of the human MHC class II X-ray structure 
without the transmembrane domain. B) and C) show a ribbon diagram of the structure whereas panel D) shows a 
schematic outline of the MHC II molecule. The molecule is compose of two transmembrane glycoprotein chains, 
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structure similar to that of the MHC class I molecule. (Adapted and modified from [1])
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1.1.5.3. Antigen presentation by MHC class I molecules
MHC class  molecules present peptides that have been generated from antigens processed in 
the cytoplasm by the proteasome. The proteasome is a large multi subunit protein complex 
with proteolytic activity. It is responsible for the degradation of proteins that have been 
marked for destruction by mechanisms, such as ubiquitination [3, 25]. The peptide fragments 
are transported from the cytosol into the ER (endoplasmic reticulum) where they are loaded 
onto MHC class  molecules. The sources of proteasome substrates are diverse and include 
endogenous or viral proteins present in the cytosol as well as incorrectly folded or truncated 
proteins and proteins retro-translocated from the endoplasmic reticulum to the cytosol [26].
Besides the proteasome, that mainly acts on ubiquitinated protein substrates, other proteases 
may play a role in antigen processing [27] Following antigen processing by the proteasome,
the antigenic peptides are then translocated into the ER lumen by the hetero-dimeric 
transporter TAP1/TAP2 which is also encoded in the MHC locus and located in the ER 
membrane. TAP is a member of the large ATP binding cassette (ABC) family of transporters
[28]. The partially assembled MHC class I molecules in the ER lumen are associated with 
chaperones such as calnexin, calreticulin and ERP57, which aid in the assembly of stable 
MHC class /peptide complexes. Another MHC encoded protein termed tapasin is believed to 
bridge TAP and the empty MHC class  molecule waiting to be loaded with a peptide. MHC
class  molecules lacking a strong peptide interaction are unstable, ensuring that only 
functional complexes are found on the cell surface. Stable MHC/peptide complexes are
transported to the cell surface via the exocytic pathway [29]. Multiple alleles for MHC 
proteins exist which comprise different binding properties compensating for the fact that only 
a minority of the generated peptides can fit into the cleft of a given MHC class I molecule.
The MHC class /peptide complexes present at the cell surface are constantly checked by
CD8+ cytotoxic T cells, which once they recognize a viral, bacterial or otherwise nonself 
peptide, presented on a MHC class I molecule, kill the nonself peptide bearing target cell. 
Killing is carried out by secretion of perforin/granzym or surface expression of the Fas ligand, 
both of which induce apoptosis in the target cell [15]. By destroying the infected cell, the 
pathogen is either destroyed together with its host cell or is set free to be opsonized by 
antibodies, recognized by pattern recognition receptors and internalized by phagocytic cells 
such as macrophages or neutrophils. Antigen processing for presentation on MHC class I, as 
described above, is schematically depicted below in Figure 4 (left side).
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Figure 4: 
Separate antigen presenting pathways are utilized for endogenous (green) and exogenous (red) antigens. The 
mode of antigen entry into cells and the site of antigen processing determine whether antigenic peptides 
associate with class I MHC molecules in the rough endoplasmatic reticulum or with class II molecules in 
endocytic compartments. (Adapted and modified from [30])
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1.1.5.4. Antigen presentation by MHC class II molecules
MHC class I molecules present peptides that have been generated from antigens engulfed by 
phagocytic cells such as dendritic cells and macrophages and processed in the endocytic 
pathway. MHC class  &- and '-chain are bound to a polypeptide termed the invariant chain 
while in the ER. This complex is transported via the Golgi apparatus to acidic endosomal or 
lysosomal compartments. These compartments which are also referred to as MHC class 
compartment (MC) are specialized for the transport and loading of MHC class  molecules 
with peptide derived from extracellular antigen bearing sources such as bacteria, soluble 
factors and worms [31-35]. During this transport process the invariant chain is cleaved into 
smaller peptides, one of which, termed CLIP (class  associated invariant chain peptide), 
stays bound to the antigen binding pocket of the MHC class  molecule until it is replaced 
with antigenic peptides destined for presentation on the cell surface [36-38]. Thus, in contrast 
to MHC  molecules that are loaded with peptide while still in the ER, MHC class 
molecules are only loaded after passaging through the Golgi network, within the MHC class 
II compartment.
Exchange of the CLIP fragment for other peptides is facilitated by a MHC class -related 
chaperone molecule called H2-M (HLA-DM) [39-41]. Once the MHC class  has formed a 
stable complex with a peptide it is transported to the cell surface, where it is recognized by T
cell receptors present on CD4+ T cells [42].
MHC class  molecules are mainly expressed on the surface of professional antigen 
presenting cells, such as macrophages, neutrophiles, dendritic cells and B cell but can be 
induced by interferon- (IFN-) stimulation on many cell types [43].
The CD4+ T cell population that recognizes MHC class II/peptide complexes on the cell 
surface of antigen presenting cells can be further subdivided into subsets such as TH1- and 
TH2-cells. This subdivision if based on the fact that recognition of MHC class /peptide
complexes on the cell surface of phagocytic cells can induce different cytokine secretion
patterns. Cytokine production by T cells influences the type of immune response induced by a
given antigen. The TH1 subclass secretes cytokines that aid professional phagocytes in their 
anti-microbial activity and hyper activates them, whereas TH2 cells mainly help to initiate and 
regulate antibody based immune responses [18]. Antigen processing for presentation on MHC
class II, as described above, is schematically depicted in Figure 4 (right side).
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Besides the thus far described classical mechanisms of MHC class I or II ligand generation, 
an alternative route for the generation of MHC class I bound peptides exists which is referred 
to as cross-presentation pathway [44]. Cross-presentation was first described in 1976 [45]. It 
has two physiological outcomes. It can either lead to induction of tolerance against peripheral 
antigens [46, 47] or to stimulation of CD8+ T cells. In the latter case, it ensures the generation 
of anti viral immune response when the professional antigen presenting cells (APCs) are not 
infected by the virus itself [48, 49] or when the virus interferes with the ability of professional 
APCs to activate T cells [50-52]. Importantly, cross-presentation has also been implicated in 
the induction anti-tumor immune responses [53, 54]. Cross-presentation of exogenous 
antigens can be induced in dendritic cells by inflammatory compounds [55-57], by Fc
receptor signaling [58], or by CD4+ T-cells [59], raising the question of whether cross-
presentation is regulated similar to the presentation of MHC class II restricted antigens during 
DC maturation. In these cells, class II molecules are rapidly internalized and recycled for 
reloading with peptides. [60, 61]. The mechanisms underlying this regulation are not well 
understood. Enhancement of cross-presentation might be achieved by shifting the proteasomal
activity from endogenous to exogenous protein processing [62], by recruitment of MHC class 
I molecules to “cross-presentation” compartments [63] or “leakiness” of the MHC class II 
compartments which would allow access of otherwise MHC II restricted peptides to the 
cytosol and thus to the MHC I processing pathway. Further investigations are necessary to 
completely understand how cross-presentation is regulated in vivo.
1.1.5.5. Antigen presenting cells
Dendritic cells, macrophages and B cells are referred to as professional antigen-presenting
cells as they process endogenous and exogenous antigens for the loading on MHC molecules 
and have the unique ability to stimulate naïve T cells. Stimulation of naïve T cells upon their 
first encounter with an antigen requires an additional signal delivered by the APC [64].
Professional APCs therefore express high levels of co-stimulatory molecules of the B7 
family, which act on T cell receptor associated surface molecules such as CD28 and CTLA-4.
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1.1.5.6. Dendritic cells
Dendritic cells (DCs) are regarded as the antigen presenting cells most efficient in the
activation of naïve T cells [33, 65]. This has been demonstrated in mice lacking DCs which 
display severe defects in the initiation of adaptive immune responses [66]. DCs are present to 
a large extend in tissues such as the skin and are mostly present in an immature state. Similar 
to macrophages, immature DCs internalize a broad range of antigens via specific and 
unspecific uptake mechanisms. Stimulation by cytokines or bacterial components causes DCs
to migrate from the periphery to the draining lymph nodes, where they come in contact with 
naïve T cells that are located in the so called T cell zones [67, 68]. During these migratory 
processes DCs differentiate into professional antigen presenting cell, so called mature DCs.
This maturation process involves various phenotypical changes and is accompanied by down 
regulation of the endocytic capacity, up regulation of co-stimulatory molecules, enhanced 
antigen processing as well as transport of MHC/peptide complexes to the cell surface [69-72].
Different DC subsets exist in vivo, which are generally classified by their tissue distribution 
and surface marker expression [73, 74].
1.1.5.7. Macrophages
Macrophages such as myeloid dendritic cells and osteoclasts belong to a family of cells 
termed mononuclear phagocytes. The mononuclear phagocytes share common hematopoietic
precursors that are distributed to all tissues of the body via the blood stream as monocytes. 
Once monocytes have entered the tissues they differentiate into the various cell types 
mentioned above. Most macrophages become and remain efficient phagocytes throughout 
their live. Macrophages possess a high endocytic capacity, which accounts for their important 
role in clearance of invading microorganism during the early phase of a host anti-pathogen 
response [75]. They can internalize almost any kind of antigen, including soluble as well as 
particulate forms, both via specific and non-specifically pathways. Both classes of MHC 
molecules are expressed on macrophages together with co-stimulatory molecules required for 
the priming of naïve T cells. However these molecules and in particular the MHCs are 
expressed at significantly lower levels on macrophages when compared to dendritic cells [76].
Even upon activation of macrophages by cytokines or microbial products such as LPS that 
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results in the up regulation of MHC and co-stimulatory molecules the expression levels do not 
reach those found on DCs. This may explain why macrophages both in vivo as well as in vitro
were found to be less efficient antigen presenting and T cell activating cells as compared to
DCs [65, 77, 78].
1.1.5.8. B cells
Antigen presentation in B cells is linked to their function as antibody secreting plasma cells 
and surface expression of the antigen specific B cell receptor (BCR). Upon binding of 
antigens, B cells internalize these together with the BCR and process them via the MHC class 
II pathway [79].
1.1.6. T cells
T cells belong to a group of white blood cells referred to as lymphocytes. They can be 
distinguished from other lymphocytes, such as B cells, by the presence of a T cell specific 
surface receptor called T cell receptor (TCR) (see Figure 6). The abbreviation T, in T cell 
stands for thymus, since the thymus is the principal organ in which precursors from the bone 
marrow develop and mature into T cells. TCRs come in two different flavors: &'	4Over 
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1.1.6.1. T cell development
T cells are derived from hematopoietic stem cells in the bone marrow. Early T cell precursors 
migrate to the thymus where they develop into T cells. The thymus is the primary lymphoid 
organ where T cells are generated [80]. The thymus can be divided into an outer cortex, where 
most of the differentiation takes place, and an inner medulla, where newly formed cells 
undergo final maturation before leaving the thymus and seeding peripheral lymphoid organs
[81]. Despite being an integral part of the hematopoietic system, the thymus does not contain 
self renewing hematopoietic stem cells. That is why the thymus needs to be continuously 
seeded by small numbers of progenitor cells from the bone marrow, which travel via the 
blood stream, entering the thymus at the cortex-medulla boundary [82]. T cell development is 
not driven cell autonomously but relies on signals from non hematopoietic stroma cells such 
as thymic epithelial cells and mesenchymal fibroblasts as well as antigen presenting cells such 
as dendritic cells [83]. The thymic stages of T cell development, also referred to as 
thymocytes, reside in distinct anatomical niches within the thymus that provide the 
appropriate differentiation signals. During their development thymocytes migrate through 
these defined thymic sub-regions.
Figure 5: 
In this scheme T cell development from less to more mature cells proceeds from left to right. The alternative 
nomenclature (double negative, DN) is included for comparison. Gene rearrangements are shown boxed in red 
and the cell surface phenotype of each subpopulation is shown below it. Fluorescence intensity, as measured by 
flow cytometry on an arbitrary scale from negative (-) through low to very bright (+++) , is indicated for each 
marker. D, diversity; DP, double positive; ISP, immature single positive; J, joined; RAG, recombination-
activation gene; SCID, severe combined immunodeficiency; SP, single positive; TCR, T-cell receptor. (Adapted 
and modified from [84])
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Thymocyte development can be tracked by measuring surface expression of developmental 
markers as well as co-receptors as described in Figure 5, using flow cytometry. The earliest T 
cell precursors found within the thymus are negative for both CD4 as well as CD8 and are 
thus referred to as double negative (DN) thymocytes. Depending on their developmental stage 
they can be further subdivided into DN1 (CD3-, CD25-, CD44+++, CD117+++), DN2 (CD3-,
CD25++, CD44+++, CD117+++), DN3 (CD3low, CD25++, CD44+, CD117+) and DN4 (CD3low,
CD25-, CD44low, CD117low) [84]. Alongside thymocyte development, rearrangement and 
expression of the TCR genes occurs. The first crucial check point for efficient rearrangement 
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has been successful and the pre-TCR is signaling competent, thymocytes can proceed in their 
development. They will then 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co-receptors CD4 and CD8, developing in CD4/CD8 double positive (DP) thymocytes [85].
As soon as a functional &' TCR is expressed, DP thymocytes are subjected to a positive and a
negative selection process resulting in the elimination of cells which are inefficient in binding 
MHC/peptide complexes or potentially self reactive [86, 87]. During this selection process a 
given TCR interacts with peptide loaded MHC molecules present on the surface of thymic 
epithelial and/or dendritic cells [88]. The resulting signals a DP thymocyte receives via its 
TCR decide on live or death. If the interaction with the MHC/self-peptide complexes is too 
weak, meaning that the TCR cannot efficiently interact with the MHC (see below),
thymocytes die by “neglect”. Conversely if the signal is too strong, thymocytes undergo 
apoptosis ensuring the removal of potentially self reactive TCRs [89]. The two lineages of T 
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 &-CPM, thymocytes were blocked in 
positive selection but could undergo negative selection [90, 91]#* #
&-CPM seems to 
participate in the generation of signals required for positive selection, a process that seems to 
include the cooperation of the TCR with CD4/8 co-receptors. [91-93]. Those cells which 
survived the selection process continue their development into self restricted CD4 or CD8 
single positive (SP) thymocytes. Mature SP thymocytes migrate out of the thymus into the 
periphery, where they populate the peripheral lymphoid organs waiting to encounter their 
cognate antigens.
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1.1.6.2. The T cell receptor
The T cell receptor is a disulfide linked heterodimer complex of membrane bound 
polypeptide chains. Similar to the rearrangement and assembly of B cell derived antibody 
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chains are assembled from V, D, J and C gene segments by means of somatic recombination
[9]. Each TCR chain has a highly variable domain which contains three complementarily 
determining regions (CDRs), responsible for the specificity of TCR binding. The mechanisms 
responsible for the generation of T cell receptor diversity, such as imprecise end-joining of 
recombined gene fragments, are essentially the same as the ones which are active for 
immunoglobulin generation. One exception are somatic point mutations, generated through 
somatic hypermutation during affinity maturation, which are usually not observed in case of 
TCRs. Despite the huge diversity observed in the variable regions of the TCR, the constant 
regions (C) are the same throughout a single species. They are made up of an extracellular 
domain consisting of an immunoglobulin like domain and a connecting peptide. In case of the 
& #	 #
 
		
	% 

 
		 #
 #%#") 
	
+
 &-chain connecting peptide 

,&-CPM), which was previously mentioned in the context of thymic development and 
positive selection. The TCR chains are anchored in the plasma membrane by a 
transmembrane region which links the extracellular domains with short cytoplasmatic tails. 
As these intracellular regions seem to contain no signaling domains, the TCR heterodimer has 
to tightly associate with accessory proteins such as the CD3 complex, in order to transduce 
signals from the outside to the inside of a T cell [94, 95]. The CD3 complex is comprised of 
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chains [96]. All CD3 chains contain at least one so-called immunoreceptors tyrosin-based 
activation motif (ITAM) (Figure 6)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chains to intracellular Src tyrosin kinases such as Lck and Fyn [97, 98].
Two other molecules that are also closely associated with the TCR are the co-receptors CD4 
and CD8, mentioned before in the context of antigen presentation by MHC molecules. T cells
express either CD4 or CD8 which are associated with Lck (or Fyn), Src family tyrosin kinases 
(SFKs), via their cytoplasmatic domain [98]. In case of an unstimulated TCR, the associated 
kinase is inactivated by phosphorylation on a C-terminal tyrosin residue (catalyzed by the Csk
kinase). Upon contact of a TCR with peptide loaded MHC, the co-receptors bind to 
- 32 - 
 
monomorphic determinants on MHC class II respectively MHC class I. Binding of the MHC 
brings the CD4/8 co-receptor associated Src kinases in close proximity of the TCR and the
CD3 complex [99].
Figure 6:
Schematic representation of the T cell receptor (TCR) complex. The TCR is a covalently linked heterodimer 
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 ITAMs in the cytoplasmatic tails 
of CD3 chains provide docking sites for molecules such as ZAP-70 which will be discussed in detail later.
(Adapted and modified from [97])
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CD45, which is also part of the TCR complex, contains a phosphatase domain in its 
cytoplasmatic part, which upon receptor stimulation dephosphorylates and activates the Src
kinases [100]. The activated Src kinases Leukocyte-specific protein tyrosin kinase (Lck) 
phosphorylate the ITAMs of the CD3 chains [97]. Phosphorylated ITAMs provide docking 
sites for the Src Homology 2 (SH2) domains of <-chain-associated protein kinase of 70 kDa
(ZAP-70) [101], which upon binding is phosphorylated by Lck, allowing propagation of 
downstream signaling events (Figure 7), discussed in the next chapter.
Figure 7
Reciprocal regulation of SFKs by CD45 and Csk. Lck is in a dynamic equilibrium between its inactive and 
primed conformations due to the reciprocal activity of CD45 and Csk. While CD45 can dephosphorylate both 
autocatalytic and inhibitory tyrosines of SFKs, the latter is enzymatically favored. This generates a pool of 
signal-competent SFK. Primed Lck is able to undergo trans-phosphorylation of Y394 generating an active kinase 
that subsequently phosphorylates the ITAMs of the CD3 chains. The phosphorylated ITAMs provide docking 
sites for the SH2 domains of ZAP-70, which is then phosphorylated by Lck, allowing propagation of 
downstream signaling events. SFKs are inactivated by Csk-mediated phosphorylation of the negative regulatory 
tyrosine. (Adapted and modified from [102]).
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1.1.6.3. T cell receptor signaling
Upon T cell receptor engagement with MHC/peptide complexes and tyrosin phosphorylation 
of ITAMs in the cytoplasmatic regions of the CD3 chains, the phosphorylated ITAMs provide 
docking sites for the SH2 domains of ZAP-70 (see above), which upon binding is
phosphorylated by Lck [103], allowing propagation of downstream signaling events such as 
the phosphorylation of LAT (linker for activation of T cells) and SLP76 (SRC-homology-2-
domain-containing leukocyte protein of 76 kDa) that act as a platform for the recruitment of 
several key signaling molecules, including phospholipase C-1 (PLC-1). Lck also 
phosphorylates the TEC-family kinase ITK (interleukin-2-inducible T-cell kinase) which 
together with TEC is recruited to the plasma membrane through interaction of their pleckstrin 
homology (PH) domain with phosphatidylinositol-3,4,5-trisphosphate (PIP3). PIP3 is 
generated from phosphatidylinositol-4,5-bisphosphate (PIP2) by the action of 
phosphatidylinositol-3-kinase (PI3K) [104]. SHIP (SRC homology 2 (SH2)-domain-
containing inositol-5-phosphatase and PTEN (phosphatase and tensin homologue) can reduce 
the levels of PIP3, thereby decreasing membrane association and activation of certain TEC 
kinases [105-109]. ITK then forms a complex with several signaling molecules that is
nucleated by the adaptors LAT and SLP76 [110, 111]. Activation of the recruited PLC-1 by 
ITK mediated phosphorylation leads to the generation of inositol-1,4,5-trisphosphate 
(Ins(1,4,5)P3; IP3), which is required for the induction of Ca2+ fluxes within the cell, (see
below) and diacylglycerol (DAG), from plasma membrane resident phosphatidylinositol-4,5-
bisphosphate (PiP2). DAD in turn activates members of the protein kinase C (PkC) family and 
RAS guanyl-releasing protein (RASGRP) [112-114]. This cascade of events results in the 
downstream activation of mitogen-activated protein kinases such as JNK (JUN amino-
terminal kinase), ERK1 (extracellular-signal-regulated kinase 1) and ERK2 as well as
calcineurin and other effectors that direct gene transcription via dephosphorylation and 
nuclear translocation of NFAT and activation of the NF- #() [101, 115]. Signaling 
intermediates such as Ca2+, IP3 and DAG are crucial for the production of cytokines and the 
expression of activation markers by T cells [116]. In addition to activation by DAG, PKC-> is 
activated through the guanine nucleotide exchange factor VAV1 and Ras-related C3 
botulinum toxin substrate (RAC) mediated pathway [117-119]. The LAT-SLP76 complex 
also functions as a platform for the accumulation of molecules including VAV1, RAC, the 
serine/threonine kinase Akt, cell-division cycle 42 (CDC42), Wiskott-Aldrich syndrome 
protein (WASP), ARP2 (actin-related protein 2 homologue) and ARP3 that regulate the 
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polymerization of F-actin [120-123]. These molecules, together with other downstream 
effectors, control TCR-mediated T-cell polarization, adhesion and migration (Figure 8) [124,
125].
Figure 8:
Signaling via the T cell receptor (TCR) as described in the corresponding text section. Abbreviations: ADAP, 
adhesion and degranulation promoting adaptor protein; AP1, activator protein 1; GADS, GRB2 related adaptor 
protein; GRB2, growth-factor-receptor-bound protein 2; IB, inhibitor of NF-B; LAT, linker for activation of T 
cells; NCK, non-catalytic region of tyrosine kinase; NFAT, nuclear factor of activated T cells; NF-B, nuclear 
factor-B; PI3K, phosphatidylinositol 3-kinase; PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; 
PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; SLP76, SRC-homology-2-domain-containing leukocyte 
protein of 76 kDa; SOS, son of sevenless homologue; ZAP70, <-chain-associated protein kinase of 70 kDa. See 
also corresponding text section for further abbreviations. (Adapted and modified from [104])
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In addition to the CD3 complex and the CD4/8 co-receptors, other co-stimulatory molecules 
such as CD28 and the cytotoxic T lymphocyte antigen 4 (CTLA-4) are recruited to the TCR 
upon formation of the immunological synapse (will be described below). Depending on the 
expression of their ligand on the antigen presenting cell (APC), B7-1 also known as CD80 
(for CTLA-4) and B7-2 also known as CD86 (for CD28), subsequent downstream signaling 
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1.1.6.4. The immunological synapse, T cell activation and homeostasis
Cross-talk between receptor mediated signalling, cytoskeletal reorganization and directed 
transport of cell surface receptors was first shown in studies utilizing soluble antibodies 
directed against major components of the TCR complex to cross-link TCRs and other surface 
molecules for T cell stimulation. Crosslinking results in “capping”, an event characterized by 
assembly and redistribution of surface receptors, cytoskeletal elements and other molecules 
such as lipids towards one end of a stimulated cell [128]. Also immunofluorescense analysis 
of T cell - APC conjugates indicated a marked polarization of the T cell towards the APC. 
This polarization seemed to particularly involve the microtubule organizing centre (MTOC) 
which moved to a location underneath the synapse [129]. Using three dimensional 
visualization techniques scientists around A. Kupfer for the first time gained insight in the 
spacial organization of T cell - APC complexes. Key molecules such as the TCR and the 
adhesion integrin leukocyte function associated antigen 1 (LFA1) were found to be polarized 
at the T cell - APC interface and organized in and restricted to distinct regions within the 
immunological synapse. These regions were termed supra-molecular activation complexes 
(SMACs) (Figure 9). The central region of the SMAC (cSMAC) is enriched for the TCR, 
CD3, CD45 (CD45 enters cSMAC only at a later stage) complex, the co-stimulatory 
molecules CD28 and CTLA-4 as well as for downstream signaling effectors of the TCR 
%	"	%
"
5#?> Cell adhesion and contact formation with the APC seems 
to be primarily mediated by the peripheral ring structure which surrounds the cSMAC (called 
the pSMAC). This region is enriched for molecules such as leukocyte function associated 
antigen 1 (LFA1), CD4/8 and talin. Large and bulky molecules such as CD43, CD44 and 
most of CD45 (especially at early stages of synapse formation) were confined to an area distal 
to the synapse, outside the pSMAC, which is known as the dSMAC [130-132]. Recently it has 
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been proposed that the cSMAC is the site of both TCR signal enhancement as well as TCR 
degradation and that the balance between these adverse processes is determined by the quality 
of the antigen, such that the cSMAC can serve as an amplifier for weak agonist signals and 
integration of co-stimulatory signals (Figure 9) [133, 134].
The precise role of the different SMAC regions remains controversial. It is however now 
widely accepted that the initiation of TCR signals occurs in peripheral microclusters which 
are assembled prior to the formation of the immunological synapse (IS). Ligation of TCRs 
with MHC/peptide complexes initiates the formation of these microclusters which contain the 
TCR complex and associated signaling molecules (see previous chapter) such as LAT, SLP-
76 and ZAP-70. These clusters initiate as well as sustain calcium signals in T cells (Calcium 
signaling in T cells will be discussed in detail below) [135, 136]. After a short time these 
clusters converge towards the cSMAC. The formation as well as the translocation of these 
clusters depends on cytoskeletal dynamics and continues even after the IS has been 
established. The importance of integrins in T cell activation is emphasized by the key role 
they play in establishing the IS and maintaining it [137-139]. Sustaining TCR ligation and 
signaling may help to maintain transcription factors such as NFAT in the nucleus where they 
initiate specific transcriptional programs [140].
TCR signal induction and propagation are driven by rapid biochemical reactions which either 
induce or amplify the physical connection and catalytic activity of TCR/IS signaling 
components. Regulatory mechanisms that oppose these reactions guarantee appropriate 
responses to external stimuli by controlling or stopping the signals generated in response to 
these stimuli. Phosphorylation and dephosphorylation are the fastest and most versatile means 
of regulating signal progression, although other protein modifications such as ubiquitination 
and de-ubiquitination as well as lipid modifications contribute to the net signal outcome 
[141].
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Figure 9: 
A) A profile view showing a selection of the key ligand pairs and signaling molecules that are involved in 
immunological synapse (IS) formation. The stimulatory peptide/MHC complex is shown in red, activating/co-
stimulatory molecules are blue, inhibitory molecules are yellow and molecules that are not contributing to 
signaling are grey. The arrow indicates converging signals that lead to T cell activation. B) The face on view of 
the synapse with the characteristic 'bulls-eye' zone pattern, including the central region of the supra-molecular 
activation complex (cSMAC) (yellow), the peripheral ring surrounding the cSMAC (pSMAC, green) and the 
region distal to the synapse outside the pSMAC (dSMAC, grey) as well the molecules/ligand pairs that are found 
enriched within. APC, antigen-presenting cell; CTLA4, cytotoxic T lymphocyte antigen 4; ICAM1, intercellular 
adhesion molecule 1; LFA1, leukocyte function-associated antigen 1; PI3K, phosphatidylinositol 3-kinase; 
SHP2, SRC homology 2-domain-containing protein tyrosine phosphatase 2; TCR, T-cell receptor; ZAP70, <-
chain-associated protein 70. *CD45 enters the cSMAC at later stages. (Adapted and modified from [130]).
1.1.6.5 T cell homeostasis and termination of immunresponses
Besides the need for controlling the underlying biochemical reactions, regulation of T cell 
responses also takes place on the cellular level to appropriately fine-tune immunoreactions.
Maintenance of cellular homeostasis in the face of rapid and dynamic alterations in 
lymphocyte populations upon infections and avoidance of autoimmune responses to self-
antigens requires tight and effective mechanisms to prevent and/or terminate lymphocyte 
reactions. Homeostasis of the immunesystem is ensured by maintaining a continuous balance 
between positive (activating) and negative (inhibiting) signals as well as the lack of certain 
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signals. The mechanisms that govern these processes fall into two categories. On the one hand 
the loss or absence of co-stimulatory signals and stimuli that provide growth and survival 
signals leads to functional inactivation, failure of initiating an effective immunresponse or 
programmed cell death. On the other hand lymphocyte activation on its own triggers 
regulatory systems which control lymphocyte proliferation, differentiation as well as 
apoptosis. Lymphocyte activation requires two signals, the first one being delivered by the 
antigen whereas the second one is provided by the APC in the form of a co-stimulatory signal 
[142]. During an infection the innate immune responses are triggered by molecules and 
molecular patterns present on the invading pathogens which are recognized by receptors such 
as the LPS receptor (CD14) and receptors of the Toll-like receptor (TLR) family which leads 
to the up-regulation of co-stimulatory molecules and enables them to efficiently activate T 
cells [143]. Self-antigens may be ignored by the immune system largely because the self 
reactive T cells have been deleted during thymic selection. In addition self-antigens mostly 
fail to initiate innate immuneresponses that are required for T cell activation. Activated innate 
immune cells provide the required co-stimulatory signals for T cell activation and effector 
function. Foreign antigens administered without an adjuvant in case of a vaccination may fail 
to initiate effective immuneresponses as the adjuvant is needed to efficiently activate innate 
immuneresponses. Omitting the adjuvant may even induce tolerance instead, a concept which 
is currently tested in clinical trials, which have the goal of preventing organ transplant 
rejection and to eliminate auto-immuneresponses. Antigen recognition by lymphocytes 
without a second signal can lead to a state of functional unresponsiveness, referred to as 
anergy [144, 145]. Some early studies actually suggest that T cell anergy, at least in some 
models, may be actively induced rather than being a result of missing co-stimulation.
According to these studies anergy is induced because T cells use the inhibitory cytotoxic T 
lymphocyte antigen-4 (CTLA-4) receptor to engage co-stimulatory B7 molecules on the APC 
rather than CD28 [146, 147]. CTLA-4 and its importance in the active termination of 
immuneresponses will be discussed in more detail below.
The frequency of antigen specific T cells is very low (in the order of 1 in 106) if an individual 
has not been exposed to the cognate antigen. However, upon exposure to the antigen under 
conditions which help to promote efficient and specific immuneresponses this otherwise low 
frequency can increase to 1/1000 or more within days and return to basal levels within 4-12 
weeks [148, 149]. Rapid elimination of lymphocytes by apoptosis is responsible for this fast 
decline in T cell numbers. Once the antigen respectively its source has been eliminated, 
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cytokine levels drop, co-stimulatory molecules are no longer expressed at high levels, T cells 
no longer encounter high numbers of MHC/peptide complexes derived from their cognate 
antigen and as a consequence die “by neglect” as the T cells become deprived of survival 
signals and lose expression of anti-apoptotic proteins. Most of these anti-apoptotic proteins 
belong to the B cell lymphoma (Bcl) family [150-152].
Active termination of T cell immune responses is based on feedback mechanisms that are 
triggered in lymphocytes during their activation. The inhibitory receptor CTLA-4, for 
example, is expressed on T cells only following activation. CTLA-4 is induced at a later stage 
during TCR stimulation and competes with CD28 for B7 (CD80/86) with very high binding
affinity [153, 154]. Another molecule that, like CTLA-4, is only expressed on T cells upon 
activation is the CD28 family protein PD-1 which also binds to B7 family molecules. PD-1
possesses an immunoglobulin domain in the extracellular part and an immunoreceptors 
tyrosin-based inhibition motif (ITIM) in the cytoplasmic region [155]. PD-1 receptor deficient 
mice, that develop autoimmune dilated cardiomyopathy, illustrate the critical in vivo role of 
PD-1 [156]. PD-1 functions as a negative regulator of immunresponses and in particular 
inhibits autoreactive lymphocytes. Judged by the time course of disease onset and 
progression, the inhibitory mechanism of PD-1 however seems to differ largely from that
exerted by CTLA-4. These results suggest that both molecules that are induced upon 
stimulation in T cells may actually function with different spacial and temporal requirements 
and restrictions as well as on different cell types and act in a coordinated fashion to keep 
lymphocyte reactions in check [157].
Activation of T cells also leads to the expression of the death receptor, Fas (CD95/APO-1).
The specific interaction of Fas with its cognate ligand, Fas ligand (FasL/CD95L), elicits the 
activation of a death-inducing caspase (cysteine aspartic acid proteases) cascade, occurring in 
a transcription-independent manner. Caspase activation executes the apoptosis process by 
cleaving various intracellular substrates, leading to mitochondrial membrane potential loss, 
genomic DNA fragmentation and the exposure of signals on the cell surface that attract 
phagocytic cells and promote uptake as well as degradation of the apoptotic cell(s). The 
induction of apoptosis in this manner is termed activation induced cell death (AICD). It is 
likely that Fas mediated T cell death is key to the elimination of cells which repeatedly 
encounter persistent antigens such as self-antigens. Analysis of Fas or FasL deficient mice 
support this hypothesis as they do not show prolonged immunresponses towards 
immunization or viral infections but rather develop autoimmune disease [158-161]. Besides 
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the molecules mentioned thus far there are many more that participate in the regulation of 
immunresponses, such as galectin-3 which destabilized the IS, shortens T cell - APC contact 
time and aids in the down regulation of TCR/CD3 complexes on T cells [162], but to mention 
them all is beyond the scope of this introduction. 
As a last point with respect to the mechanism that fine tune as well as negatively regulate 
immune responses two sets of cells that have been proposed to play a key role in this process 
should be mentioned, immature dendritic cells and regulatory T cells (TREG). The paradigm of 
tolerogenic/immature versus inflammatory/mature dendritic cells has remained controversial
regarding the role these APCs play in mediating immune homeostasis and self-tolerance,
versus efficient immunresponses mounted against invading pathogens. The discovery of 
PAMPs and TLRs has provides a molecular basis for understanding the recognition of specific 
pathogens by DCs and the resulting induction of appropriate innate and adaptive immune 
responses. During the last years researchers have gained further insight into the mechanism by 
means of which DCs contribute to establishing and/or maintaining immunological tolerance. 
The spectrum ranges from non-inflammatory DCs which lack the ability to induce T cell
activation to CDs that actively suppress T cell responses and induce regulatory T cell subsets 
[163, 164]. Murine regulatory T cells are characterized by the expression of CD4, CD25 as 
well as the TREG specific transcription factor FoxP3 [165]. Disruption of FoxP3 results in the 
fatal lymphoproliferative disorders of the scurfy mouse. Genetic complementation 
demonstrated that the protein product of FoxP3, scurfin, is essential for normal immune 
homeostasis and thus helped to establish FoxP3 as well as the T cell subset that expresses 
FoxP3 as an important regulatory component of the immunesystem [166, 167]. An early 
response of CD4+ T cells to an antigen encounter is the production of cytokines, mostly IL-2.
Within hours of T cell priming, IL-2 dependent STAT5 phosphorylation occurres primarily in 
FoxP3 expressing regulatory T cells and only at a later stage in the T cell subset which
initially produced the IL-2. As a response to IL-2 signals regulatory T cells proliferate and 
develop enhanced suppressive activity. This findings indicate that one of the earliest events in 
a T cell response is the activation of endogenous regulatory cells, probably to prevent 
autoimmunity [168]. Besides the various mechanism that control T cell responses and help to 
prevent autoimmunity as well as immune-over-activation, other regulatory mechanisms exist 
which help to maintain the peripheral pool of mature T cells. The next chapter will address 
the different requirements of naïve and memory T cells in respect to T cell homeostasis and 
survival.
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1.1.6.6 T cell homeostasis and survival
Positive and negative selection in the thymus allow only a tiny fraction of the initially 
generated immature thymocytes with a low affinity for MHC/self-peptides to survive and 
differentiate into mature, naive T cells that can emigrate from the thymus to the periphery. 
These cells form a long lived population of naive T cells which circulate through the 
peripheral lymphoid organs in search for their cognate antigen. Activation by antigens 
expressed on pathogens induces naive T cells to proliferate and acquire the effector functions 
needed to eliminate the pathogen. As described above, most effector cells die within a few 
weeks upon clearance of the pathogen and disappearance of their cognate antigen. Only a 
small fraction of the cells survives for a very long time as memory T cells. Effector and 
memory states of T cells are separate fates determined by differential TCR signaling [169].
Both naive as well as memory T cells have different requirements for their survival which 
will be described in this part of the chapter. T cell homeostatic signals are largely derived 
from contact with MHC/self-peptide complexes and members of the gamma chain family of 
cytokines, in particular IL-7 and IL-15. Prolonged survival of naive T cells in interphase 
depends on the combination and availability of contacts with MHC/self-peptide complexes 
and IL-7 (to a lesser extend IL-15) [170, 171]. Abrogation of TCR expression or of TCR 
proximal kinases such as Fyn and Lck was shown to reduce the lifespan of naive T cells [172-
174]. Similar results were obtained using mice lacking MHC II molecules where T cells are 
deprived of MHC/self-peptide contacts [175, 176]. The same rules apply if large numbers of 
naive transgenic T cells with only one fixed TCR compete for few specific MHC/self-peptide 
contacts but not if these T cells express a diverse repertoire of TCRs, resembling the very low 
clonal frequency of cells in a polyclonal population [177, 178]. These results again suggest 
that recognition of specific MHC/self-peptide ligands is required for naive T cell homeostasis.
The essential role of IL-7 in mature T cell survival was discovered by the finding that the 
absence of IL-7 prevented naive T cell survival, whereas IL-7 overexpression or potentiation 
by use of IL-@=&-IL-7 antibody complexes dramatically increased the pool size of naive T 
cells [171, 179-181]. During lymphopoiesis IL-7 is produced by stromal and epithelial cells 
both in the bone marrow as well as in the thymus. For mature T cell homeostasis IL-7 is 
produced locally within the secondary lymphoid organs where it is most likely retained to a 
large extend, bound to the extracellular matrix, as described for other members of the gamma 
chain family of cytokines (Figure 10) [182]. In contrast to naive T cells, longevity as well as 
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intermittent turnover of long lived memory T cells seems to be largely MHC independent and 
maintained through contact with a combination of IL-7 as well as IL-15 [183-186].
Finally, this section will deal with some of the key molecules that are involved in the effects 
exerted by IL-7 and IL-15 in regard to T cell homeostasis and survival (Figure 10). Survival 
of naive CD4+ and CD8+ T cells under normal physiological conditions requires signals from 
contact with MHC/self-peptide complexes on DCs and IL-7 on fibroblastic reticular cells 
(FRC). T cells receive these signals in the T cell zones of secondary lymphoid organs. Naive 
CD8+ T cells are also partly dependent on signals resulting from contact with IL-15 expressed 
on DCs. Signaling through IL-7/15 cytokine receptors induces activation of the receptor 
bound Janus Kinases JAK1 and JAK3, that in turn phosphorylate and activate the STAT5a-b
dimer. Suppressor of cytokine signaling-1 (SOCS-1) negatively regulates the responsiveness 
of naive CD8+ T cells to IL-15 by neutralizing the activity of JAKs. Once phosphorylated, the 
activated STAT5a-b dimers migrate into the nucleus where, together with signals derived 
from the TCR, they initiate transcription of genes coding for various proteins. Among these 
proteins are the anti-apoptotic molecules Bcl-2 (B-cell lymphoma 2) and Mcl-1 (Myeloid cell 
leukemia sequence 1) that prevent mitochondria-mediated apoptosis by blocking the BH-3-
only (Bcl-2-homology domain 3 only) proteins Bim (BCL-2-interacting mediator of cell 
death) and Bid (BH3 interacting domain death agonist) from activating Bax (Bcl-2–associated 
X protein) and Bak (Bcl-2 homologous antagonist/killer). Activated Bax and Bak otherwise 
terminally induce apoptosis by causing loss of cytochome C and other molecules from 
mitochondria that initiate caspase activation and finally cell death [151, 187-194].
Wojciechowski et al., examined the role of the anti-apoptotic molecule Bcl-2 in combating 
the pro-apoptotic molecule Bim in the context of naive and memory T cell homeostasis using 
Bcl-2(-/-) mice that were additionally deficient in one or both alleles of Bim. Naive T cells 
were significantly decreased in Bim(+/-)Bcl-2(-/-) mice, but were largely restored in Bim(-/-)Bcl-
2(-/-) mice, indicating that T cell death is primarily mediated through Bim [193]. Newly 
initiated protein synthesis via STAT5 and TCR derived signals also leads to repression of IL-
7 receptor transcription, thereby reducing the IL-7 receptor expression on the cell surface and 
rendering the cell to become temporarily starved of IL-7. During such IL-7-deprived state, 
cell survival appears to depend on intact autophagy [195, 196].
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Figure 10:
Survival of naive T cells under normal physiological conditions. Self-peptide MHC (pMHC) ligands on dendritic 
cells (DCs) together with IL-7 on fibroblastic reticular cells (FRC) (and IL-15 on DCs) stimulate IL-7/15
receptor bound Janus Kinases (JAK). Activated JAKs phosphorylate and activate signal transducer and activator 
of transcription (STAT). Suppressors of cytokine signaling (SOCS-1) negatively regulates the responsiveness of 
naive T cells to IL-7/15 by neutralizing the activity of JAKs. Phosphorylated STAT5a-b dimers then migrate into 
the nucleus, and together with signals transmitted via the TCR, initiates synthesis of various proteins that 
counteract mitochondria-mediated apoptosis by blocking the BH-3-only proteins. During a IL-7-deprived state, 
cell survival appears to depend on intact autophagy. For a detailed description of the events depicted in this 
figure see corresponding text section. (Adapted and modified from [183])
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1.1.7. Calcium signaling in T lymphocytes
Calcium signals in cells of the immune system regulate diverse cellular functions, including 
proliferation, differentiation, gene transcription and effector functions. Engagement of 
immunoreceptors, such as the T cell receptor (TCR), the B cell receptor (BCR) and Fc 
receptors result in an increase in intracellular calcium levels. Calcium elevation is essential 
for activation of signaling molecules such as protein kinase C, calcium dependent adenylate 
cyclases and the phosphatase calcineurin as well as for the initiation of gene transcription.
The major pathways implicated in the induction of an increase in cytosolic calcium 
concentrations are store-operated calcium entry (SOCE) and calcium-release-activated 
(CRAC) channels. In this section the signaling pathways leading to calcium influx and the 
major components of the involved molecular machineries will be discussed.
1.1.7.1. Role of calcium in T lymphocytes
Intracellular calcium elevation occurring downstream of the T cell receptor (TCR) as a result 
of TCR ligation, is an essential signal for T cell activation by antigens and other stimuli that 
act upon the TCR. The binding of MHC/antigen complexes to the TCR induces the 
recruitment of several tyrosine kinases and their substrates to the TCR/CD3 signaling 
complex. This series of events results in the phosphorylation of phospholipase C , 
[197]. PLC  "
+
 the membrane phospholipid phosphatidylinositol-4,5-bisphosphate
(PIP2) in the plasma membrane thereby generating the second messenger inositol-1,4,5-
trisphosphate (IP3). IP3 binds to IP3-receptors on the endoplasmatic reticulum (ER) thereby 
inducing calcium release from this intracellular calcium store, giving rise to transiently 
elevated cytoplasmatic calcium concentration. This first cytoplasmatic calcium elevation then 
results in a second wave of calcium influx via calcium permeable channels which span the 
plasma membrane, thus allowing calcium entry from the extracellular space. The major 
components of this system will be discussed in detail in the next section. In most cases,
calcium influx must be maintained for 1-2 h to efficiently drive the activation events that lead 
to the expression of factors such as interleukin-2 (IL-2). Once this point has been passed,
further T cell activation becomes antigen independent [115]. This requirement for sustained 
calcium signaling arises mostly from the need to keep specific transcription factors in the 
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nucleus in a transcriptionally active state. One of the best studied and most important 
transcription factors not only in T cells, but also in other cells of the immunesystem, is the 
Nuclear Factor of Activated T cells (NFAT) which upon elevation of the cytoplasmatic 
calcium concentration becomes dephosphorylated by the phosphatase calcineurin and 
translocates into the nucleus where it induces the transcription of genes such as IL-2 [198]. In
order to efficiently generate the sustained signals in T cells which are needed for cell 
activation, T cells, once having encountered an APC presenting the right antigen, must switch 
from an motile to an immobile state. This is essential for maintaining the stability of the 
immunological synapse formed between the T cell and the APC. In vitro experiments have 
revealed that the interaction of cloned T cells or hybridoma T cells with APCs induces 
cytosolic calcium elevations within ~ 30 sec. Shortly after this, the T cells round up and stop 
crawling. It appears that calcium by itself is sufficient to account for the observed changes in 
motility, as the addition of the ionophore ionomycin as well as the ER calcium store depleting 
agent thapsigargin induce similar changes independent of the TCR [199, 200].
Today a large number of pathways that participate in the generation of calcium signals in T
cells following an antigen encounter are known. Interactions between these different 
pathways may help to generate the huge complexity of calcium signaling patterns, which 
transmit different and specific types of information to the cells [201].
1.1.7.2. Mechanisms of calcium signaling in T lymphocytes
The nature of the feedback mechanisms between ER calcium stores and the plasma membrane 
have remained a mystery for a long time. Early studies revealed that the depletion of the ER 
calcium stores by themselves, rather than the resulting rise of the cytosolic calcium 
concentration, is the signal that following inositol-1,4,5-trisphosphate (IP3, InsP3) induced 
calcium release from the ER triggers a second wave of calcium influx (SOCE). Calcium 
influx occurres through calcium channels spanning the plasma membrane [202]. Calcium 
release activated calcium (CRAC) channels were and still are the best characterized store 
operated calcium (SOC) channels [203, 204]. However until recently the underlying 
molecular machinery, which on the one hand senses calcium depletion within the ER and on 
the other hand couples this depletion with the activation of calcium channels within the 
plasma membrane, remained ill defined.
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The breakthrough came when RNAi screens picked up the STIM 1 proteins as the missing 
molecular linkers between ER store depletion and SOCE as well as defined the Orai 
(CRACM) proteins as the pore forming subunits of the CRAC channel [205-209] (see also 
Figure 11).
Figure 11:
In resting T cells, a steep gradient in Ca2+ concentrations exists between the cytoplasm and the extracellular 
space, as well as between the cytoplasm and the lumen of the endoplasmic reticulum (ER). The intracellular Ca2+
concentrations in T cells is tightly regulated and kept between ~ 100 nM in resting cells and ~ 1 AM following T 
cell receptor (TCR) stimulation. Antigen recognition through the TCR results in the activation of protein tyrosine 
kinases, such as LCK and ZAP70 (<-chain-associated protein kinase of 70 kDa), which initiate phosphorylation 
events of adaptor proteins, such as SLP76 (SRC-homology-2-domain-containing leukocyte protein of 76 kDa) 
and LAT (linker for activation of T cells). This leads to the recruitment and activation of the TEC kinase ITK 
(interleukin-2-inducible T-cell kinase) and phospholipase C1 (PLC1). PLC1 catalyses the hydrolysis of the 
membrane phospholipid phosphatidylinositol-4,5-bisphosphate (PiP2, PtdIns(4,5)P2) to inositol-1,4,5-
trisphosphate (IP3, InsP3) and diacylglycerol (DAG). InsP3 binds to and opens InsP3 receptors (InsP3Rs) in the 
membrane of the ER, resulting in the release of Ca2+ from intracellular Ca2+ stores. A decrease in the Ca2+
content of the ER is 'sensed' by stromal interaction molecule 1 (STIM 1), which in turn activates calcium-
release-activated calcium (CRAC) channels in the plasma membrane. Ca2+ influx though CRAC channels and 
elevated intracellular Ca2+ concentration activate Ca2+-dependent enzymes, such as calcineurin, and thereby 
transcription factors, such as NFAT (nuclear factor of activated T cells). (Adapted and modified from [210])
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In the following part the underlying molecular mechanisms of STIM 1 as well as Orai 
function will be discussed. STIM 1 molecules are found in a calcium bound state in resting 
cells in which ER stores are filled and release calcium when ER stores are depleted, thus 
initiating the activation of CRAC channels. Under normal resting condition, the calcium 
concentration within the ER is much higher than in the cytoplasm, a state which is maintained 
by the activity of the ATP dependent SERCA pump. This pump which can be blocked by the 
drug thapsigargin (induces ER store depletion) permanently pumps calcium from the cytosol 
back into the ER. In the resting state STIM 1 is found as a dimer which is formed by C-
terminal coiled-coil interactions. Upon ER store depletion STIM 1 molecules further 
oligomerize within seconds, a process mediated by the sterile alpha motif (SAM) domains 
which are positioned next to the EF hand domains (Figure 12).
Figure 12:
STIM 1 molecules are shown in the basal state as dimers (left); the Ca2+ sensor EF-hand domain has bound Ca2+
(red dots) when the ER Ca2+ store is filled. Background colours represent basal Ca2+ concentrations of ~ 50 nM 
in the cytosol (blue) and > 400 AM in the ER lumen (brown/yellow). ER Ca2+ store depletion causes Ca2+ to 
unbind from the low affinity EF-hand of STIM 1; this is the molecular switch that leads to STIM 1
oligomerization and translocation (dashed arrows) to ER–plasma membrane junctions. Non-conducting Orai 
channel subunits are shown as dimers. (Adapted and modified from [211])
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The function of STIM 1 as an important component of SOCE has been analyzed using high 
resolution microscopy, RNAi and mutagenesis. It soon became apparent that rendering an EF 
hand motif, near the N-terminus of STIM 1, which is located in the ER lumen unable to bind 
calcium by mutagenesis, leads to constitutive calcium influx and CRAC channel activation, 
independent of ER store depletion [208]. Oligomerization precedes interaction of STIM 1 
with and activation of CRAC channels at the plasma membrane [212-215]. Oligomerization 
of STIM 1, as described above, is necessary and sufficient for its translocation to ER-plasma 
membrane junctions [215]. STIM 1 molecules were shown to form clusters (puncta) close 
(10-25 nm) to the plasma membrane shortly after store depletion, whereas they co-localized 
with ER resident proteins, showing ER distribution if the ER stores were filled [216]. The 
close proximity of STIM 1 puncta to the plasma membrane allows the direct interaction of
STIM 1 with proteins located at or within the plasma membrane. It appears that the protein 
STIM1 interacts with, Orai, is the subunit from which CRAC channels are build. Work from 
several laboratories has demonstrated that STIM 1 not only undergoes an interaction with the 
CRAC channel component Orai and activates CRAC channels but also aids in organizing 
Orai subunits into plasma membrane clusters, adjacent to the STIM 1 puncta [213, 217, 218]
(Figure 13).
Besides the direct activation of calcium influx by STIM 1, additional regulatory mechanisms 
exist to fine-tune calcium influx and signaling within the cells as well as to guard cells against 
damage caused by excessive calcium influx. An important calcium buffer within cells are the 
mitochondria, organelles which have been shown to functionally interact with SOC channels 
in T lymphocytes [219]. Mitochondria are required to maintain CRAC channel activity by 
preventing local calcium accumulation around the sites of calcium entry. It has been further 
shown that mitochondria accumulate at the immunological synapse, a site where strong 
calcium signals are generated [220]. Consistent with these findings acute blockage of 
mitochondrial calcium uptake in T cells stimulated via their TCR prevented nuclear 
translocation of NFAT alongside with CRAC channel activation [219].
Another mechanism of CRAC channel regulation which has been proposed recently is via 
STIM 2, a molecule similar to STIM 1 that might have arisen by gene duplication alongside 
STIM 1. STIM 2 is a feedback regulator that stabilizes basal calcium concentrations in the 
cytoplasm and ER by counteracting STIM 1 [221, 222].
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Figure 13:  
STIM 1 accumulation induces Orai channels to cluster in the adjacent plasma membrane. The C-terminal 
effector domain of STIM induces Orai channels to open by direct binding of the distal coiled-coil domain, and 
Ca2+ enters the cell (red arrows). Two STIMs can activate a single CRAC channel consisting of an Orai tetramer; 
channel activation by STIM may involve a preliminary step of assembling Orai dimers into a functional tetramer. 
Background colors represent changes in cytosolic Ca2+ concentration (from that in the basal state (Ca2+
concentrations of ~ 50 nM in the cytosol (blue) and > 400 AM in the ER lumen (brown/yellow) as represented in 
the previous figure to > 1 AM in the cytosol (now pink) due to Ca2+ entry, and ER luminal Ca2+ (now lighter 
yellow) to < 300 AM. (Adapted and modified from [211])
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The last molecule implicated in the fast calcium dependent inactivation (CDI) which limits 
calcium influx into cells via CRAC channels and should be mentioned here is calmodulin. In 
a recent report, scientists showed that a N-terminal membrane proximal region of Orai
interacts with calmodulin. Mutation of the calmodulin interaction site within Orai ablated 
CDI. Thus a potential explanation for this observation is that upon calcium entry 
calcium/calmodulin displaces STIM 1 from the N-terminus of Orai and in effect reverses the 
activation process initiated by STIM 1 [223]. Further work will however be needed to fully 
understand the mechanisms by which STIM 1, calmodulin, Orai and other molecules act in 
concert to rapidly induce calcium influx as well as evoke inactivation of the SOC channels.
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1.2. The Coronin Family of Proteins
Analysis of actin/myosin complexes isolated from the slime mold Dictyostelium discoideum
resulted in the identification of a 57 kDa protein. [224]. As antibodies, raised against the 
newly identified protein stained the plasma membrane surface projections of Dictyostelium,
which have a crown-shaped appearance, the protein was named “coronin”. The deletion of 
coronin in Dictyostelium cells resulted in pleiotropic defects, such as reduced motility and 
phagocytosis, both of which are actin dependent processes [225-227]. These findings resulted 
in the classification of coronin as an actin binding protein. Additional experiments, which 
were carried out using coronin deficient Dictyostelium cells as well as in vitro actin 
polymerization assays using purified yeast coronin, prompted scientists to assign coronin as 
an actin regulating protein. As a consequence of these initial assignations all coronin family 
members identified thereafter, such as coronins in multicellular invertebrates and mammals 
have been referred to as actin binding and regulating proteins [228-230].
In the following, our current knowledge in respect to what is known about Dictyostelium
coronin, yeast coronin and coronins from multicellular invertebrates such as Drosophila 
melanogaster and Caenorhabditis elegans will be summarized. The remaining part of this 
chapter will then focus on mammalian coronin 1 (Coro 1A), the closest Dictyostelium
homologue of all known seven mammalian coronin isoforms, which is exclusively expressed 
in leukocytes.
Recent work, part of which is described in this thesis, based on biochemical, physiological 
and genetic analysis suggests that coronin 1 has evolved to function, unlike the short 
Dictyostelium coronin, in the regulation of leukocyte specific signaling events, rather than in 
the regulation of F-actin.
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1.2.1. Overview and Molecular Phylogeny:
The coronin gene family comprises seven vertebrate paralogs and at least five unclassified 
subfamilies in non-vertebrate metazoa, fungi and protozoa. Thus far no representatives in 
plants or distant protists have been described. All known members exhibit structural 
conservation in two unique domains of unknown function (DUF1899 and 1900), interspaced 
by three canonical WD40 domains (plus additional pseudo domains), that form part of a 7-
bladed-propeller scaffold and a C-terminal “coiled coil domain” needed for oligomerization.
Figure 14:
A) Overview over the seven mouse coronin paralogs as well as the single coronin genes found in Yeast,
Dictyostelium and Drosophila. B) Molecular Phylogeny of the coronins listed under (A).
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1.2.2. Coronin in Dictyostelium and Yeast
Several years after the identification and characterization of Dictyostelium coronin, which by 
then had been classified as an F-actin binding and regulating protein (see introduction to this 
chapter), a yeast homologue was described [231]. While in Dictyostelium two additional 
coronin like proteins are present besides the short coronin (a coronin 7 homologue and 
villidin) yeast cells only express a single coronin gene. 
Despite the in vitro observed interactions of yeast coronin with the Arp 2/3 complex and 
inhibitory effects on in vitro F-actin polymerization assays [232, 233], coronin deficient Yeast
cells, unlike coronin deficient Dictyostelium cells (see above), fail to display an obvious 
phenotype and defects which could be related to F-actin based processes and dynamic [231].
These experimental systems thus do not unequivocally support an in vivo function of coronins 
in F actin regulation. Further work will be needed to define, on a molecular basis, the precise 
role(s) of coronins in different model organisms.
1.2.3. Coronin in Multicellular Invertebrates
To date only little is known about the function of coronin family members in multicellular 
invertebrates, such as Caenorhabditis elegans and Drosophila melanogaster. Both organisms 
contain a gene (coro) with a high homology to Dictyostelium coronin. Deletion of the gene in 
Drosophila results in a pleiotropic phenotype which has been attributed to endocytosis /
exocytosis events involving F actin-coated vesicles and the establishment of morphogen 
gradients [234]. As for C. elegans coronin, no information is available on its function. 
Another molecule identified in C. elegans, termed Pod-1, shows homology to coronin family 
members and contains two stretches of WD repeats but unlike other coronins no C-terminal 
coiled-coil region. It has been reported that Pod-1 may be involved in the embryonic 
establishment of polarity during the development of C. elegans [235]. A Pod-1 homologue in 
Drosophila has been implicated in neuronal development and axonal growth cone targeting 
[236].
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1.2.4. Mammalian Coronin 1
Mammalian cells can express up to seven coronin isoforms, of which coronin 1 is the closest 
homologue to Dictyostelium coronin (Figure 14) [237-239]. Coronin 1 which will be the 
major topic during most of this thesis is exclusively expressed in leukocytes. As besides 
coronin 1 other coronin isoforms are co-expressed in leukocytes but are also found in other 
cell types, it is reasonable to assume that coronin 1 has evolved to exert a specialized function 
which is of particular importance in leukocytes.
1.2.5. The Three-Domain structure of Coronin 1
A characteristic feature of all coronins is the central WD (Tryp-Asp) repeat domain linked to 
a C-terminal coiled-coil region. Coronin 1, the closest mammalian homologue of 
Dictyostelium coronin, is made up of three domains, as outlined in Figure 15 [240, 241]. The 
first, N-terminal domain, contains the five WD repeats, it #	'-sheets and referred to as 
'-propeller (amino acid 1-355). The second domain, which is referred to as “linker” region 
has little secondary structure (amino acid 356-429). The third, C-
	" 
	  	 &-
helix rich, coiled-coil containing segment which is needed for oligomerization (amino-acid 
430-461). 
1.2.5.1. The N-terminal 7-bladed Propeller domain
Biochemical, bioinformatics and structural data obtained for coronin 1 revealed that the WD 


 
%
	 
" 	
  
+
	 $"
 '-propeller with the N- and C-terminal extensions 
forming the first and the last blade respectively [241, 242]. This structure is reminiscent of the 
'-

""
 
"    
	 	 #
 '-subunits of trimeric G-proteins and the yeast 
transcription repressor Tup1, both of which are WD repeat containing seven-$"
 '-
propeller proteins. As this domain mediates protein-protein interactions of G proteins it is 
possible that it has a similar function in coronin 1 [243-245]. It has been demonstrated 
recently that coronin 1 interacts with the plasma membrane via its N-terminal domain, 
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however whether the interaction occurs between coronin 1 and another protein or rather with 
plasma membrane lipids remains to be determined [241].
1.2.5.2. The C-terminal coiled-coil trimerization motif and the linker domain
Biophysical analysis of the C-terminal coiled-coil domains in coronin 1 revealed that this 
portion of the molecule folds into a parallel three-stranded coiled coil, mediating trimerization 
of coronin 1 molecules [241]. Representative electron microscopic pictures, which lead to the 
current model of coronin 1 oligomerization as well as a cartoon model are shown in Figure 15 
and 16. Gatfield et al., were further able to demonstrate that the trimerization of coronin 1
generated a cytoskeleton binding site comprising positively charged residues located within 
the linker region (amino acids 400-416) [241]. These findings are consistent with previous 
reports where basic peptides have been shown to be important for the interaction with actin 
[246, 247]. The assembly of the coiled-coil domain into trimers was further confirmed by X-
ray crystallography [248].
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Figure 15: 
A) The N-terminal, 7-bladed '-propeller region consists of 5 WD repeats complemented with two stretches of 
sequence each forming four '-strands, representing two additional blades of the propeller. The propeller region 
is followed by a linker region. The C-terminal part of coronin 1 is composed of a coiled coil. B) Secondary 
structure prediction suggests a seven-bladed '-propeller fold reminiscent of the ones of the yeast transcriptional 
repressor Tup1 and '-subunit of the G protein. The GlyHis and TrpAsp dipeptides of the five WD repeats are 
highlighted in bold. Predicted blade numbers and corresponding '-strands (gray arrows) are shown on the left 
and on the bottom of the alignment, respectively. The N-and C-terminal domain extensions are underlined. C) 
Model of coronin 1 lacking the coiled coil domain based on the X-ray structure [242, 249].
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Figure 16:
A) Transmission electron micrographs of affinity-purified and negatively stained coronin 1 complexes isolated 
from macrophages. The gallery shows multiple examples of the trimeric structure. Scale bar, 10 nm. B) Cartoon 
presenting the organization of the coronin 1 trimer deduced from the image analysis [249].
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1.2.6. Coronin 1 in the innate immune system
A role for coronin 1 in innate immunity was first identified during a screen for host 
molecules, possibly involved in blocking phagosome-lysosome fusion in macrophages, 
following an infection with pathogenic mycobacteria. While most bacteria upon
internalization into macrophages are rapidly delivered to the bactericidal environment of 
lysosomes, followed by their destruction, live pathogenic mycobacteria upon internalization, 
actively block the maturation of their phagosomes to, or fusion with lysosomes. Mycobacteria 
thereby create their own niche within the otherwise hostile environment of host macrophages.
The screen mentioned above led to the identification of a single detectable protein which was 
exclusively retained on mycobacterial phagosomes containing live bacteria [237]. The newly 
identified protein, coronin 1 (at the time known as TACO, for Tryptophane Aspartate 
containing Coat protein), was shown to distribute equally between cytosol and plasma 
membrane in resting macrophages. When macrophages were infected with live, pathogenic 
mycobacteria, coronin 1 was exclusively retained around phagosomes containing live 
bacteria, whereas in macrophages infected with heat killed mycobacteria, coronin 1 was 
initially associated with phagosomes but rapidly dissociated after uptake. Based on these 
results, coronin 1 was suggested to play an essential role in preventing phagosome-lysosome 
fusion during mycobacterial infection. As at the time when these discoveries were made no 
coronin 1 deficient mouse models or cell lines were available, the researchers made use of 
Kupffer cells, the resident macrophages of the liver which were shown to not express coronin 
1. Consistent with the above described findings, upon infection of Kupffer cells, mycobacteria 
were rapidly delivered to lysosomes and degraded [237].
Another pathogen which was shown later to be equally capable of retaining coronin 1 around 
its phagosomes upon internalization is the human pathogen Helicobacter pylori [250]. These 
findings suggest that the block in phagosome-lysosome fusion mediated by coronin 1 is not 
only utilized by pathogenic mycobacteria and could be utilized by other, thus far not 
characterized pathogens. 
The mechanisms by which coronin 1, once retained around mycobacterial phagosomes,
prevents phagosome-lysosome fusion and mycobacterial survival have remained elusive for a 
long time. The recent analysis of a coronin 1 deficient mouse model as well as a tissue culture 
model system of mycobacterial infection (J774 macrophages stably depleted of coronin 1 by 
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plasmid based expression of coronin 1 specific siRNA) has however shed some light on the 
molecular activities of coronin 1 in macrophages.
As mentioned earlier, based on the homology to the single coronin isoforms expressed in 
Dictyostelium all thus far identified seven mammalian coronin family members have been 
classified as F-actin interaction proteins as well as F-actin regulators [228, 229].
However, when coronin 1 deficient macrophages and neutrophils were analyzed, no actin 
related defects or disturbances of the F-actin cytoskeleton were apparent. All analyzed 
processes, such as phagocytosis, macropinocytosis, cell spreading, membrane ruffling as well 
as migration were unaffected by the lack of coronin 1 in macrophages and neutrophils [251, 
252]. Instead of regulating F-actin dynamics, coronin 1 was found to be not only retained 
around mycobacterial phagosomes [237-239, 251] but essential for mycobacteria induced 
activation of the phosphatase calcineurin. Calcineurin phosphatase activity has been 
implicated in a large variety of cellular processes covering the range from transcriptional 
activation to dephosphorylation of proteins involved in endocytic processes and degradation 
of signalling molecules in order to shut down receptor mediated signalling cascades [253, 
254]. The phenotype of coronin 1 deficient macrophages could be mimicked by incubation of 
wild type cells with the calcineurin blockers cyclosporine A or FK506 which induced 
lysosomal delivery of the pathogen as observed in the absence of coronin 1. On the other 
hand, mycobacteria were prevented from being delivered to lysosomes in the absence of 
coronin 1 by use of the calcium ionophore calcimycin. These results established coronin 1
dependent regulation of calcineurin activation as key event during mycobacterial infections as 
well as pathogen survival [249, 253]. The above described findings have been summarized in 
Figure 17 (see below).
A role for coronin 1 in the regulation of mycobacterial trafficking and calcineurin activation
fits with a possible role of protein kinase C (PKC) regulated localization of coronin 1 as well 
as its preferred localization within cholesterol rich membrane regions, which are known to act 
as signaling platforms [255-261]. Mycobacteria require cholesterol to be efficiently engulfed 
by macrophages, thus it is reasonable to assume that their uptake in a cholesterol dependent 
manner has evolved as a mechanism which ensures that once they have been internalized they 
can reside within coronin 1 coated phagosomes, thus preventing their degradation in 
lysosomes.
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Figure 17: 
Model for the activity of coronin 1 in macrophages. In resting macrophages coronin 1 is distributed between the 
cytoplasm and the cell cortex. Upon the entry of pathogenic mycobacteria, coronin 1 is recruited to and retained 
at the phagosomal membrane, thereby ensuring the activation of calcineurin. Activation of calcineurin results in 
a block in the fusion of mycobacterial phagosomes with lysosomes. As a consequence, deletion of coronin 1 or 
inhibition of calcineurin activity results in the induction of phagosome-lysosome fusion and mycobacterial 
killing [249].
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1.3. Aims of this thesis 
1.3.1. Part I
Activation of lymphocytes results in the opening of Ca2+ release activated Ca2+ (CRAC) 
channels in the plasma membrane, allowing influx of extracellular Ca2+. CRAC channel 
activation occurs following depletion of Ca2+ stores in the endoplasmic reticulum (ER) [201].
One current model, to explain the coupling of store-emptying to CRAC channel activation, is 
the secretion-like conformational coupling model [262]. This model proposes that store 
depletion increases junctions between the endoplasmic reticulum and the plasma membrane, a
process which could be regulated by the cortical actin cytoskeleton. It is however unclear to 
what extend this model, as well as the involvement of the actin cytoskeleton in store operated 
calcium entry (SOCE), applies to T cells. Thus the aim of the first part of this thesis was to 
analyzed the involvement of the actin cytoskeleton in CRAC channel activation in Jurkat T
cells.
1.3.2. Part II
Coronin 1 is a member of the conserved WD repeat family of coronin proteins that is 
exclusively expressed in leukocytes. A possible function of coronin 1 in innate immunity was 
first described following a screen for proteins expressed in macrophages, that are possibly 
involved in the mycobacterial block of phagosome-lysosome fusion [237]. Macrophages 
infected with live, pathogenic mycobacteria retained coronin 1 around phagosomes containing 
live bacteria, whereas in macrophages infected with heat killed mycobacteria, coronin 1 was 
initially associated with phagosomes but rapidly dissociated from them after uptake. Based on 
these findings coronin 1 was assigned an essential role in preventing phagosome-lysosome 
fusion during mycobacterial infection.
However, the normal role of coronin 1 in immune cells has remained unclear. In order to 
define a molecular role for coronin 1, mice deficient for coronin 1 were generated in the 
laboratory and backcrossed onto the C57BL/6 background. It was shown that in the coronin 1 
deficient animals T cell numbers are significantly reduced. 
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The aim of the second part of this theses was to build upon these preliminary results and to
define a role for coronin 1 in T cell development, proliferation and signaling as well as to
elucidate the underlying molecular defect(s) responsible for the observed phenotype.
1.3.3. Part III
The original isolation of the single coronin isoform found in the slime mold Dictyostelium,
bound to an actin-myosin affinity matrix, has led to the assignment of all coronin protein 
family members as actin interacting and regulating proteins [228, 229]. Additional in vitro
experiments performed with purified yeast coronin suggested that yeast coronin might 
modulate the formation of F-actin by acting as a regulator of the actin-related protein 2/3 
(Arp2/3) complex [233]. However living yeast cells lacking coronin displayed no obvious 
phenotype [231].
The evidence for F-actin regulation by mammalian coronin isoforms is based to a large extend 
on in vitro polymerization assays which use purified proteins, or on overexpression of coronin 
domains in a heterologous system. The only in vivo evidence linking coronin 1 and 
modulation of the F-actin cytoskeleton is based on the ~2 fold higher phalloidin fluorescence
observed in coronin 1 deficient leukocytes as compared to the wild type control [263]. As a 
consequence of this observations, the decrease in cell viability as well as migration of naïve T
cells derived from coronin 1 deficient mice was attributed to deregulation of the F-actin 
cytoskeleton.
In contrast to the above mentioned conclusions, the results derived from the research 
presented in the second part of this thesis suggested that coronin 1 promotes T cell survival by 
allowing signal transduction downstream of the T cell receptor rather than by modulating the 
actin cytoskeleton. They further suggest that the migration defect observed in coronin 1 
deficient T cells is not a consequence of a non functional F-actin cytoskeleton.
The third and last part of this thesis aims at providing an explanation for this apparent 
discrepancy and unravel the molecular basis of the observed survival and migration defects, 
which are specifically observed in coronin 1 deficient naïve T cells.
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Part I
2.1. Disruption of the cortical actin cytoskeleton does not affect store 
operated Ca2+ channels in human T cells 
2.1.1. Abstract
Lymphocyte signaling and activation leads to the influx of extracellular Ca2+ via the 
activation of Ca2+ release activated Ca2+ (CRAC) channels in the plasma membrane. 
Activation of CRAC channels occurs following emptying of the endoplasmic reticulum 
intracellular Ca2+ stores. One model to explain the coupling of store-emptying to CRAC 
activation is the secretion-like conformational coupling model. This model proposes that store 
depletion increases junctions between the endoplasmic reticulum and the plasma membrane in 
a manner that could be regulated by the cortical actin cytoskeleton. Here, we show that 
stabilization or depolymerization of the actin cytoskeleton failed to affect CRAC activation. 
We therefore conclude that rearrangement of the actin cytoskeleton is dispensable for store-
operated Ca2+ entry in T-cells.
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2.1.2. Introduction
Ca2+ is one of the most fundamental signaling messengers in all eukaryotic cells. Cytosolic 
Ca2+ signals are the key to the regulation of a wide variety of physiological events, such as 
gene transcription, protein folding, apoptosis and exocytosis. Following stimulation of 
lymphocytes or other non-excitable cells, bi-phasic increases in the intracellular Ca2+
concentration ([Ca2+]i) are observed [201, 264] and [265]. The first phase involves activation 
of phospholipase C by either trimeric G proteins or tyrosine kinase coupled receptors [266].
The active enzyme hydrolyzes phosphatidylinositol bisphosphate, thus generating the second 
messenger inositol-1,4,5-trisphosphate (IP3), which binds to IP3 receptor molecules within 
the endoplasmic reticulum (ER) membrane, thereby triggering Ca2+ release from ER Ca2+
stores [264]. In a second phase, store-emptying triggers a sustained influx of extracellular 
calcium via the plasma membrane, a process termed store-operated calcium entry (SOC) or 
capacitive calcium entry [202, 203, 267]. Different models exists as to explain how the 
emptying of ER stores results in the activation of Ca2+ influx via the plasma membrane. A 
first model postulates a mobile messenger that links store content to plasma membrane 
channel activation. Such a messenger could be a luminal ER resident protein or a small 
organic molecule that is released upon ER store depletion, or is generated de novo within the 
cytosol and/or ER/plasma membrane [268-273]. A second model is based on transport of 
vesicles to the plasma membrane inserting Ca2+ channels into the plasma membrane via 
fusion following store-emptying [274]. Third, the secretion-like coupling model postulates 
migration of the endoplasmic reticulum to the plasma membrane in order to locally activate 
CRAC channels [262, 275]. Coupling of store depletion to the activation of CRAC channels is 
believed to occur via the stromal interaction molecules (STIM) 1 and 2 by relocalizing within 
the endoplasmic reticulum to preformed endoplasmic reticulum–plasma membrane contact 
sites [208, 209, 212, 216, 242, 276].
The secretion-like coupling model is based on results obtained using a variety of F-actin-
modulating drugs that suggest the involvement of the cortical actin cytoskeleton in the 
interaction of ER stores with plasma membrane channels following depletion. For example, 
studies in a variety of cell types such as smooth muscle cells, platelets, endothelial cells, 
glioma cells, and pancreatic acinar cells suggest a role for actin in the coupling of store 
depletion to the activation of store-operated calcium entry (SOC) [262, 277-279]. Induced 
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polymerization of the cortical actin cytoskeleton by a variety of drugs resulted in the ablation 
of store-operated calcium entry, suggesting that actin polymerization acts as a physical barrier 
in preventing the translocation of the endoplasmic reticulum to the plasma membrane [280].
However, in RBL cells, stabilization or disassembly of the actin cytoskeleton fails to affect 
Ca2+ influx via store-operated CRAC channels [281], suggesting that the contribution of the 
cortical actin cytoskeleton may be cell type dependent. These divergent findings could 
indicate that coupling to CRAC channels is affected differently by the activity of actin-
modulating drugs in different cell types. Alternatively, in some cell types, store-operated 
calcium entry may predominantly occur through other classes of calcium channels.
A role for the actin cytoskeleton in T-cells has not been described. In this work, we have 
analyzed the involvement of the actin cytoskeleton in CRAC activation in Jurkat T-cells, and 
found that modulation of the actin cytoskeleton by either stabilizing or disassembling actin 
has no significant effect on the activation or function of CRAC channels.
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2.1.3. Results
2.1.3.1. Modulation of the T-cell cytoskeleton by actin interfering drugs
To analyze whether in T-cells the cortical actin cytoskeleton can be disassembled by actin-
interfering drugs, Jurkat T-cells were left untreated or incubated with Latrunculin B or 
Cytochalasin D. Whereas both Latrunculin B and Cytochalasin D disrupt F-actin filaments, 
they do so by different mechanisms. Latrunculin B is a marine toxin isolated from the Red 
Sea sponge Latrunculia magnifica, and inhibits actin polymerization by binding to G-actin
[282, 283].
Figure 1: Effect of actin-modulating drugs on the F-actin cytoskeleton.
Jurkat T-cells were left untreated (A) or were treated for 30 min at RT with Latrunculin B (Lat B, 4 AM; B), 
Cytochalasin D (Cyt D, 10 AM; C) or Jasplakinolide (Jasp, 1 AM; D). Cells were fixed and F-actin was 
visualized with phalloidin-Alexa Fluor 568. Bar: 10 AM.
Cytochalasin D disrupt the F-actin cytoskeleton by binding to the barbed, fast growing end of 
actin filaments inhibiting their elongation thereby preventing polymerization [284, 285].
Following treatment, cells were fixed and stained for F-actin using phalloidin coupled to 
Alexa-568 to visualize F-actin and processed for immunofluorescence microscopy. As shown 
in Figure 1A–C, while the F-actin cytoskeleton in untreated T-cells was largely cortical, as 
indicated by the phalloidin staining, following incubation with Latrunculin B and 
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Cytochalasin D, F-actin was barely detectible. In contrast to the action of Latrunculin B and 
Cytochalasin D, the fungal peptide Jasplakinolide induces polymerization of F-actin by 
enhancing the rate of actin filament nucleation [286]. When T-cells were treated for 30 min
with Jasplakinolide, followed by fixation and visualization of F-actin by phalloidin, the 
cortical actin was drastically enhanced compared to non-treated cells (Figure 1A,D).
Induction of F-actin polymerization or depolymerization by these actin-modulating drugs was 
mirrored using a biochemical assay to separate filamentous actin from G-actin [241, 287].
Cells were left untreated or treated with the drugs indicated in Fig. 2 for 30 min, followed by 
cell lysis and sedimentation of F-actin. Quantitative recovery of F-actin was achieved by 
depolymerization using Cytochalasin D followed by SDS–PAGE analysis and 
immunoblotting. As shown in Figure 2, while in control cells similar amounts of G-versus F-
actin were recovered, following Jasplakinolide treatment of the cells virtually all of the actin 
was recovered from the pelleted fraction, indicating massive polymerization of actin upon 
Jasplakinolide treatment (Figure 2, Jasp). Conversably, when cells were treated with either 
Latrunculin B or Cytochalasin D, almost all cellular actin was recovered in the soluble 
fraction, indicating complete depolymerization. Together the morphological and biochemical 
results suggest that the polymerization and depolymerization of the actin cytoskeleton can be 
achieved efficiently in human T-cells using these F-actin-modulating drugs.
Figure 2: Biochemical analysis of F/G-actin from T-cells treated with actin-modulating drugs.
Jurkat T-cells were left untreated or treated with either Jasplakinolide (1 AM), Latrunculin B (4 AM) or 
Cytochalasin D (10 AM) for 30 min at RT followed by cell lysis. Proteins present in supernatant (S) and pellet 
(P) were prepared as described in methods, separated by SDS-PAGE and immunoblotted using anti-actin 
antibodies. The supernatant resembles the soluble or G-actin whereas the pellet corresponds to the F-actin.
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2.1.3.2. Store-operated calcium mobilization following disruption of the actin 
cytoskeleton
The actin cytoskeleton has been proposed to play an important role in the coupling of the 
endoplasmic reticulum stores to store-operated Ca2+ channels at the plasma membrane. In a 
variety of cell type, both depolymerization as well as polymerization of F-actin results in the 
inhibition of store-operated Ca2+ influx [262, 279, 280, 288-291].
To analyze whether store-operated Ca2+ influx in T-cells is dependent on the actin 
cytoskeleton, cells were incubated for 30 min. with Jasplakinolide to induce complete F-actin 
polymerization. Store depletion was initiated by Thapsigargin which induces store depletion 
by blocking the Ca2+ SERCA pumps in the endoplasmic reticulum thereby preventing Ca2+
uptake within the ER stores [292]. As shown in Figure 3A, Jasplakinolide incubation did 
neither alter release of Ca2+ from stores by Thapsigargin nor Ca2+ influx through CRAC 
channels as measured by Ca2+ re-addition (Figure 3A). The pharmacological modulation of 
CRAC channels by 2-APB is considered a hallmark of store-operated Ca2+ influx through 
CRAC channels. Whereas 2APB increases CRAC activity at a concentration below 10 AM, it 
inhibits CRAC activity at higher concentrations [205, 293]. As a control for CRAC channel 
activity, cells were treated with 3 AM 2-APB after re-addition of Ca2+ to elevate Ca2+ influx 
and sequentially with 100 AM 2-APB to completely block Ca2+ influx, resulting in the typical 
bi-phasic behavior of CRAC channel mediated Ca2+ entry (Figure 3A).
Similar to the effect of Jasplakinolide, incubation of T-cells with the F-actin depolymerizing 
drugs Cytochalasin D or Latrunculin B did not significantly modulate Ca2+ entry following 
store depletion (Figure 3B and C). Together these results suggest that polymerization or 
depolymerization of the actin cytoskeleton do not affect cytosolic Ca2+ influx in T-cells.
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Figure 3: Calcium Fluorimetry in the presence and absence of actin-modulating drugs.
(A–C) Jurkat T-cells were processed as described under methods and calcium influx was analyzed in cells 
treated for 30 min with the indicated actin-modulating drugs or left untreated as control. Jasplakinolide was used 
at 1 AM, Latrunculin B at 4 AM and Cytochalasin D at 10 AM. After 8 min calcium was added to the cells, at 
12 min 3 AM 2-APB was added to enhance calcium influx and at 14 min 100 AM 2-APB was added to block 
calcium influx. (D) Additional control samples of untreated cells, as under A–C (Control) or without 2-APB 
treatment (no 2-APB) or the solvent DMSO used instead of Thapsigargin dissolved in DMSO without 2-APB 
treatment (DMSO).
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2.1.3.3. Patch-clamp analysis in the presence and absence of actin-modulating drugs
To directly analyze the influence of disturbance of the actin cytoskeleton on CRAC channel 
activity, patch-clamp experiments were performed. As shown in Figure 4, the presence of 
neither Latrunculin B nor Jasplakinolide significantly influenced the amplitude of CRAC 
currents in T-cells. We conclude that neither polymerization nor depolymerization of the actin 
cytoskeleton alter Ca2+ influx through CRAC channels in T-cells.
Fig. 4. Effect of actin-modulating drugs on CRAC current.
(A) CRAC current recordings at -80 mV in the presence or absence of Jasplakinolide (1 AM) or Latrunculin B 
(10 Ag/ml) following a 20–30 minutes pre-incubation with the drugs. (B) Average of maximal CRAC currents in 
control cells (n = 13), in latrunculin-treated cells (n = 8) or in Jasplakinolide-treated cells (n = 4) (Experiments 
presented in this figure were performed by Quintana A. and Griesemer D.)
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2.1.4. Discussion
The processes that regulate the influx of Ca2+ following T-cell activation are not fully 
understood. After T-cell activation, the endoplasmic reticulum Ca2+ stores are depleted, which 
results in the activation of store-operated CRAC/ORAI1 channels at the plasma membrane in 
a STIM1 dependent manner [202, 205, 208, 217, 276, 294]. While in a variety of cell types, 
the activation of store-operated Ca2+ channels has been suggested to be regulated by the F-
actin cytoskeleton, we here describe that in T-cells, as is the case for RBL cells [281], CRAC 
activation was fully independent of rearrangement of the F-actin cytoskeleton, as analyzed by 
Ca2+ imaging and patch-clamp analysis of cells whose F-actin cytoskeleton was drastically 
disturbed by actin poisoning reagents.
Evidence for a role of the cortical actin cytoskeleton is supported by experiments in which 
drugs similar to the ones used here showed a decrease of SOC dependent Ca2+ signals in 
smooth muscle cells, platelets, endothelial cells, glioma cells, and pancreatic acinar cells
[280]. How can one reconcile these apparent differences concerning the influence of actin 
polymerization or depolymerization on SOC channel activity observed between different cells 
types?
First, it is possible that Ca2+ entry channels in the cell types mentioned above are regulated by 
the actin cytoskeleton; for example, upon growth factor stimulation, members of the transient 
receptor potential (TRP) calcium influx channels undergo regulated exocytosis to be inserted 
at the plasma membrane, a step that could well involve the actin cytoskeleton [295, 296].
Also, in platelets and smooth muscle cells, the cortical actin cytoskeleton is tightly linked to 
the plasma membrane via proteins such as filamin and dystrophin, and polymerization of this 
cortically located F-actin may prevent any coupling of the ER with plasma membrane Ca2+
channels [297, 298]. The precise mode of coupling emptied ER stores to plasma membrane 
Ca2+ channels may thus be distinct in different cell types. For example, it is possible that the 
subcellular organization of the endoplasmic reticulum in smooth muscle cells and platelets is 
different from that of RBL and T-cells.
Recent work in T-cells revealed that the majority of contact sites between the ER and the 
plasma membrane are already preformed in resting cells [216]. Upon Ca2+ release, the number 
of STIM1 junctional contact sites increase significantly, probably since STIM1 proteins 
within the ER membrane move to those preformed membrane junctions in order to form the 
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puncta that mediate the activation of CRAC channels. Since formation of STIM puncta 
beneath plasma membrane mainly depends on STIM recruitment rather than migration of ER 
membranes towards the plasma membrane, it is plausible that neither depolymerization nor 
polymerization of cortical actin affects CRAC activity in T-cells, as reported here [217].
An alternative explanation for the observed discrepancies are the methodologies used to 
analyze Ca2+ signaling. While in the study presented here, patch-clamp measurements of 
CRAC and Ca2+ imaging by flow cytometry was used to analyze a potential influence of the 
actin cytoskeleton on CRAC activity, most of the other studies rely solely on Ca2+ imaging. 
While both techniques have their advantages and disadvantages [299], Ca2+ imaging alone 
does not allow to distinguish effects of the actin cytoskeleton on Ca2+ influx channels, 
membrane potential, Ca2+ buffering or Ca2+ export mechanisms such as Ca2+ ATPases or 
mitochondrial Ca2+ uptake, all of which contribute to Ca2+ signals [300]. Interestingly, the 
conclusion that modulation of the actin cytoskeleton affects store-operated Ca2+ entry was 
solely based on experiments involving Ca2+ imaging [262, 277-280, 291]. It therefore can not 
be exclude that the target of the actin cytoskeleton was not the SOC channel itself but rather 
for example a K+ channel, since inhibition of a K+ channel would depolarize the membrane 
potential thereby resulting in a reduced Ca2+ entry through SOC channels. Harper and Sage 
have in fact recently shown that in platelets, which have been used as a prominent model 
system to analyze the influence of the actin cytoskeleton on store-operated Ca2+ entry, the 
Na+–Ca2+ exchanger but not SOC was modulated by the actin cytoskeleton. In T-cells, Na+–
Ca2+ exchange appears not to be of functional importance [301, 302], and therefore our 
conclusion that the cortical actin cytoskeleton does not affect store-operated Ca2+ channels in 
T-cells is consistent with these data.
While our results exclude a role for the F-actin cytoskeleton in CRAC activation in T-cells, 
the actin cytoskeleton does play a role at other levels of the signaling cascade leading to T-
cell activation. In T-cells deficient for the Wiskott–Aldrich syndrome protein (WASp) or the 
WASP interacting protein WIP, both of which are involved in the regulation of the actin 
cytoskeleton, T-cell activation is deficient but at a step that lies upstream of store depletion
[303-305]. Similarly, T-cells deficient in Vav, a guanine–nucleotide exchange factor for the 
GTPase Rac which modulates the actin cytoskeleton, cannot properly be activated because of 
pleiotropic defects related to T-cell receptor clustering [306]. Interestingly, in cells in which 
expression of the WASP-family verprolin (WAVE)-homologous protein is knocked down, 
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signaling events immediately downstream of the T-cell receptor are defective [307, 308]; in 
addition, the absence of WAVE inhibits store-operated Ca2+ entry [308]. It should be noted, 
however, that in natural killer cells the WASp protein regulates the nuclear translocation of 
transcription factors, which occurs downstream of store-operated Ca2+ influx, independently 
of its effect on the actin cytoskeleton [309].
The process that couples depletion of intracellular stores to plasma membrane Ca2+ channels 
is crucial for the proper functioning of T-cells since a defect in this pathway would render T-
cells unresponsive towards immunological stimuli. However, the precise pathways leading to
activation of plasma membrane Ca2+ channels are far from being defined. Whereas in certain 
cell types, the cortical actin cytoskeleton may play a role in this activation pathway, our work 
reported here shows that in T-cells actin rearrangement is dispensable for coupling the 
intracellular store release to plasma membrane CRAC channels.
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Part II
2.2. Regulation of T cell survival through coronin-1–mediated 
generation of inositol-1,4,5-trisphosphate and calcium 
mobilization after T cell receptor triggering
2.2.1. Abstract
T cell homeostasis is essential for the functioning of the vertebrate immune system, but the 
intracellular signals required for T cell homeostasis are largely unknown. We here report that 
the WD-repeat protein family member coronin-1, encoded by the gene Coro1a, is essential in 
the mouse for T cell survival through its promotion of Ca2+ mobilization from intracellular 
stores. Upon T cell receptor triggering, coronin-1 was essential for the generation of inositol-
1,4,5-trisphosphate from phosphatidylinositol-4,5-bisphosphate. The absence of coronin-1, 
although it did not affect T cell development, resulted in a profound defect in Ca2+
mobilization, interleukin-2 production, T cell proliferation and T cell survival. We conclude 
that coronin-1, through activation of Ca2+ release from intracellular stores, is an essential 
regulator of peripheral lymphocyte survival.
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2.2.2. Introduction
Maintaining T cell homeostasis is central to the ability of vertebrate organisms to mount an 
effective immune response. Lymphocyte precursors, originating from the bone marrow, home 
to the thymus, where positive and negative selection result in the production of CD4+ or CD8+
single-positive T lymphocytes [86]. From the thymus, single-positive T lymphocytes seed the 
peripheral organs, where they circulate for prolonged times between the secondary lymphoid 
organs and the blood in a naive state [310].
The pool of T cells that are present in the periphery consists of naive T cells as well as 
effector-memory T cells, which each seem to occupy separate homeostatic niches [170, 311].
The peripheral T cell population is maintained at near-constant numbers; maintenance of 
naive T cells in the periphery is dependent on the appropriate stimulation of T cells through 
their T cell receptors (TCRs). Indeed, in hosts that lack peripheral major histocompatibility 
complex (MHC) class I or class II expression, T cells are unable to survive because of the 
absence of TCR-mediated T cell stimulation [175, 312]. Also, induction of TCR deletion
results in the disappearance of peripheral T cells [172, 173], showing that T cells need input 
signals through their TCR to support their survival in the periphery [311]. However, the 
molecular requirements for T cell activation and survival in vivo remain poorly understood.
In mice lacking coronin-1, a leukocyte-specific molecule that is associated with the 
lymphocyte cortex [241], T cells are deleted from the periphery. This process has been 
suggested to be linked to prevention of F-actin mediated apoptosis by coronin-1, as judged by 
the observed increase in phalloidin staining in coronin-1 deficient cells [263]. However, the 
increased phalloidin signal upon coronin-1 deletion does not reflect altered F-actin abundance 
(P.M. and J.P., unpublished observations). Accordingly, in macrophages, coronin-1 was found 
to be fully dispensable for F-actin dynamics [238, 251].
In this work we report that in T cells, instead of regulating F-actin dynamics, coronin-1
interacts with phospholipase C-1 (PLC-1) and is essential for the generation of inositol-
1,4,5-trisphosphate (InsP3) upon TCR stimulation, thereby mediating Ca2+ release from 
intracellular stores that is essential for T cell activation and survival [201, 264]. The function 
of coronin-1 as a specific survival factor for peripheral T cells may allow a better 
understanding of T cell homeostasis as well as provide a basis for rational approaches for the 
development of compounds to treat autoimmune as well as lymphoproliferative disorders.
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2.2.3. Results
2.2.3.1. Coronin-1 and F-actin in T cells
In mice lacking the coronin-1 gene Coro1a ('coronin-1 deficient mice'), which encodes a 
leukocyte-specific member of the WD-repeat protein family of coronin molecules, naive T 
cells are deleted from the periphery ( [263] and Supplementary Figs. 1, 2, 3, 4 see below). On 
the basis of an increase in phalloidin fluorescence in the absence of coronin-1, coronin-1 was 
suggested to prevent F-actin induced apoptosis [263]; however, other studies showed that in 
macrophages lacking coronin-1, owing either to siRNA-mediated knockdown of Coro1a or to 
its deletion [238, 251], all measurable F-actin mediated processes occur normally.
Consistent with the latter results, we found no correlation between the elevated phalloidin 
staining and F-actin amounts, as analyzed using a sensitive biochemical assay as well as 
apoptosis as judged by Annexin V staining (P.M. and J.P., unpublished observations). We 
further evaluated a role for coronin-1 in F-actin distribution and dynamics in T cells by using 
wild-type (Coro1a+/+) or coronin-1 deficient (Coro1a-/-) T cells that were seeded onto 
microscope slides, fixed and stained for coronin-1 and actin, using either an actin monoclonal 
antibody or phalloidin, followed by confocal laser scanning microscopy. Although in cells 
lacking coronin-1 the phalloidin fluorescence intensity was increased ~ 2-fold, as anticipated 
([263] and P.M. and J.P., unpublished observations), the actin distribution as well as the 
intensity of cortical actin labeling was identical in wild-type and coronin-1 deficient T cells 
(Fig. 1a,b). Similarly, analysis of F-actin:G-actin ratio using a biochemical assay [287]
showed an identical F:G actin ratio in wild-type and coronin-1 deficient T cells (Fig. 1c). The 
mean values ± s.d. are listed in the legend to Figure 1.
To further define a possible influence of coronin-1 on actin dynamics, we analyzed TCR-
mediated cell spreading on anti-CD3 and anti-CD28 coated microscope slides to define
defects in the T cell actin cytoskeleton [308, 313]. The results showed qualitatively identical 
spreading in wild-type as well as in coronin-1 deficient cells (Fig. 1d). Finally, live cell 
imaging was used to record the activity of wild-type or coronin-1 deficient T cells seeded 
onto anti-CD3 plus anti-CD28 coated coverslips; the dynamics of the two types of T cells was 
similar (Fig. 1e,f and Supplementary Videos 1, 2, 3, 4 online). Together, these data indicated 
that deletion of the gene encoding coronin-1 did not affect F-actin dynamics in T cells.
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Figure 1: T cell cytoskeleton and F-actin dynamics in the presence and absence of coronin-1.
(a) Immunoblot after separation by SDS-PAGE of total proteins from wild-type (+/+) or coronin-1 deficient (-/-)
T cells for coronin-1 (left panel) or actin (right panel). (b) Immunofluorescence microscopy of wild-type 
(bottom) and coronin-1 deficient (top) T cells on poly-L-lysine-coated slides stained with phalloidin-Alexa Fluor 
568 and anti-actin and anti-coronin-1 followed by Alexa Fluor 488-and Alexa Fluor 633-labeled secondary 
antibodies, respectively. Two representative fields are shown. The ratio of the fluorescence values between the 
488 (anti-actin) and 568 (phalloidin) fluorophores was 1.24 for wild-type cells and 0.59 for coronin-1 deficient 
cells (n = 20 cells). (c) Immunoblot with anti-actin on supernatant (S) and pellet (P) fractions of wild-type or 
coronin-1 deficient cells left untreated or treated with either jasplakinolide or latrunculin B. Quantitation of F-
actin:G-actin ratio: 0.95 0.17 in untreated +/+ and 1.00 0.18 in untreated -/- cells (n = 4). (d) 
Immunofluorescence microscopy of T cells left to adhere to anti-CD3 plus anti-CD28 coated or control slides. 
After fixation, cells were stained with phalloidin Alexa Fluor 568 (red) and antibodies to coronin-1 (green), 
followed by Alexa Fluor 488 labeled secondary antibodies. (e,f) Video microscopy of wild-type or coronin-1
deficient T cells seeded on either anti-CD3 plus anti-CD28 coated or control slides (e). Quantitation of 
membrane ruffling in T cells from two independent movies (f). Values were normalized to ruffling over a period 
of 10 min. Shown are mean values (± s.d.; +/+, n = 17 cells; -/-, n = 23 cells). Data are representative of three 
independent experiments (Experiments presented in part b, e and f of this figure were performed together with 
Jayachandran R.).
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2.2.3.2. T cell signaling and proliferation in the absence of coronin-1
Because peripheral T cells are known to require a TCR-mediated signal in order to maintain 
their survival in peripheral lymphoid organs in vivo [173, 314, 315], we analyzed whether 
coronin-1 performs a role in signaling downstream of the TCR. To analyze TCR stimulation, 
we examined the capacity of wild-type or coronin-1 deficient cells to respond to allogeneic 
MHC stimuli. In contrast to wild-type T cells, which proliferated strongly upon allogeneic 
stimulation, the proliferation of coronin-1 deficient T cells was markedly reduced (Fig. 2a).
Figure 2: T cell proliferation and cycling in the presence and absence of coronin-1.
(a) Proliferation assay of purified splenic T lymphocytes (1 x105) cultured with the indicated number of 
mitomycin C treated BALB/c spleen cells for 3 d, followed by measurement of [3H]Thymidine incorporation. 
(b) Proliferation assay of naive T cells (CD4+CD62Lhi, 0.5 x105) from wild-type (+/+) or coronin-1 deficient 
mice (-/-) stimulated with anti-CD3 (1 μg/ml) on irradiated syngeneic spleen cells (2.5 x105). (c) ELISA for IL-2
production by wild-type or coronin-1 deficient cells after the stimulation indicated below. (d-f) Flow cytometry 
of total CD4+ T cells (0.5 x105) labeled with the fluorescent cell linker compound PKH26 and stimulated with 
0.1 μg/ml of anti-CD3 on 2.5 x105 mitomycin C treated syngeneic spleen cells for 36 h; proliferation of CD4+ T 
cells was monitored by dilution of the PKH26 dye: dot plot of wild-type cells (blue) and coronin-1 deficient T 
cells (red) (d); histograms of wild-type (e) or coronin-1 deficient (f) T cells with (blue, red) or without (black) 
anti-CD3 treatment. Data are representative of three independent experiments. The mean value of triplicate 
cultures ±s.d. is shown for a-c (Experiments presented in part a of this figure were performed by Massner J.).
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Similarly, whereas anti-CD3 stimulation resulted in substantial proliferation and interleukin-2
(IL-2) production, proliferation and release of IL-2 was severely depressed in coronin-1
deficient cells (Fig. 2b,c). Finally, we analyzed TCR-induced cell cycling in T cells; upon 
incubation of wild-type or coronin-1 deficient naive CD4+ T cells with anti-CD3, wild-type 
cells readily underwent cell cycle progression (Fig. 2d,e), whereas in the absence of coronin-
1, T cells failed to enter the cell cycle (Fig. 2d,f). Together these data suggested that coronin-1
is essential for TCR-mediated proliferation and cell cycle progression of T cells.
2.2.3.3. Coronin-1 and TCR-induced InsP3 generation
To investigate the molecular defect underlying the failure of T cells to proliferate in the 
absence of coronin-1, we analyzed signaling processes in naive wild-type and coronin-1
deficient T cells (Fig. 3). TCR triggering results in the clustering of TCR molecules, which 
precedes the activation of adaptor molecules through tyrosine phosphorylation, resulting in 
the activation of PLC-1[316].
We found no difference in clustering of TCRs or tyrosine phosphorylation in wild-type and 
coronin-1 deficient T cells stimulated with anti-CD3 plus anti-CD28 (Fig. 3a,b). Furthermore, 
analysis of the phosphorylation as well as localization of the adaptor proteins SLP-76 (SH2 
domain-containing leukocyte protein of 76 kDa) and LAT (linker for activation of T cells
[317]) showed similar phosphorylation and localization upon TCR triggering (Fig. 3c,d,g).
TCR triggering of both wild-type and coronin-1 deficient cells resulted in a similar PLC-1
phosphorylation and cellular localization (Fig. 3e,g), although in coronin-1 deficient cells 
PLC-1 dephosphorylation occurred slightly faster (Supplementary Fig. 5, see below). 
Finally, we evaluated recruitment of PKCq the Ca2+-independent protein kinase C family 
member that integrates TCR-CD28 costimulatory signals, which are essential for productive 
T-cell activation [118] to the interface between wild-type and coronin-1-deficient T cells 
stimulated with anti-CD3 and anti-CD28 coated beads; recruitment of PKCq was 
indistinguishable in both cell types (Fig. 3h,i).
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Figure 3: T cell signaling, InsP3 generation and localization of signaling molecules.
(a) Fluorescence microscopy of wild-type (+/+) or coronin-1 deficient (-/-) T cells stimulated with anti-CD3, 
anti-CD28 and goat anti-hamster Alexa Fluor 568. (b,c) Immunoblot of lysates from wild-type or coronin-1
deficient naive T cells stimulated with anti-CD3, anti-CD28 and mouse anti-hamster for the times indicated. 
Proteins were separated by SDS-PAGE (12.5%) and immunoblotted with anti-phosphotyrosine (b) or 
immunoblotted with anti-phosphotyrosine and then reprobed with anti-SLP-76 (asterisk). (d,e) Immunoblots as 
in b immunoblotted for either phospho- (p)-Lat and total Lat (d) or p-PLC-1, total PLC-1 and coronin-1 (e). (f) 
Competitive radio-receptor assay for InsP3 amounts in cells prepared and treated as under b. (g) Fluorescence 
microscopy of wild-type and coronin-1 deficient naive T cells mixed in a 1:1 ratio and then adhered to anti-CD3
plus anti-CD28 coated slides for 30 min, fixed and stained with either anti-PLC-1 (red, top right), anti-SLP-76
(red, bottom right) or anti-Lat (red, middle right) and rat anti-coronin-1 (green, left panels). (h,i) Fluorescence 
microscopy of wild-type (right column), coronin-1 deficient (middle column) or mixed (left column) splenic T 
cells incubated with (middle and right columns) or without (left column) beads coated with anti-CD3 plus anti-
CD28, and then stained with anti-coronin-1 (green) and anti-PKCq (red). Top, bright field; bottom, merged (red 
plus green plus bright field). (i) Graph of the percentage of polarized conjugates containing PKCq. (Mean values 
±s.d. from three independent experiments are shown.) Data are representative of at least three independent 
experiments (Experiments presented in part g and i of this figure were performed together with Jayachandran 
R.).
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Activation of PLC-1 leads to the generation of InsP3 and diacylglycerol from 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2). InsP3 binds to InsP3 receptors 
(InsP3Rs) and triggers Ca2+ release from intracellular stores [201, 264]. Triggering of the 
TCRs of coronin-1 deficient T cells resulted in a markedly reduced InsP3 generation 
compared to that in wild-type T cells (Fig. 3f).
 
Figure 4: PtdIns(4,5)P2 localization and Ca2+ mobilization in wild-type and coronin-1 deficient T cells.
(a) Fluorescence microscopy of wild-type (+/+) or coronin-1 deficient (-/-) naive T cells mixed in a 1:1 ratio and 
placed on anti-CD3 , anti-CD28 coated slides for the indicated time periods; cells were then incubated with anti-
PtdIns(4,5)P2 and rat anti-coronin-1 followed by Alexa Fluor conjugated secondary antibodies (red, 
PtdIns(4,5)P2; green, coronin-1). (b) Calcium mobilization upon anti-CD3 plus anti-CD28 stimulation of splenic 
wild-type or coronin-1 deficient T cells loaded with Indo-1. Arrow, time of addition of stimulus. (c) Calcium 
mobilization upon anti-CD3 plus anti-CD28 stimulation in calcium-free Ringer's solution in splenic wild-type or 
coronin-1 deficient T cells loaded with Fluo-3. The arrow indicates the time of addition of the stimulus; added 
after 30 s in the absence of calcium. For details, see Methods. Data are representative of at least three 
independent experiments (Experiments presented in part a of this figure were performed together with 
Jayachandran R.).
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As visualized using confocal microscopy, in wild-type cells, all PtdIns(4,5)P2 disappeared 
within 45 s after TCR triggering (Fig. 4a, top row, green box). Consistent with defective InsP3
generation in the absence of coronin-1, PtdIns(4,5)P2 amounts remained unaltered when the 
TCRs of coronin-1 deficient T cells were stimulated (Fig. 4a, top row, white box).
In accordance with defective InsP3 production, no Ca2+ flux was generated in coronin-1
deficient T cells after TCR-mediated activation (Fig. 4b), despite normal store content as 
analyzed using the Ca2+ ATPase blocker thapsigargin [292] (data not shown). TCR 
stimulation in the absence of extracellular Ca2+ resulted in normal Ca2+ release in wild-type T 
cells, whereas no Ca2+ was released in coronin-1 deficient T cells (Fig. 4c), which is 
consistent with the lack of InsP3 generation in the absence of coronin-1. In order to assure the 
viability of the T cells used in this assay, we stained a parallel sample with Annexin V. Less 
than 5% of the gated cells stained positive (data not shown).
2.2.3.4. Coronin-1 and thymocyte signaling
The observed normal T cell development in the absence of coronin-1 suggested that coronin-1
was crucial for TCR-mediated signaling in peripheral T cells (Figs. 3 and 4) but dispensable 
for thymocyte development (Supplementary Figs. 2, 3, 4 see below). To understand the 
relative contributions of coronin-1 to peripheral T cell signaling and thymocyte development, 
we evaluated coronin-1 expression and TCR-mediated signaling in thymocytes from wild-
type and coronin-1 deficient mice. Coronin-1 expression was strongly upregulated in single-
positive cells, whereas double-positive cells expressed only small amounts of coronin-1 (Fig. 
5a,b and [318]). Double-positive thymocytes showed little Ca2+ mobilization after TCR 
triggering, and this Ca2+ mobilization was independent of coronin-1, as no significant 
differences were observed between wild-type and coronin-1 deficient double-positive 
thymocytes (Fig. 5c). Single-positive thymocytes from wild-type mice reacted toward TCR 
triggering with a strong Ca2+ mobilization, as expected [319] (Fig. 5d, blue lines). In contrast 
to that in double-positive thymocytes, calcium mobilization was greatly depressed in coronin-
1 deficient single positive thymocytes. 
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We concluded from these data that, for thymocytes, generation of coronin-1 independent Ca2+
fluxes are sufficient to result in proper T cell development; whether or not such Ca2+ signaling 
depends on the expression of other coronin isoforms in the thymocyte subsets, however, 
remains unknown (Supplementary Fig. 6 and Methods, see below) [320]. Notably, whereas in 
single-positive thymocytes and naive T cells, coronin-1 was essential for TCR-mediated Ca2+
mobilization, in both wild-type as well as coronin-1 deficient memory-effector T cells, TCR 
triggering did not induce Ca2+ fluxes (Supplementary Fig. 7, see below), which is consistent 
with the normal survival of memory-effector T cells in the absence of coronin-1 [321-324].
Figure 5: Thymocyte coronin-1 and Ca2+ flux.
(a,b) Flow cytometry of wild-type (+/+) and coronin-1 deficient (-/-) total thymocytes from 5- to 6-week-old 
mice stained with anti-CD4, anti-CD8 and Alexa Fluor 633 conjugated anti-coronin-1. Histogram of anti-
coronin-1 staining for coronin-1 deficient thymocytes and double-positive (DP) and single-positive (SP) wild-
type thymocytes (a); corresponding mean fluorescence intensity (MFI) values (b). (c,d) Calcium fluxes upon 
CD3-induced TCR triggering compared in anti-CD4, anti-CD8 stained, Indo-1 loaded wild-type and coronin-1
deficient thymocytes. Arrow indicates the time of addition of the stimulus. Data are representative of at least 
three independent experiments.
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2.2.3.5. Coronin-1 and PLC-1
The data presented thus far suggest that coronin-1 is specifically involved in the activation of 
Ca2+ release through PLC-1 mediated formation of InsP3. To analyze the consequences of 
defective InsP3 production and to investigate whether coronin-1 is specifically involved in 
PLC-1 mediated processes, we evaluated the activation of several signaling molecules 
downstream of TCR activation. Whereas the activation of the extracellular signal regulated 
kinases (ERK) 1 and 2 [325, 326], which are PLC-1 and Ca2+ dependent, was defective in 
the absence of coronin-1 (Fig. 6a), the phosphorylation pattern of p38 as well as 
phosphorylation and degradation of IB-& were unaltered (Fig. 6b). In addition, whereas in 
the absence of coronin-1 the Ca2+-dependent translocation of NFAT (nuclear factor of 
activated T cells) to the nucleus was defective upon TCR stimulation, TCR triggering induced 
nuclear translocation of NF-B in equal numbers of wild-type and coronin-1 deficient T cells 
(Supplementary Fig. 8, see below). These results are consistent with a specific role for 
coronin-1 in InsP3-mediated Ca2+ release and furthermore showed that deletion of Coro1a
does not result in a general defect in TCR-mediated signaling.
To further corroborate a role for coronin-1 in PLC-1 mediated InsP3 release, we evaluated T 
cells after treatment with the PLC activator N-(3-trifluoromethylphenyl)-2,4,6-
trimethylbenzenesulfonamide (m-3M3FBS) [327]. Whereas PLC activation in wild-type cells 
resulted in rapid mobilization of intracellular Ca2+, activation of PLC in the absence of 
coronin-1 failed to induce Ca2+ release (Fig. 6c,d). Similarly, when Jurkat T cells were 
depleted of coronin-1 by expression of siRNA specific for human coronin-1 (Fig. 6e), 
activation failed to result in Ca2+ mobilization, whereas normal Ca2+ mobilization occurred 
after treatment with siRNA specific for mouse coronin-1 (Fig. 6f).
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Figure 6: Signaling pathways in wild-type and coronin-1 deficient cells upon TCR and PLC activation.
(a,b) T cells were prepared and treated as described in Figure 3 and immunoblotted using the indicated 
antibodies. (c,d) T cells from wild-type (c) or coronin-1–deficient (d) mice were loaded with Fluo-3 a.m. and 
stimulated with m-3M3FBS (blue) or DMSO (red). For details, see Methods. (e) Jurkat T cells transfected with 
pSUPER::hTACO1 or pSUPER::mTACO1. msiRNA, mouse coronin-1–specific siRNA; hsiRNA, human 
coronin-1–specific siRNA. Immunoblot of total cell lysates of with coronin-1 or actin-specific antibodies. (f) 
Measurement of calcium flux by fluorescence in Jurkat T cells transfected as in e (blue, msiRNA; red, hsiRNA) 
and then loaded with Indo-1 a.m., stimulated with 10 μM m-3M3FBS. Arrow indicates the time of addition of 
the stimulus. Data are representative of three independent experiments (Experiments presented in part c to f of 
this figure were performed mainly by Jayachandran R.).
- 90 - 
 
Finally, we analyzed whether coronin-1 directly interacted with PLC-1 by performing co-
immunoprecipitation from detergent lysates [34] of wild-type T cells. We readily detected 
coronin-1 by immunoblotting when we immunoprecipitated PLC-1 from T cell lysates (Fig. 
7a); co-immunoprecipitation of coronin-1 with PLC-1 was not due to the association of 
PLC-1 and coronin-1 with the actin cytoskeleton, however, because actin was not detectable 
in the immune complexes (Fig. 7b-d). Together the above data suggested that coronin-1, by 
forming a complex with PLC-1, acts as an essential cofactor for InsP3 generation and is 
therefore a key mediator of intracellular Ca2+ release.
Figure 7: Interaction of Coronin-1 and PLC-1.
(a) T cells from wild-type mice were lysed, immunoprecipitated (IP) using PLC-1 specific antibodies and 
separated by two-dimensional IEF SDS-PAGE followed by immunoblotting using coronin-1 specific antibodies 
(upper panel). As controls, lysates immunoprecipitated with protein A beads only (second panel), control IgG 
(third panel) or total lysate (lower panel) were similarly separated by two-dimensional IEF SDS-PAGE and 
immunoblotted for coronin-1 (arrows). (b). Anti-PLC-1 immunoblot of 20% of the immunoprecipitated beads 
from an experiment similar to that in a separated by 7.5% SDS-PAGE to analyze the efficiency of PLC-1
immunoprecipitation. Lane 1, total lysate; lane 2, beads only; lane 3, anti-PLC-1 immunoprecipitate. (c,d) Blots 
as in a reprobed with anti-actin. The box indicates the position of actin on the immunoblot. The box indicates the 
position of actin on the immunoblot. Data are representative of three independent experiments.
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2.2.4. Discussion
Coronin-1 is a leukocyte specific molecule that associates with the cell cortex in a cholesterol-
dependent manner and has been proposed to be involved in the regulation of leukocyte-
specific signal transduction processes [241, 255]. Here, we found that coronin-1 was essential
for the survival of naive T cells in the periphery by activating Ca2+ release from intracellular 
stores upon TCR triggering. Coronin-1 associated with PLC-1, thereby promoting the 
generation of the second messenger InsP3, responsible for the release of Ca2+ from 
intracellular stores.
The role defined here for coronin-1 in the generation of InsP3 upon TCR triggering differs 
markedly from a recent conclusion that coronin-1 is dispensable for TCR-mediated signaling, 
instead preventing F-actin induced apoptosis [263]. However, in contrast to the results 
described here, the previous conclusion that coronin-1 is dispensable for TCR-mediated 
signaling was based on the analysis of mice possessing a fixed T cell repertoire [263]. In such 
animals, T cells with an activated-memory phenotype develop even in the absence of previous 
exposure to antigen (ovalbumin); this does not occur in non-transgenic mice [328, 329]. The 
lack of a signaling defect in the TCR-transgenic T cells used in that study [263] may therefore 
be because TCR triggering is especially important for the survival of naive T cells, whereas 
effector-memory cells can survive in the absence of TCR ligation [173, 314, 315]. Consistent 
with that notion, we found a severe reduction in absolute numbers of naive T cells in coronin-
1 deficient mice, although effector-memory cells survive in the absence of coronin-1 [321-
323].
Several other lines of evidence support a specific role for coronin-1 in T cell signaling rather
than, as reported by a previous study [263], in modulating F-actin dynamics. First, F-actin 
dynamics were normal in the absence of coronin-1 as analyzed by several independent 
morphological, biochemical and functional assays, including the analysis of TCR-mediated 
cell spreading. Second, the conclusion that coronin-1 regulates F-actin dynamics in T cells, 
thus preventing F-actin induced apoptosis, relies on the observation of increased phalloidin 
staining in cells lacking coronin-1 [263]. However, enhanced phalloidin staining was detected 
in all coronin-1 deficient leukocyte subsets, independent of their in vivo depletion, 
cytoskeletal functioning (P.M. and J.P., unpublished observations) or cortical actin staining 
(using antibodies to actin). Third, a role for coronin-1 in modulating PLC-1 activity rather 
than in regulating F-actin dynamics is consistent with the capacity of coronin-1 to prevent 
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lysosomal delivery of pathogenic mycobacteria in macrophages through activation of the 
Ca2+-dependent phosphatase calcineurin [237, 251, 330], a role which might be mediated by 
the function of coronin-1 in PLC-1 mediated processes described here.
Coronin-1 was initially isolated from mammalian leukocytes co-purifying with a 
phospholipase activity [240]. The physical interaction between coronin-1 and PLC-1 shown 
here suggests that coronin-1 may function as a docking site for PLC-1 required for the 
generation of InsP3. Alternatively, although the overall localization of PLC-1 or its activators 
does not seem to be altered upon coronin-1 deletion, coronin-1 may be involved in the 
appropriate positioning of PLC-1 at the membrane, which is known to be required for proper 
generation of InsP3 [241, 331, 332]. In this context, we note that only a fraction of coronin-1
was found to associate with the total PLC-1 present in T cells (data not shown), suggesting 
that either PLC-1 interacts with a post-translationally modified form of coronin-1 or, 
alternatively, that coronin-1 provides a scaffold at the cell cortex to locally modulate the 
interaction of PLC-1 with PtdIns(4,5)P2.
The definition of coronin-1 as an essential signaling component allowing intracellular Ca2+
mobilization through InsP3 generation may allow a better understanding of T cell activation 
and homeostasis as well as provide a basis for rational approaches for the development of 
compounds to treat autoimmune as well as lymphoproliferative disorders.
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2.2.6. Supplementary Figures and Tables
Supplementary Figure 1: Analysis of coronin 1 expression in lymphoid organs from wild type and coronin 
1 deficient mice. 
Cell lysates were prepared from the indicated organs, and equal protein amounts separated by SDS-PAGE and 
immunoblotted for the detection of coronin 1 (left panel) and GFP (right panel) (Experiments presented in this 
figure were performed by Massner J.).
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Supplementary Figure 2: Normal lymphocyte development in wild type and coronin 1 deficient mice.
Single cell suspensions of the indicated organs were prepared and stained with antibodies directed against 
antigens being specifically expressed at the various developmental stages of the lymphoid and myeloid lineage. 
(a) Bone marrow cells were stained for the B cell lineage marker B220 and IgM. (b) Bone marrow cells of the 
myeloid lineage were characterized by expression of CD11b and B220. (c) Thymocyte populations were 
analyzed by CD4 and CD8 staining. (d) Thymi from wild-type (+/+) or coronin 1-deficient (–/–) mice were 
prepared for histology and stained for CD4+ as well as CD8+ cells using antibodies coupled to APC (CD4) or 
FITC (CD8). Magnification: 10X. (e) Cell suspensions of the thymus of 6 weeks old homozygous (–/–) or wild-
type (+/+) mice were analyzed by flow cytometry using antibodies directed against the indicated thymocyte 
subsets CD4/CD8 double-negative (DN), double-positive (DP) and single-positive (CD4+ and CD8+)
thymocytes). Cells were counted using a Neubauer chamber. Subset specific cell numbers were calculated by 
referring the percentage of a certain cell type (determined by flow cytometry) to the total cell counts. Filled bars: 
wild-type, open bars: coronin 1-deficient. Data represent means ± s.d. of 5 animals (n = 5) (Experiments 
presented in part a, b, c and e of this figure were performed by Massner J. and Ceredig R.;
Immunohistochemistry (part d) was performed by Blum C.).
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Supplementary Figure 3: Depletion of peripheral T cells in coronin 1-deficient mice.
(a) Tail blood from coronin 1-deficient mice (open bars) and wild-type littermates (filled bars) was 
hematological analyzed on an ADVIA instrument. Data represent means ± s.d.; +/+, n = 13 animals ; –/–, n = 19 
animals). (b). For leukocyte counts, peripheral blood of 6 weeks old mice was analyzed by flow cytometry using 
antibodies against the indicated leukocyte subsets markers. Cells were counted using a Neubauer chamber and 
total cell counts were corrected to 1 ml peripheral blood. Subset specific cell numbers were calculated by 
referring the percentage of a certain cell type (as determined by flow cytometry) to the total cell counts. Data 
represent means ± s.d. of 5 animals (n = 5). (c, d). Cell suspensions of spleen (c) or inguinal lymph nodes (d) 
were analyzed by flow cytometry. Lymphocyte specific cell numbers were calculated by referring the percentage 
of a certain cell type to the total cell counts. Data represent means ± s.d. of 5 animals (n = 5). Spleen (e) or 
inguinal as well as cervical lymph nodes (f) were prepared for histology and stained for B220 (FITC) and Thy 
1.2 (PE) or DAPI (f, lower panel) as described in Supplementary Methods. Magnification: 10X (Experiments 
presented in part a to d of this figure were performed by Massner J. and Ceredig R.; Immunohistochemistry (part 
e and f) was performed by Blum C.).
- 96 - 
 
Supplementary Figure 4: T cell populations in the periphery of wild-type and coronin 1-deficient mice.
Erythrocyte depleted splenocytes from wild-type (filled bars) and coronin 1-deficient animals (open bars) were 
stained with the indicated surface markers and total cell numbers were calculated. Data represent means ± s.d. of 
3 animals (n = 3).
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Supplementary Figure 5: Phosphorylation of PLC-1 in wild-type and coronin 1-deficient T cells.
PLC-1 phosphorylation after TCR cross-linking was quantified in wild-type (filled bars) and coronin 1-deficient 
naive T cells (open bars) using data sets derived from experiments as shown in Figure 3e. Background subtracted 
signal intensities were expressed relative to the highest signal intensity at 45 seconds which was set to 100% in 
all experiments. Data represent means ± s.d. of 4 data sets from 3 independent experiments (n = 4).
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Supplementary Figure 6: Expression of coronin isoforms in thymocyte and T cell subsets. 
(a) RT-PCR was carried out using total RNA isolated from single positive thymocytes, double positive 
thymocytes and splenic T cells, loaded onto a 1.2 % agarose gel and electrophoresed. Coronin 1-7 isoforms are 
numbered from 1 to 7. (b) Single positive thymocytes, double positive thymocytes and splenic T cells purified 
from wild-type animals using MACS were lysed and equal protein amounts as determined by BCA protein assay 
were separated by SDS PAGE (10 %) followed by immunoblotting for the proteins indicated. Data are 
representative of 3 independent experiment (Experiments presented in this figure were performed together with
Jayachandran R. and Combaluzier B.)
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Supplementary Figure 7: T cell receptor induced calcium fluxes in memory-effector T cells from wild-type 
and coronin 1 deficient mice. 
Splenic memory-effector T cells from wild-type or coronin 1-deficient mice were stimulated with anti-CD3 + 
anti-CD28 as described in Supplementary Methods and calcium fluxes were analyzed. Naive wild-type T cells 
were stimulated and analyzed as described for the memory-effector T cells. Data are representative of 3 
independent experiments.
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Supplementary Figure 8: Nuclear translocation of NF-kB and NFAT in wild-type and coronin 1-deficient 
T cells upon T cell receptor triggering.
Wild-type as well as coronin 1-deficient splenic T cells were prepared and stimulated with anti-CD3 + anti-
CD28 as described in Supplementary Methods. Cells were stained with anti-p65 (a) or anti-NFAT (b); nuclei 
were stained using DRAQ5. For quantization of nuclear translocation of p65 (c) or NFAT (d) two times 100 
cells were analyzed for both wild-type as well as coronin 1 deficient T cells from two independent experiments.
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Part III
2.3. Coronin 1 Maintains the Balance between Survival and Apoptosis 
in Naive T Cells Independent of F-Actin
2.3.1. Abstract
Coronins are WD repeat containing proteins highly conserved in the eukaryotic kingdom 
implicated in the regulation of F-actin. Mammalian coronin 1, one of the most conserved 
isoforms expressed in leukocytes, regulates survival of T cells which has been suggested to be 
due to its role in preventing F-actin induced apoptosis. We here come to a different 
conclusion. We show that coronin 1 does not modulate F-actin and that induction of F-actin 
failed to induce apoptosis. Instead, coronin 1 was required for providing pro-survival signals, 
in the absence of which T-cells rapidly underwent apoptosis. These results overhaul the long 
held view that coronin 1 functions through modulation of F-actin and establish coronin 1 as 
an essential regulator of Ca2+/calcineurin dependent signaling in T-cells.
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2.3.2. Introduction
Coronin 1 is a member of the conserved WD repeat family of coronin proteins that is 
exclusively expressed in leukocytes [237]. In mice lacking coronin 1, naïve T-cells are deleted 
from the periphery, [239] [263, 333-335], suggesting that coronin 1 has a specific and 
essential role in the regulation of cellular homeostasis and the survival of these cells.
Coronin 1 is homologous to Dictyostelium discoideum coronin, that was originally isolated as 
an actin/myosin binding protein [224]. Deletion of coronin from these slime molds was 
subsequently shown to result in pleiotropic defects such as reduced phagocytosis, 
macropinocytosis, cell locomotion and cytokinesis [225, 226]. In yeast, the single coronin 
isoform has been suggested to modulate the formation of actin filamentous networks via 
regulation of the actin-related protein 2/3 (Arp2/3) activity, based on in vitro experiments 
[233]. However, living yeast cells lacking coronin do not show any obvious phenotype [231].
The original isolation of Dictyostelium coronin from an actin-myosin affinity matrix has led 
to the assignment of all coronin protein family members as actin-interacting and regulating 
proteins [224, 228, 229]. However, the evidence for F-actin regulation by mammalian coronin 
isoforms is largely based on in vitro polymerization assays using purified proteins [336-338],
or overexpression of coronin domains in a heterologous system [339, 340]. In vivo, the only 
evidence linking coronin 1 to a direct modulation of the F-actin cytoskeleton is based on the 
observation that coronin 1 deficient leukocytes display a ~2-fold higher phalloidin 
fluorescence as compared to wild type cells. Consequently, the decrease in cell viability as 
well as migration of T-cells lacking coronin 1 as observed in coronin 1 deficient mice was 
attributed to defective functioning of the F-actin cytoskeleton [263, 333-335]. In contrast to 
linking a role for coronin 1 in T-cell survival to the modulation of F-actin, recent work 
suggested that coronin 1 promotes T-cell survival by allowing signal transduction 
downstream of the T-cell receptor [239].
We here provide an explanation for this apparent discrepancy. We show that phalloidin 
cannot be used to quantitate F-actin in cells expressing different coronin 1 levels and 
furthermore that coronin 1 does not directly modulate F-actin. In cells depleted of coronin 1 
by either gene deletion or RNA interference, phalloidin levels increased in direct inverse 
relation to the amount of coronin 1, without affecting the F/G-actin ratio or cell viability. 
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Conversely, expression of coronin 1 in non-leukocytes resulted in decreased phalloidin 
fluorescence without affecting F/G actin levels or viability.
Instead of regulating the F-actin cytoskeleton, we describe here that coronin 1 is required for 
the generation of pro-survival signals upon T-cell receptor ligation, in the absence of which 
naïve T-cells undergo apoptosis. Importantly, we show that the proposed role for coronin 1 in 
modulating T-cell migration, is not a cell intrinsic property of coronin 1 deficient T-cells, but 
is due to imbalanced T-cell receptor signaling. This, in turn, results in the depletion of pro-
survival signals and as a result causes defects in cellular survival and migration. The here 
described results are therefore crucial for a better understanding of the function of coronin 1 
as well as the processes that regulate cellular survival and migration.
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2.3.3. Results
2.3.3.1. Phalloidin Fluorescence, F-actin and Apoptosis
Coronin 1 has been proposed to prevent apoptosis via the modulation of the F-actin 
cytoskeleton. This conclusion was based on the observed ~2-fold increase in phalloidin 
fluorescence intensity in coronin 1 deficient T-cells versus wild type T-cells [263, 333-335].
To analyze the correlation between phalloidin fluorescence and apoptosis, the different 
leukocyte populations as indicated in Figure 1 and Supplementary Figure 1 (see below) were 
isolated from wild type or coronin 1 deficient mice, and analyzed for coronin 1 expression, 
phalloidin fluorescence and Annexin V staining. Staining of all leukocyte populations using 
Alexa Fluor 568 or 633 -conjugated phalloidin resulted in a ~2-fold increase of fluorescence 
in coronin 1 deficient cells versus wild type cells (Figure 1A and B). 
Figure 1: Coronin 1 expression, phalloidin fluorescence and apoptosis in wild type, heterozygous and 
coronin 1 deficient cells.
The indicated cell populations from wild type, heterozygous and coronin 1 deficient mice were stained for 
coronin 1 using an AlexaFluor633 conjugated polyclonal anti coronin 1 antibody (A, upper row). The same cells 
were stained using Alexa Fluor 568 or 633 conjugated phalloidin (B, middle row) and PE or APC-conjugated 
Annexin V (C, lower row). Depicted are mean +/– SD of three mice in each group. Stainings were analyzed 
using FACS. 
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However, with the exception of CD4+ single positive thymocytes as well as T-cells, none of 
the leukocyte populations lacking coronin 1 showed an increase in apoptosis, as judged by 
Annexin V labeling (Figure 1C). Notably, the heterozygous CD4+ single positive thymocytes 
as well as T-cells showed intermediate levels of phalloidin staining but no elevated Annexin 
V staining.
The above results show that the increased phalloidin fluorescence upon depletion of coronin 1 
does not correlate with the induction of apoptosis in the analyzed leukocyte populations. 
Possibly, the observed increase in phalloidin fluorescence is a result of coronin 1 depletion 
rather than of increased F-actin. To directly address this possibility, the F/G-actin ratio in wild 
type or coronin 1 deficient cells was analyzed under conditions where the F-actin 
cytoskeleton was perturbed by the addition of F-actin interfering drugs. For that purpose, we 
used either the fungal peptide Jasplakinolide to induce polymerization of F-actin [286] or 
Latrunculin B to depolymerize F-actin [282, 283]. As expected, the addition of Jasplakinolide 
resulted in F-actin polymerization while the presence of Latrunculin B induced 
depolymerization of F-actin in both wild type as well as coronin 1 deficient cells to the same 
extent (Figure 2A). In order to demonstrate the sensitivity as well as the reproducibility of the 
biochemical F versus G-actin assay, untreated wild type and coronin 1 deficient T-cells were 
compared with wild type cells exposed to CCL19, a member of the chemokine compounds 
that are known to result in the induction of F-actin polymerization [341]. The amount of 
CCL19 was titrated to yield a similar elevation of phalloidin staining as observed in the 
untreated coronin 1 deficient T-cells (Figure 2B). Cells treated as described above were 
subjected to the F versus G-actin assay as in Figure 2A, total proteins were separated by SDS-
PAGE, immune-blotted for actin and the F versus G-actin ratio was calculated. As shown in 
Figure 2, panels C and D, while CCL19 induced the same increase in phalloidin fluorescence 
as coronin 1 deletion (Figure 2B), only CCL19 triggering resulted in an elevation of the F/G-
actin ratio as measured biochemically. Finally, to analyze whether F-actin modulation results 
in elevated spontaneous apoptosis, as suggested earlier [263], wild type CD4+ single positive 
thymocytes were incubated with the F-actin modulating reagents as indicated in panel E and 
the viability of the cells was analyzed by Annexin V and 7-AAD staining. As shown in Figure 
2, Panel E, neither depolymerization nor polymerization of the F-actin cytoskeleton in wild 
type cells resulted in an altered viability while untreated coronin 1 deficient cells showed a 
severe defect in survival.
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Figure 2: F/G-actin ratio, spontaneous apoptosis and F-actin induced apoptosis in wild type and coronin 1 
deficient T-cells.
(A) For the analysis of G- and F-actin content in response to actin modulating drugs, wild type (+/+) or coronin 1 
deficient (–/–) splenic T-cells were left untreated or treated with either Jasplakinolide (1 AM) or Latrunculin B (4 
AM) for 45 min at room temperature followed by cell lysis. Proteins present in supernatants (S) and pellets (P) 
prepared as described in methods were separated by SDS-PAGE and immuno-blotted using anti-actin antibodies. 
(B) Wild type T-cells were treated with CCL19 (250 ng/ml for 60 seconds) to result in the same phalloidin 
staining as coronin 1 deficient T-cells, shown is a representative histogram of untreated and CCL19 wild type T-
cells as well as untreated coronin 1 deficient T-cells stained with phalloidin-633. (C) Cells treated as in B were 
analyzed for F/G actin as described in methods. (D) Quantitation of a representative experiment out of three as 
described under B and C. Shown are mean +/– SD of three independent samples. (E) Wild type CD4+ single 
positive thymocytes were incubated for 4 and 20h with DMSO (carrier), Latrunculin B (LatB, 4 AM) or 
Jasplakinolide (JP, 1 AM) at 37°C, 5% CO2 as indicated and stained with Annexin V and 7-AAD at the indicated 
time points. Coronin 1 deficient cells treated with DMSO were used as an internal control. Cells negative for 
both Annexin V and 7-AAD were considered as viable cells.
To further analyze the correlation between coronin 1 expression, F-actin accumulation and 
Annexin V labeling, two additional experiments were performed. First, coronin 1 was 
depleted in the human T-cell line Jurkat using siRNA specific for mouse (control) or human 
coronin 1. While coronin 1 expression was effectively knocked down in Jurkat cells 
expressing the human, but not the mouse siRNA (Figure 3A), the ratio of F/G actin as 
measured biochemically was similar in wild type and coronin 1 depleted cells (Figure 3B). 
However, phalloidin fluorescence increased ~2-fold upon coronin 1 depletion (Figure 3C). 
Analysis of Annexin V labeling revealed no differences (Figure 3D). Also, incubation of 
Jurkat cells expressing the murine or human specific siRNA with the apoptosis inducing agent
tumor necrosis factor-& (TNF-&) revealed no differences in either the time course or degree of 
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apoptosis induction (Figure 3D, insert). Conversely, while in the non-leukocyte cell line Mel 
JuSo transfected with cDNA encoding coronin 1 [237], expression of coronin 1 resulted in a 
decrease of phalloidin fluorescence, as observed in T-cells, no differences were found in the 
F/G actin ratio or Annexin V labeling of control versus coronin 1 expressing cells (Figure 3E-
H). In addition, incubation of control or coronin 1 expressing Mel JuSo cells with the 
apoptosis inducing agent staurosporin revealed no differences in either the time course or 
degree of apoptosis induction (Figure 3H, insert). In accordance with these findings, 
staurosporin induced the same degree of apoptosis in both wild type and coronin 1 deficient 
B-cells (Supplementary Figure 2, see below). These results therefore corroborate the 
conclusion that expression or deletion of coronin 1 interferes with phalloidin fluorescence, but 
does not affect F-actin levels nor has a direct effect on or protects cells from apoptosis.
2.3.3.2. Chemokine induced migration of wild type and coronin 1 deficient T-cells
An important question to address was why, in the absence of an F-actin phenotype, coronin 1 
deficient T-cells as opposed to B-cells [334], macrophages [238, 251] and neutrophils [252],
show a significantly lower migratory capacity as well as a survival defect when compared to 
wild type cells. For this purpose wild type and coronin 1 deficient T cell subsets as well as B-
cells were analyzed for spontaneous apoptosis as well as the ability to migrate in a transwell 
migration assay. Naïve CD4+ T-cells (Figure 4A) and B-cells (Figure 4B), isolated from wild 
type or coronin 1 deficient mice, were left in medium for the indicated time and stained with 
Annexin V and 7-AAD to assess the number of viable cells. Double negative cells were 
scored as viable. Cells from the same preparation were analyzed for their ability to migrate in 
a transwell migration assay towards the indicated concentrations of chemo-attractants. Our 
results demonstrate that freshly isolated coronin1 deficient naïve T-cells show elevated levels 
of spontaneous apoptosis and that the number of migration competent naïve T-cells is far 
lower in case of coronin 1 deficient cell preparations as compared to the wild type control. 
Our results further show that in B-cells, which in the absence of coronin 1 show elevated 
levels of phalloidin fluorescence similar to that observed in T-cells (see Figure 1), neither 
cellular viability nor their capacity to migrate is affected.
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Figure 3: Phalloidin fluorescence, F/G actin ratio and apoptosis in siRNA transfected Jurkat T-cells and 
coronin 1 expressing Mel JuSo cells.
The human Jurkat T-cell line was transfected for 5 days with human anti-coronin1 siRNA or a control siRNA 
specific for the murine coronin 1 [238]. (A) Proteins from cell lysates obtained from the same cells as used under 
B-D were separated by SDS-PAGE and immunoblotted using anti-coronin 1 or anti-actin antibodies. (B) Jurkat 
T-cells transfected with either the human or control mouse anti-coronin 1 siRNA were analyzed for their G- and 
F-actin content. Cells were lysed and proteins present in supernatants (S) and pellets (P) prepared as described 
above were separated by SDS-PAGE and immunoblotted using anti-actin antibodies. (C) The cells used in B 
were stained using Alexa Fluor 568 phalloidin and analyzed by FACS. (D) Cells as under B and C were stained 
with PE-conjugated Annexin V and analyzed by FACS. Depicted are means +/- SD of cells from three cell 
samples analyzed individually. Cells as above were incubated for 0, 4 or 6 hours with 20 ng/ml of human TNF
to induce apoptosis (D, insert). (E-H) Mel JuSo cells stably expressing coronin 1 or coronin 1 negative control 
cells [237] were analyzed as described for the siRNA treated Jurkat T-cells under A-D with the exception of 
panel H were staurosporin (1 μM) was used instead of TNF- (see insert).
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Figure 4: Spontaneous apoptosis and migration of naïve splenic T-cells and B-cells in the presence and 
absence of coronin 1.
(A) Spontaneous apoptosis and transwell migration of freshly isolated naïve splenic T-cells and (B) B-cells using 
the indicated chemo-attractants. Depicted are means +/– SD of duplicates. The experiments were repeated at 
least 3 times.
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Using the same experimental setup we also analyzed isolated double positive thymocytes, 
CD4+ single positive thymocytes and memory/effector T-cells for spontaneous apoptosis as 
well as their ability to migrate in a transwell migration assay (Supplementary Figure 3, see 
below). We found that coronin 1 deficient single positive thymocytes are affected to a similar 
extend as naïve T-cells regarding spontaneous apoptosis as well as transwell migration, but 
that coronin 1 deficient double positive thymocytes as well as memory/effector T-cells only 
show a mild increase in apoptosis as well as a minor reduction in transwell migration when 
compared to the wild type control.
The observation that single positive thymocytes and naïve T-cells are the only leukocytes 
which show severe defects upon coronin 1 deletion regarding both survival and migration 
prompted us to hypothesize that the two observed defects are connected and due to the same 
molecular defect which has to be naïve T-cell specific as well as coronin 1 dependent. 
A feature which distinguishes T-cells from other leukocytes is their T-cell receptor. 
Downstream signaling of the T-cell receptor has been shown to be essential for naïve T-cell 
survival [183] as well as defective in coronin 1 deficient naïve T-cells [239]. An important 
question to address was thus whether the observed reduction in viability and migration of 
freshly isolated coronin 1 deficient naïve T-cells was a primary defect and thus cell intrinsic 
property of coronin 1 deficient naïve T-cells or rather a secondary defect due to the defect in 
T-cell receptor signaling.
To analyze whether the migration defect is a cell intrinsic property of coronin 1 deficient 
cells, or secondary to a T-cell receptor signaling defect, the following experiment was 
designed (Figure 5 A): Wild type and coronin 1 deficient single positive thymocytes as well 
as naïve T-cells (CD62Lhigh, CD44low) were analyzed for phalloidin staining, spontaneous 
apoptosis as well as their ability to migrate in a transwell migration assay. After this first 
transwell migration assay, the migrated wild type and coronin 1 deficient cells were washed 
extensively and further recovered in fresh medium for 1 hour at 37°C. The recovered cells 
were used to carry out the same analysis as described above for a second time, that is 
phalloidin staining, spontaneous apoptosis and transwell migration.
If reduced viability and migration were cell intrinsic properties of coronin 1 deficient naïve T 
cells the previously migrated coronin 1 deficient cells should display the same defects when 
reanalyzed after recovery using the same assays and conditions.
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As can be seen in Figure 5 B and C, freshly isolated coronin 1 deficient CD4+ single positive 
thymocytes as well as naïve T-cells displayed the above described defects in cellular viability 
and migration as well as yielded an approximately 2 fold higher phalloidin fluorescence when 
compared to the wild type control. 
Figure 5: Phalloidin fluorescence, survival and migration of migrated wild type and coronin 1 deficient 
single positive thymocytes and naive T-cells following recovery.
(A) Schematic outline of the experiment as described under B-E. (B) Freshly isolated CD4+ single positive 
thymocytes from which all dead and apoptotic cells had been removed (see method) were stained for phalloidin 
and assayed for spontaneous apoptosis as well as transwell migration against 300 ng/ml of CCL19 in the lower 
chamber. (C) Assay as described under B performed with naive splenic T-cells. (D and E) Cells as used in B and 
C were subjected to a transwell migration assay against 300 ng/ml of CCL19 in the lower chamber. Migrated 
cells were washed to remove all CCL19 and left to recover in complete medium for 1h at 37°C/5% CO2. After 
this period, cells were again subjected to phalloidin staining and assayed for spontaneous apoptosis as well as 
transwell migration as done under B and C. Depicted are means +/– SD of duplicates. The experiments were 
repeated at least 3 times.
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However, when coronin 1 deficient single positive thymocytes as well as naïve T-cells that 
had migrated in the first assay, were allowed to recover and were subjected to the second 
round of assays, neither higher levels of spontaneous apoptosis nor a defect in cell migration 
were observed when compared to the wild type control (Figure 5, panel D and E). In order to 
exclude that CCL19 by itself was responsible for the observed effects and not selection by 
migration, the same assay was performed without selection for migrated cells (Supplementary 
Figure 4). Survival and migration was analyzed for cells that had been left in migration 
medium for 3h, had been incubated with the same amount of CCL19 used for transwell 
migration for 3h or had migrated for 3h as described above (Supplementary Figure 4). As can 
be seen from our data CCL19 by itself had no effect on migration or survival of coronin 1 
deficient cells in any of the conditions tested.
Noteworthy is also the fact that migrated and recovered coronin 1 deficient cells still showed 
the same elevated phalloidin fluorescence as observed for freshly isolated cells. Taken 
together, these data suggest that the observed migratory defect in coronin 1 deficient T-cells is 
a secondary defect which is directly linked with T-cell survival and not a result of disturbed 
F-actin dynamics.
2.3.3.3. T-cell viability and migration.
Our data presented thus far demonstrate a clear correlation between the reduced viability of 
coronin 1 deficient T-cells and their inability to migrate in a transwell assay. To directly 
address the importance of cellular viability in T-cell migration, the ability of wild type naïve 
T-cells in which apoptosis had been induced using the indicated reagents to migrate in a 
transwell migration assay was analyzed (Supplementary Figure 5). As expected, the 
manipulated cells were no longer capable of migrating to the same extent as the untreated 
control cells.
To analyze the result of increasing the viability of coronin 1 deficient naïve T-cells on 
migration as well as subsequent survival, cells were incubated for 20h with the anti apoptotic 
cytokine interleukin-7 (IL-7) [179, 187, 342, 343] and the same assays as described above 
(Figure 5) were performed, namely phalloidin staining, transwell migration and survival with 
or without added IL-7.
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As shown in Supplementary Figure 6, IL-7 restored the viability of coronin 1 deficient naïve 
T-cells as well as their migratory capacity to wild type levels.
Together these data therefore establish that reduction of T-cell viability severely affects their 
ability to migrate, and conversively, that increasing the viability of coronin 1 deficient naïve 
T-cells restores their ability to migrate and survive, again highlighting the causative link 
between cellular viability and migration.
2.3.3.4. The molecular basis of the observed defects in coronin 1 deficient naïve T-
cells
Maintenance of naïve T-cell homeostasis depends on signals that are predominantly delivered 
via the T-cell receptor [183, 310, 323, 344]. In the absence of coronin 1, naïve T-cells show a 
specific defect in T-cell receptor dependent signaling and in particular calcium signaling (see 
Figure 6A and [239]). The specificity of this defect can be demonstrated by using a T-cell 
receptor specific stimulus versus PMA/Ionomycin to induce T-cell proliferation. 
While in the presence of the T-cell receptor specific stimulation proliferation was strongly 
reduced in coronin 1 deficient naïve T-cells, stimulation with PMA/Ionomycin, which 
bypasses the T-cell receptor thus directly acting on downstream signaling pathways [101],
was comparable between coronin 1 deficient cells and the wild type control (Figure 6B). 
A direct consequence of T-cell receptor ligation and subsequent elevation of the cytosolic 
calcium concentration is activation of the phosphatase calcineurin [115, 345, 346]. Activation 
of calcineurin results in nuclear translocation of nuclear factor of activated T-cells (NFAT) 
and subsequent transcriptional activation of target genes like IL-2 [115, 201, 347, 348].
One key molecule in naïve T-cell survival [349, 350], which has been previously reported to 
depend on coronin 1 for its activation during mycobacterial infection in macrophages is 
calcineurin [251]. We therefore measured the levels and the activity of calcineurin in freshly 
isolated wild type or coronin 1 deficient naïve T-cells. While the total levels of calcineurin 
A', which is the predominantly expressed isoforms in T lymphocytes [350], were identical in 
wild type and coronin 1 deficient cells (Figure 6C), calcineurin phosphatase activity was 
severely reduced upon T-cell receptor ligation in the absence of coronin 1 (Figure 6D). 
- 115 - 
 
However when coronin 1 deficient as well as wild type naïve T-cells were stimulated with 
PMA and Ionomycin, no significant differences in calcineurin activation were detected 
(Figure 6E), consistent with the proliferation data presented above. 
Our data therefore demonstrate that the defect in coronin 1 deficient naïve T-cells is T-cell 
receptor specific as both coronin 1 deficient as well as wild type cells showed similar 
responses upon stimulation with the T-cell receptor bypassing reagents PMA and Ionomycin, 
whereas a T-cell receptor specific stimulus resulted in defective calcium signaling, calcineurin 
activation as well as proliferation in coronin 1 deficient naïve T-cells. We conclude that 
coronin 1 by regulating calcium/calcineurin signaling upon T-cell receptor stimulation is a 
key regulator of naïve T-cell survival. 
In order to independently show that calcineurin activation is the critical step in the signaling 
regulated by coronin 1 the following experiment was performed: Migrated wild type and 
coronin 1 deficient naïve T-cells were incubated with or without the specific calcineurin 
inhibitor cyclosporine A (CsA) in the presence or absence of either &-CD3/CD28 coated 
dynal-beads or plate bound &-CD3/CD28 (Figure 7A and B). After 20h, cell viability was 
determined using Annexin V/7-AAD labeling. The results show that &-CD3/CD28 treatment 
increases the rate of apoptosis in coronin 1 deficient naïve T-cells as compared to the 
untreated control. Importantly, the coronin 1 deficient phenotype is phenocopied by 
incubating wild type cells with CsA. Also, the beneficial effect of IL-7 on cell survival was 
ablated by &-CD3/CD28 treatment in the absence of coronin 1, indicating that naïve T-cells 
are susceptible to activation induced cell death upon &-CD3/CD28 stimulation in the absence 
of coronin 1 or upon inhibition of calcineurin via CsA. One expected consequence of 
defective calcineurin activation in T-cells is the down-regulation of the anti-apoptotic 
molecule Bcl-2 [350]. To analyze Bcl-2 downregulation, naïve T-cells were isolated from 
wild type and coronin 1 deficient mice and the levels of Bcl-2 analyzed in lysates by 
immunoblotting of SDS-PAGE separated proteins (Figure 7C). Bcl-2 levels were significantly 
lower in coronin 1 deficient cells as compared to the wild type control. Separately, when wild 
type cells were treated with the calcineurin inhibitors CsA and FK506, Bcl-2 expression was 
significantly lower as compared to the control (Figure 7D), again showing that blocking 
calcineurin in wild type cells phenocopies the coronin 1 deletion. 
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Furthermore, freshly isolated and migrated naïve T-cells (as described in Figure 5) were 
analyzed for Bcl-2 expression (Figure 7e). While in freshly isolated cells Bcl-2 level were 
significantly lower in the absence of coronin 1 migrated coronin 1 deficient cells showed 
levels similar to the wild type control.
Finally, given the recent report that that inhibition of calcineurin in the presence of T-cell 
receptor stimulation and co-stimulation via CD28 leads to a super-induction of caspase 3, 
rendering cells susceptible to apoptosis [351] the levels of caspase 3 in wild type and coronin 
1 deficient naïve T cells were analyzed (Figure 7F). While in freshly isolated cells, caspase 3 
levels were significantly elevated in the absence of coronin 1, migrated coronin 1 deficient 
cells showed levels similar to the wild type control.
These findings explain the elevated levels of apoptosis observed in freshly isolated coronin 1 
deficient naïve T-cells in molecular terms, namely that the lack of coronin 1 causes a defect in 
calcineurin activation upon T-cell receptor stimulation which in turn leads to a massive 
induction of caspase 3 and reduced expression of bcl-2.
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Figure 6: T-cell receptor mediated calcineurin activation in wild type and coronin 1 deficient naive T-cells.
(A) Calcium measurements in Fluo-3 loaded T-cells were performed as described in methods. The first arrow 
indicates the addition of antibodies in calcium free medium whereas the second arrow indicates the addition of 
calcium. (B) Proliferation of coronin 1 deficient and wild type naive T-cells using the indicated stimuli as 
described in methods. Depicted are means +/– SD of triplicate cultures. (C) FACS analysis of Calcineur	'
expression in CD4+ single positive thymocytes or naïve splenic T-cells. (D) Calcineurin activity was analyzed in 
naive coronin 1 deficient and wild type T-cells left untreated or activated with anti CD3/28 and cross linking 
secondary antibody for 15 minutes, as described in methods. Depicted are means +/– SD of triplicates. (E) 
Calcineurin activity was analyzed in naive coronin 1 deficient and wild type T-cells left untreated or activated 
with PMA/Ionomycin for 15 minutes, as described in methods. Depicted are means +/– SD of triplicates. 
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Figure 7: T-cell receptor signaling in wild type and coronin 1 deficient naive T-cells in the presence and 
absence of IL-7 and calcineurin inhibitors
Migrated wild type and coronin 1 deficient naive T-cells were analyzed for their survival using the indicated 
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2.3.4. Discussion
Coronin 1, also known as P57 or TACO (for tryptophan aspartate containing coat protein 
[237]), is a leukocyte specific molecule that is crucial for the survival and migration of naïve 
T-cells in the periphery [239, 263, 333-335]. Based on the ~25% homology of coronin 1 with 
Dictyostelium coronin, a molecule that co-purifies with an actin/myosin complex, as well as 
in vitro actin binding assays, it has been widely suggested that coronin 1 allows cellular 
survival and migration by preventing F-actin formation. Since coronin 1 deletion results in a 
~2-fold increase in phalloidin staining, absence of coronin 1 was concluded to lead to 
excessive F-actin accumulation thereby preventing cell migration and inducing apoptosis 
[263]. In this paper, we show that coronin 1 does not modulate the F-actin cytoskeleton in 
leukocytes and non-leukocytes, and furthermore, that F-actin accumulation does not correlate 
with apoptosis in naïve T-cells as proposed previously [263]. Instead, we find that both 
survival as well as migration defects occurred as a result of defective signaling and 
calcineurin activation in coronin 1 deficient naïve T-cells. We further demonstrate that 
cellular viability and the ability to migrate are linked. When freshly isolated coronin 1 
deficient cells are selected for their ability to migrate in a transwell migration assay, the 
migrated, coronin 1 deficient cells survive and migrate to a similar extend as observed for 
wild type cells.
We conclude that instead of regulating the F-actin cytoskeleton, coronin 1 functions in 
balancing pro and anti-apoptotic signals by regulating Ca2+ fluxes and calcineurin activation 
downstream of the T-cell receptor.
2.3.4.1. Coronin 1 and F-actin
The evidence linking coronin 1 to the modulation of the F-actin cytoskeleton is predominantly 
based on the observed two-fold difference in phalloidin fluorescence between wild type and 
coronin 1 deficient cells [263, 333, 334]. Several lines of evidence however argue against the 
differential phalloidin fluorescence being an appropriate measure for altered F-actin dynamics 
in cells expressing different levels of coronin 1. 
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First, a sensitive biochemical assay, that accurately measured the influence of chemo-
attractant induced F-actin accumulation on the F/G-actin ratio, failed to show any difference 
in the F/G actin ratio between coronin 1 negative and coronin 1 expressing cells. This is not 
only the case for T-cells, but also for macrophages deficient for coronin 1 [251] or depleted 
for coronin 1 using siRNA [238], Jurkat cells depleted for coronin 1 using siRNA and Mel 
JuSo cells over expressing coronin 1 (this manuscript). Second, depletion of coronin 1 in 
macrophages, B cells and neutrophils does not affect any of the F-actin dependent functions, 
such as phagocytosis, macropinocytosis and migration [238, 251, 252, 352]. Third, rather than 
being an indication of reduced F-actin formation in coronin 1 expressing cells, the reduced 
phalloidin fluorescence may be a result of a reduction in phalloidin binding to F-actin because 
of the presence of large amounts of coronin 1 that sterically hinder phalloidin binding to F-
actin at the cell cortex. A similar observation has been reported previously, where the authors 
failed to stain F-actin cables using phalloidin due to accessory F-actin binding factors but 
were able to label these using anti-actin antibodies [353]. These findings are also consistent 
with the observation that despite a twofold difference in phalloidin fluorescence we were 
unable to detect any differences regarding cortical F-actin levels using anti-actin antibodies in 
coronin 1 deficient versus wild type cells [239].
While in vitro, coronin 1 has been shown to co-precipitate with F-actin [240] [354], and 
modulate F-actin filament dynamics [355-357], a survey of all available literature on coronin 
1 reveals that no data exist showing that coronin 1 directly participates in modulating F-actin 
dynamics in vivo (Table S1, see below). Most of the previous studies linking coronin 1 
activity to F-actin dynamics rely either on (i) in vitro co-sedimentation of coronin 1 fusion 
proteins with F-actin, (ii) expression of coronin 1 domains in cell lines or (iii) a difference in 
phalloidin fluorescence (see Table S1, below).
2.3.4.2. F-actin and Apoptosis
One important argument put forward to implicate coronin 1 in preventing F-actin induced 
apoptosis is based on the observed increase in cell death upon forced F-actin formation in 
yeast [358] as well as mammalian cell lines [359]. However, when the actin cytoskeleton of
primary murine naïve T-cells was polymerized or depolymerized using actin modulating 
drugs, no differences in apoptosis were apparent (this study). Further, none of the other 
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leukocyte populations such as B-cells and macrophages, which have been found to be 
sensitive to F-actin accumulation [360], display a survival defect despite showing elevated 
phalloidin staining similar to T-cells. 
Moreover, induction of apoptosis in a variety of coronin 1 expressing and deficient cell types 
by TNF-& or staurosporin demonstrated that coronin 1 does not protect cells from apoptosis. It 
is noteworthy that at least staurosporin induced apoptosis involves F-actin and that proteins 
which prevent F-actin formation such as human gelsoline, unlike coronin 1, are able to 
prevent the onset of apoptosis upon staurosporin treatment [361].
We therefore conclude that F-actin modulation cannot account for the elevated levels of 
apoptosis in coronin 1 deficient cells and that coronin 1 does not protect cells from apoptosis.
2.3.4.3. Coronin 1 and Calcineurin Activation
In coronin 1 deficient cells calcineurin activation following T-cell receptor ligation cannot 
occur because of defective calcium mobilization, whereas when the T-cell receptor is 
bypassed using PMA/Ionomycin, calcineurin as such is functional in coronin 1 deficient T-
cells. Interestingly, there is a striking resemblance between a recently described calcineurin 
A' deficient mouse model and mice lacking coronin 1 [349] [350]. Both calcineurin A' and 
coronin 1 deficient single positive thymocytes as well as naïve T-cells are specifically 
depleted in vivo and show elevated spontaneous apoptosis in vitro while double positive 
thymocytes as well as memory/effector T-cells and B-cells show none or only mild defects. 
Experiments with calcineurin A' deficient mice have demonstrated that defective activation 
of the phosphatase leads to susceptibility of T-cells to apoptosis induction due to an 
imbalance between pro- and anti-apoptotic stimuli, leading to reduced naïve T-cell viability 
and finally cell death. Consistent with these results, we found that inhibition of calcineurin in 
naïve wild type T cells phenocopies the coronin 1 deficient T cells, demonstrating that 
calcineurin activation is the critical step in signaling regulated by coronin 1.
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The results presented in this manuscript not only highlight the importance of coronin 1 in 
calcineurin activation but also provide a rational for the observed migration and survival 
defects in the absence of coronin 1. As we demonstrate, Bcl-2 levels are reduced and caspase 
3 is induced at high level in coronin 1 deficient naïve T-cells as a consequence of defective 
calcineurin activation. Furthermore, the data described here provide, on the molecular level, 
an explanation for the diverse phenotypes such as migration and survival defects described for 
naïve T-cells from coronin 1 deficient mice. 
The here presented results highlight the importance of coronin 1 dependent calcium and 
calcineurin signaling for cellular survival. They also provide a direct link between coronin 1, 
T-cell receptor mediated calcineurin activation and calcineurin dependent cellular viability. In 
addition, these data link cellular viability with the migratory capacity of a cell and thus 
provide an explanation for both the survival as well as the migration defect in coronin 1 
deficient naïve T-cells. The results presented here further offer an explanation of why the 
observed defects are specific for single positive thymocytes as well as naïve T-cells as these 
cells are heavily dependent on calcineurin A' for their survival [38].
The definition of coronin 1 as an essential regulator of calcineurin mediated cellular viability 
in naïve T-cells and consequently their ability to migrate may allow a better understanding of 
leukocyte activation and homeostasis.
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2.3.6. Supplementary Figures and tables
Figure S1: Phenotypic characterization, thymocytes and T-cells in wild type and coronin 1 deficient mice.
(A) T-cells from wild type and coronin1 deficient mice were lysed in SDS sample buffer, separated by SDS page 
and immune-blotted for coronin 1 and Actin. (B) Single cell suspensions from thymus, spleen and lymph nodes 
were stained for CD4 positive cells and the indicated cell populations quantitated. (C) Annexin V stainings of 
CD4+ SP thymocytes from wild type and coronin 1 deficient animals were quantitated. Quantitation was carried 
out with data obtained from at least 3 animals. Depicted are mean +/- SD. (D) Single cell suspensions from 
thymus, spleen and lymph nodes were stained for CD4 and CD62L positive cells and the indicated cell 
populations quantitated. (E) Dot blot of thymus suspensions from representative wild type and coronin 1 
deficient animals stained with the indicated antibodies. (F) CD4+ single positive thymocytes from wild type and 
coronin 1 deficient animals were stained with the indicated antibodies. Shown are representative contour blots.
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Figure S2: Staurosporin induced apoptosis of wild type and coronin 1 deficient B-cells 
Wild type and coronin 1 deficient B-cells were incubated for the indicated time with DMSO (carrier) (C) or 
staurosporin (STS, 1 μM) and the percentage of viable cells was determined using Annexin V and 7-AAD
labeling.
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Figure S3: Spontaneous apoptosis and migration of double positive thymocytes, single positive thymocytes 
and memory/effecter T-cells in the presence and absence of coronin 1.
(A) Spontaneous apoptosis and Transwell migration of double positive thymocytes. (B and C) Same setup as 
described under A for single positive thymocytes (B) and memory/effector T-cells (C). Depicted are means +/–
SD of duplicates. The experiments were repeated at least 3 times.
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Figure S4: Spontaneous apoptosis and migration of differentially treated naïve splenic Tcells and single 
positive thymocytes in the presence and absence of coronin 1.
(A/B) Spontaneous apoptosis and transwell migration (3h against 300 ng/ml of CCL19) of naïve splenic T-cells 
and (C/D) single positive thymocytes analyzed after migration (3h against 300 ng/ml of CCL19), incubation in 
migration medium (3h) only or migration medium containing 300 ng/ml of CCL19 (3h) as a 9 control. Depicted 
are means +/– SD of duplicates. The experiments were performed at least 2 times.
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Figure S5: T-cell viability and migration in the presence and absence of coronin 1.
Naïve wild type T-cells were left untreated or exposed to Dexamethasone (0,5 μM), Ionomycin (2 μM), plate 
bound anti CD3 and anti CD95 (Jo-2) (each 10 μM/ml) supplemented with 10 μM of Cyclosporine A, Etoposide 
(2 μM), C6 Ceramide (50 μM), Staurosporine (0,1 μM), Actinomycin D (1 μM) or Cyclohexamide (20 μM). At 
the indicated time points the number of viable cells was determined using Annexin V and 7-AAD staining. The 
percentage of viable (double negative) cells is expressed as % of the untreated control which was set to 100%. 
Cells exposed for two hours to the indicated drugs at the indicated concentrations were analyzed for their ability 
to migrate in a transwell migration assay for two hours against migration medium only as a control or medium 
supplemented with 300 nM of CCL19, as described in methods. Migrated cells were quantitated on a FACS 
Calibur. Counts were normalized to the percentage of untreated cells, migrated against CCL19, which was set to 
100%. Depicted are means +/– SD of duplicates.
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Figure S6: Phalloidin fluorescence, survival and migration of wild type and coronin 1 deficient naive 
Tcells following IL7 treatment.
(A) Freshly isolated naive splenic T-cells from which all dead and apoptotic cells had been removed (see 
method) were stained for phalloidin and assayed for spontaneous apoptosis as well as transwell migration against 
300 ng/ml of CCL19 in the lower chamber. (B) Cells as used in A were treated with interleukin-7 (IL-7, 
20ng/ml, mouse recombinant from R&D). After this period, cells were analyzed using Annexin V/7-AAD 
staining to determine the number of viable cells. (C) Dead cells were removed from the IL-7 treated population 
as described in methods, viable cells were subjected to phalloidin staining, assayed for spontaneous apoptosis 
(with or without the addition of 20ng/ml recombinant IL-7) and transwell migration as done under A. Depicted 
are means +/– SD of duplicates. The experiments were performed at least 2 times.
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Table S1: Mammalian Coronin 1 and F-actin: A Survey of the Existing Coronin 1A Literature
Author Date of Publication Coronin1 and F-actin
Suzuki et al., 1995 - GST-Coronin 1 co-sedimentation with F-actin [240]
Garcia-Higuera et al., 1996 - No direct F-actin interaction and modulation data [244]
Grogan et al., 1997 - No direct F-actin interaction and modulation data [362]
David et al., 1997 - Coronin 1 as part of the Listeria actin tail [363]
Machesky et al., 1997 - Coronin 1 co-elution with Arp2/3 from neutophil lysates [354]
Ferrari et al., 1999 - No direct F-actin interaction and modulation data [237]
Mishima et al., 1999
- GST-Coronin 1 co-sedimentation with F-actin
- Truncated versions of Coronin were used to define F-actin 
interacting regions
- Truncated versions of Coronin 1 interfere with cell spreading 
and inhibit lammelipodia extension when over expressed in 3T3 
fibroblasts [364]
Reeves et al., 1999 - No direct F-actin interaction and modulation data [258]
Gatfield et al., 2000 - No direct F-actin interaction and modulation data [255]
Didichenko et al., 2000 - No direct F-actin interaction and modulation data [365]
Itoh et al., 2002 - No direct F-actin interaction and modulation data [257]
Zheng et al., 2003 - No direct F-actin interaction and modulation data [250]
Oku et al., 2003
- GST-Coronin 1 co-sedimentation with F-actin
- Truncated versions of Coronin were used to define F-actin 
interacting regions [338]
Nal et al., 2004 - No direct F-actin interaction and modulation data [318]
Oku et al., 2005 - No direct F-actin interaction and modulation data [366]
Gatfield., 2005
- Definition of Coronin 1 domains that are important for 
trimerization, plasma membrane attachment as well as F-actin 
interaction [241]
Yan et al., 2005
- TAT-fusion constructs of Coronin-1 WD domains introduced 
into RAW 264.7 cells interfere with early steps of phagosome 
formation
- Macrophages depleted of Coronin 1 by siRNA showed reduced 
phagocytosis [339]
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Appleton et al., 2006 - Crystal structure of murine Coronin 1[242]
Liu et al., 2006
- GST-Coronin 1 co-sedimentation with F-actin
- Truncated versions of Coronin were used to define F-actin 
interacting regions
- Electron microscopy reveals cross linking of F-actin filaments 
by Coronin 1 [367]
Foeger et al., 2006
- Phalloidin fluorescence taken as evidence that Coronin 1 
deficient naive T-cells accumulate F-actin. Used to explain 
elevated T-cell death in the absence of Coronin 1 as well as 
defective T-cell migration
- Flag-Coronin 1 WT and S2A but not S2D co-immunoprecipitate 
with Arp2. Correlation of these results with phalloidin 
fluorescence of cells over expressing the above mentioned 
constructs [263]
Brieher et al., 2006
- In vitro F-actin depolymerization assays of Listeria actin comet 
tails using purified proteins [355]
Yan et al., 2007
- TAT-fusion constructs of Coronin-1 WD domains introduced 
into neutrophils interfered with transwell migration, cell adhesion, 
spreading and phagocytosis
- In vitro F-actin polymerization assay using purified GST-
Coronin 1 [340]
Jayachandran et al., 2007
- No defects in F-actin dependent processes such as migration, 
phagocytosis and cell spreading were detected in Coronin 1 
deficient macrophages
- F-actin levels were found to be similar in wild type and Coronin 
1 deficient cells by biochemical analysis [251]
Jayachandran et al., 2008
- No defects in actin dependent processes such as migration, 
phagocytosis and cell spreading were detected in J774 
macrophages depleted of Coronin 1 by siRNA
- F-actin levels were found to be similar in wild type and Coronin 
1 depleted cells by biochemical analysis [238]
Galkin et al., 2008
- Electron microscopy and 3D reconstitution of Coronin 1 bound 
to F-actin
- Coronin 1 was found to stabilize F-actin [356]
Haraldsson et al., 2008
- Phalloidin fluorescence taken as evidence that Coronin 1 
deficient naive T-cells accumulate F-actin
- B-cells were found to be functional and not prone to elevated 
cell death despite the fact that they displayed elevated phalloidin 
staining in the absence of Coronin 1 as observed for T-cells [333]
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Mueller et al., 2008
- No defects in actin dependent processes such as cell spreading 
and membrane ruffling were detected in Coronin 1 deficient naive 
T-cells [239]
Kueh et al., 2008
- In vitro F-actin depolymerization assays using purified proteins 
[357]
Oku et al., 2008
- Analysis of Coronin 1/F-actin association using EGFP fusion 
proteins [368]
Shiow et al., 2008
- Phalloidin fluorescence taken as evidence that Coronin 1 
deficient T-cells accumulate F-actin
- In vitro Coronin 1/F-actin co-sedimentation as well as F-actin 
polymerization assay [334]
Mugnier et al., 2008
- Phalloidin fluorescence taken as evidence that Coronin 1 
deficient T-cells accumulate F-actin [335]
Shiow et al., 2008 - No direct F-actin interaction and modulation data [369]
Combaluzier et al., 2009 - No F-actin defects in coronin 1 deficient B cells [352]
Combaluzier et al., 2009
- Chemotaxis, phagocytosis as well as cell spreading was found to 
be unaffected in murine coronin 1 deficient neutrophils when 
compared to the wild type control [252]
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3. MATERIALS AND METHODS
3.1. Mice and tissue culture
Mice lacking coronin-1 were generated as described [251]. Experiments shown used mice that 
were backcrossed to C57BL/6 for at least four generations, using wild-type littermates as a 
control. Animal experiments were approved by the Kantonales Veterinäramt Basel-Stadt.
Human Jurkat T-cells were grown in medium consisting of RPMI 1640 (Gibco) supplemented 
with 2 mM L-glutamine (Gibco), 10% FBS (Gibco) and penicillin-streptomycin (Mice used in 
this study were generated by Massner J.).
3.2. Biochemical methods
We performed cell homogenization, lysis and immunoblotting as described [31, 34, 237].
Polyclonal anti-coronin-1 serum has been described[241]. Actin was detected using
MAB1501 (Chemicon) at 1:500 dilution. Anti-GFP was from Roche (monoclonal mouse 
IgG1, clones 7.1 and 13.1). Anti-phosphotyrosine (horseradish peroxidase-conjugated 4G10) 
was from Upstate. Anti-PtdIns(4,5)P2 (clone 2C11) was from Santa Cruz. Antibodies to PLC-
1, phospho–PLC-1, ERK1/2, phospho-ERK-1/2, p38, phospho-p38, IB-& and phospho-
IB-& were from Cell Signaling Technology. Anti-CD3 and anti-CD28 were from BD 
Biosciences, and the secondary mouse anti-hamster IgG was from R&D (clone MAH1.12). 
SLP-76 antibodies were from Santa Cruz; Lat and phospho-Lat (171) antibodies were from 
Cell Signaling Technology; phospho-Lat (136) antibody was from Sigma-Aldrich; and goat 
anti-hamster Alexa Fluor 568 was from Invitrogen. Antibodies to Calcineurin-A' were from 
Santa Cruz. Anti CD95 (Jo-2). Phalloidin Alexa Fluor-568 and -633 were from Molecular 
probes. Jasplakinolide and 2-APB were from Calbiochem, Latrunculin B, Cytochalasin D and 
Thapsigargin were from Sigma, Ionomycin from Calbiochem, Cyclosporine A from Fluka, 
Etoposide from Sigma, C6 Ceramide from Sigma, Staurosporin from Sigma, Actinomycin D 
from Sigma, Dexamethasone from Sigma, and Cyclohexamide from Sigma. Annexin V and 
7-AAD were from BD Biosciences.
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3.3. Analysis of F-actin and G-actin
The relative proportions of G-actin and F-actin in Jurkat T-cells were analyzed by 
sedimentation of filamentous actin followed by the quantitative determination of F- and G-
actin by SDS–PAGE[287]. In brief, cells were left untreated or treated with Jasplakinolide 
(1 AM), Latrunculin B (4 AM) or Cytochalasin D (10 AM) for 30 min at room temperature 
followed by lysis (also at RT) in 200 Al F-actin stabilization buffer for 10 min (50 mM 
PIPES), pH 6.9, 50 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 5% glycerol, 0.1% Triton X-100, 
0.1% NP-40, 0.1% Tween 20, 0.1% beta-mercaptoethanol, 1 mM ATP, protease (complete 
EDTA free cocktail, Roche) and phosphatase inhibitor (HALT™ phosphatase cocktail, 
Pierce).
In the case of total erythrocyte-depleted splenocytes cells were left untreated or were treated 
with jasplakinolide (1 μM) or latrunculin B (4 μM) for 45 min at room temperature (23–26 
°C) followed by homogenization (also at room temperature) in 200 μl F-actin stabilization 
buffer for 10 min.
Alternatively cells were incubated with 250 ng/ml CCL19 for 60 seconds at 37 °C in a water 
bath, followed by lysis (at room temperature) in F-actin stabilization buffer. 
Cell lysis was followed by trypan blue exclusion microscopy. Cell lysates were sedimented at 
150 000 × g for 60 min at 37 °C. The pellets were resuspended in 200 Al ice cold distilled 
water containing Cytochalasin D (10 AM) and incubated at 4 °C for 60 min to depolymerize 
the F-actin. The resuspended pellet was gently mixed every 15 min. Ten microliters of 
supernatant (G-actin) and pellet (F-actin) fractions were subjected to analysis by 
immunoblotting following SDS–PAGE. Actin was detected using anti-actin antibody (MAB 
1501, Chemicon (1:1000)).
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3.4. Confocal Laser Scanning microscopy
Cells were adhered on poly-l-lysine treated 10 well Teflon-coated glass slides (Polysciences) 
for 15 min and left either untreated or treated with Jasplakinolide (1 AM), Latrunculin B 
(4 AM) or Cytochalasin D (10 AM) for 30 min at room temperature. After fixation (20 min, 
4% paraformaldehyde in PBS, 37 C) and permeabilization in 0.2% saponin/3% BSA in PBS, 
cells were stained overnight with phalloidin-AlexaFluor568 (Molecular Probes) in 0.2% 
saponin/3% BSA/PBS at 4°C. Overnight labeling was necessary to allow phalloidin-
AlexaFluor568 to compete with and displace Jasplakinolide, since Jasplakinolide binds to the 
same site as phalloidin [286].
In the case of murine T-cells cells were adhered to poly-L-lysine coated, 10-well, Teflon-
coated glass slides (Polysciences) for 20 min on ice. We fixed cells with methanol or 4% 
paraformaldehyde and then blocked and permeabilized them in PBS, 3% BSA, 0.1% TritonX-
100. The cells were then stained for 60 min at room temperature with antibodies to actin 
and/or coronin-1 and subsequently with phalloidin Alexa Fluor 568 (Molecular Probes, 1:25) 
and/or secondary antibodies (goat anti-mouse Alexa Fluor 546, goat anti-rabbit Alexa Fluor 
488; 1:200 each) applied for 45 min at room temperature. We washed slides extensively and 
mounted them using Fluoroguard antifade mounting medium (Bio-Rad). Slides were analyzed 
using a LSM 510 Meta confocal laser scanning microscope (Zeiss) and the corresponding 
software. We analyzed cell spreading as described in the figure legend according to refs. [122, 
308].
For quantitation of T cells double-stained with phalloidin Alexa Fluor 568 and anti-actin 
followed by Alexa Fluor 488–labeled secondary antibodies, we processed the images for the 
fluorescence intensity in the 488 nm and 568 nm channels after selecting a region of interest 
for wild-type and coronin-1-deficient cells using the software provided (Zeiss).
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3.5. Video microscopy
Wild-type or coronin-1 deficient T cells purified using magnetic cell sorting (Milteny 
Biotech), resuspended in RPMI, 10 % FBS, L-glutamine, were seeded on eight-well 
chambered coverglass slides (Nunc) previously coated with anti-CD3 plus anti-CD28 
(Pharmingen) (10 μg/ml each) or poly-L-lysine as a control [122], and time-lapse images 
were acquired every 10 s for a period of 30 min using a Carl Zeiss Axiovert microscope and 
processed using Open Lab software [241] (Video microscopy was performed by 
Jayachandran R.).
3.6. Ca2+ mobilization measurements
Total spleen cell suspensions were subjected to erythrocyte lysis, washed with RPMI 1640 
(Gibco) supplemented with 3% heat inactivated FCS (Gibco) and loaded with Indo-1 or Fluo-
3 by incubation in 3 μg/ml of Indo-1 AM or 3 μg/ml of Fluo-3 AM (Molecular Probes) for 45 
min at 37 °C in the dark. After loading, cells were washed once or twice with RPMI 1640 
containing 3% FCS and stained with anti-CD19 (clone 1D3, BD Pharmingen) conjugated to 
phycoerythrin (PE) for indo-1 experiments or conjugated to allophycocyanin (APC) for Fluo-
3 experiments and with anti-CD11b-PE (Indo-1 experiments) or anti-CD11b-APC (Fluo-3
experiments) (clone M1/70, BD Pharmingen) for 30 min on ice. Cells were subsequently 
washed twice with RPMI 1640, 3% FCS or with calcium free Ringer's solution. After 
equilibrating the cells at 37 °C for 5-10 min and establishing a baseline for 30 s, we induced 
calcium flux by TCR cross-linking using anti-CD3 (7.5-10 μg/ml; clone 145-2C11, BD 
Pharmingen), anti-CD28 (5 μg/ml) and mouse anti–hamster (5 μg/ml) [370]. Cells were 
analyzed by flow cytometry on a FACSVantage, FACSCalibur or a LSR II for a further 9-9.5
min, measuring the 405 nm:510 nm ratio (Indo-1) or the 585 nm signal (Fluo-3). Only PE or 
APC negative cells, respectively, were considered for calcium mobilization measurements. 
Thymocytes were loaded with Indo-1 as described above, labeled with PE-conjugated anti-
CD8 and PE-Cy7-conjugated anti-CD4 for 30 min on ice and triggered with 5-7.5 μg/ml anti-
CD3 and 5 μg/ml mouse anti-hamster. For analysis of PLC activation, cells were loaded with 
Fluo3-AM(2 μM) and labeled with APC-conjugated anti-CD5 antibody (to detect T cells) and 
PE-Cy7 conjugated anti-CD19 (to exclude B cells). Cells were washed and resuspended in 
- 136 - 
 
HBSS without calcium in the presence of 1 mM EGTA. The cells were treated with either 
PLC activator (m-3M3FBS, 10 μM) or DMSO at the indicated time points, followed by the 
addition of 2 mM CaCl2. For analysis, only PE-Cy7 negative, CD5+ cells were included. Data 
were analyzed using FlowJo software. (Experiments were performed together with 
Jayachandran R.)
For the analysis of Ca2+ mobilization in Jurkat T cells, Jurkat cells were transfected with 2 μg
each of pSUPER::mTACO1 or pSUPER::hTACO1 as described [238] or left untransfected 
and were loaded with Indo 1-AM (4 μg/ml) for 45 min in RPMI with 10% FBS at 37 °C. 
Cells were washed in HBSS without calcium (Invitrogen/GibcoBRL) and seeded at 50,000 
cells per well in a 96-well special optics black plates (Costar Corning). Cells were stimulated 
with 10 μM m-3M3FBS after 30 s and the changes in fluorescence emission at 405 nm and 
480 nm measured with excitation at 340 nm using Synergy 2 multi-detection-microplate 
reader for a period of 8 min. The ratio of 405 nm to 480 nm emission values was calculated 
and normalized using the software provided. (Experiments were performed together with 
Jayachandran R.)
Calcium measurements in memory-effector T cells. Splenic memory-effector T cells from 
wild-type (+/+) or coronin 1-deficient (B=B
(


	%#
	-cell isolation 
kit from Miltenyi in a first step to obtain untouched total T cells. In a second step T cells 
expressing CD62L were depleted using anti CD62L micro beads (Miltenyi). The remaining 
population of CD62Llow/CD44high memory-effector T cells was loaded with Fluo-3 and 
calcium fluxes following T cell receptor crosslinking (7.5 Ag/ml anti- CD3, 5 Ag/ml anti-
CD28 and 5 Ag/ml mouse-anti-hamster) were analyzed on a FACSCalibur. As a control we 
labeled Fluo-3 loaded erythrocyte depleted wild type splenocytes with PE-Cy7-conjugated 
antibodies against CD19 and CD11b and APCconjugated antibodies against CD62L on ice. 
PE-Cy7 negative APC positive cells were considered as naive T cells. Naive T cells were 
stimulated and analyzed as described for the memory-effector T cells.
In the case of calcium measurements in the context of F-actin and SOC Jurkat T-cells were 
washed with medium, RPMI 1640 (Gibco)/10% heat inactivated FBS (Gibco)/2 mM L-
glutamine (Gibco-BRL) and loaded with 2.0 Ag/ml of Indo-1 (Molecular Probes) for 45 min 
at 37 °C in the dark. After loading, cells were washed two times in medium and left either 
untreated or were incubated with Jasplakinolide (1 AM), Latrunculin B (4 AM) or 
Cytochalasin D (10 AM) for 20 min at RT. Cell were washed twice with Ca2+ free Ringer 
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solution in the presence of the drugs (total of 10 min) and taken up in Ca2+ free Ringer 
solution containing 1 mM EGTA (1 ml) and the indicated drugs. After acquiring a baseline 
for 30 s cells were triggered with 1 AM of Thapsigargin to induce ER Ca2+ store release. After 
a total time of 8 min 500 Al of cell suspension was transferred to a new tube with 500 AL
2 mM calcium containing Ringer. 2-APB, either 3 AM to enhance Ca2+ influx or 100 AM to 
inhibit calcium influx were added as indicated in the corresponding result section. Ca2+
measurements were all done on a LSR II (Becton Dickinson). Data were analyzed using 
FlowJo software.
3.7. Electrophysiology
Patch-clamp experiments were performed at 22-23 °C in the tight-seal whole-cell 
configuration using fire-polished patch pipettes (2-5 MC uncompensated series resistance). 
Pipette and cell capacitance were electronically cancelled before each voltage ramp with an 
EPC-9 patch-clamp amplifier controlled by Pulse 8.4 software (Heka elektronik). Membrane 
currents were filtered at 1.5-2.3 kHz and digitized at a sampling rate of 5-10 kHz. Whole-cell 
currents were elicited by 200 ms voltage-clamp ramps from -100 mV to +100 mV from a 
holding potential of 0 mV. To measure leak currents before activation of store-operated 
currents, 20 voltage ramps were applied within the first 5 s after establishment of the whole-
cell configuration, followed by voltage ramps applied every second. All voltages were 
corrected for a liquid junction potential of -12 mV between internal solutions and the bath 
solution. The standard pipette solution for whole-cell patch-clamp recordings contained (in 
mM): 0.05 InsP3, 0.00005 TG, 10 EGTA, 140 Cs-aspartate, 2 MgCl2, 5 Mg-ATP, 0.5 Tris-
GTP, 2.5 malic acid, 2.5 Na-pyruvat, 1 NaH2PO4 and 10 Hepes (pH 7.2 with CsOH). The 
extracellular solution contained (in mM): 101.66 NaCl, 3 KCl, 20.66 CaCl2, 1.22 MgCl2, 6.66 
d-glucose, and 3.33 Hepes (pH 7.4 with NaOH) (Experiments were performed by Quintana A. 
and Griesemer D.).
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3.8. Mixed lymphocyte reaction and proliferation
We isolated splenic T lymphocytes from coronin-1 deficient mice and wild-type littermates 
using magnetic beads according to the manufacturers protocol (Pan T-cell isolation kit, 
Miltenyi). For allogeneic stimulation of T lymphocytes, we isolated spleen cell suspensions
from BALB/c mice (RCC) and treated them with 50 μg/ml mitomycin C (Sigma) in PBS for 
30 min at 37 °C after erythrocyte lysis. We cultured responding T lymphocytes (1 x105)
together with either 2 x105 (2:1 ratio) or 4 x105 (4:1 ratio) stimulating spleen cells in flat-
bottom 96-well plates (BD Falcon) using the following medium: RPMI-1640 (Gibco), 1x
MEM nonessential amino acids (Gibco), 1 mM sodium pyruvate (Gibco), 100 units penicillin 
(Sigma), 100 μg/ml streptomycin (Sigma), 10 μM 2-mercaptoethanol (Gibco), 10% FCS 
(Gibco). After 3 d incubation in 6% CO2 at 37 °C, and 20 h before harvesting, we added 1 
μCi [3H]thymidine (Amersham) to each well. Incorporation of the isotope was measured in a 
liquid scintillation counter (Packard TopCount) and expressed as the average cpm (± s.d.) per 
well of triplicate cultures. Proliferation of sorted naive CD4+ T cells (FACs ARIA) and 
cycling of CD4+ T cells as monitored by dilution of the 4 μM PKH26 dye was performed as 
described in the figure legend. For IL-2 measurement, erythrocyte-depleted spleen 
suspensions were stimulated with anti-CD3 (7.5 μg/ml) or with anti-CD3 (7.5 μg/ml) plus 
anti-CD28 (5 μg/ml) for 24 h. IL-2 production was analyzed using the FlowCytomix assay 
(Bender MedSystems) according to the manufacturer's protocol.
For PMA/Ionomycin experiments naïve CD4+ splenic T-lymphocytes were isolated from 
coronin 1 deficient mice and wild-type littermates using magnetic beads according to the 
manufacturers protocol (MACS, Miltenyi). For stimulation we incubated T-cells with soluble 
anti-CD3 (0,1 μg/ml) or PMA 20 nM /Ionomycin 100 nM on splenic feeder cells as 
describedabove. Results were expressed as the average cpm (± s.d.) per well of triplicate 
cultures (Mixed lymphocyte reactions were performed by Massner J.).
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3.9. TCR signaling and IP3 measurements
Isolated naive splenic T cells were starved for 2 h in medium without FBS at 37 °C in 5% 
CO2, coated with anti-CD3 (10 μg/ml) or anti-CD3 plus anti-CD28 (10 μg/ml each) for 15 
min on ice and washed once in serum-free medium to remove unbound antibody. TCRs were 
cross-linked with a secondary antibody (mouse anti-hamster) for the times indicated in the 
figures at 37 °C in a water bath. We terminated reactions by adding 5x SDS sample buffer and 
boiling for 10 min at 95 °C. Proteins were separated by SDS-PAGE and blotted with 
antibodies to total phosphotyrosine (horseradish peroxidase conjugated 4G10 antibody from 
Upstate), phospho-PLC-1, total PLC-1, ERK1/2, phospho-ERK-1/2, p38, phospho-p38, 
IB-&, phospho-IB-&, Lat, phospho-Lat (171) (all from Cell Signaling Technology), 
phospho-Lat (136; Sigma-Aldrich) and coronin-1 (1002 rabbit polyclonal antibody [241] or 
polyclonal rat antibody; where the latter has been used, this is indicated in the figure legend). 
To measure cellular InsP3, we prepared and treated cells as stated above and extracted InsP3.
InsP3 amounts were analyzed using a competitive radio-receptor assay kit according to the 
manufacturers protocol (Perkin Elmer). For bead binding assays, Dynabeads M450 Epoxy 
(Invitrogen) were coated with anti-CD3 and anti-CD28 (5 μg/ml each) according to the 
manufacturer's specifications.
3.10. Immunoprecipitation of PLC 
We isolated total T cells from the spleens of WT mice using the Pan T-cell isolation kit 
(Miltenyi). Cells (8 x106 in 450 μl lysis buffer per immunoprecipitation reaction) were lysed 
(50 mM Tris HCl, pH 7.5, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Triton X-100,
0.05% digitonin, protease (complete EDTA-free cocktail, Roche) and phosphatase inhibitor 
(HALT phosphatase cocktail, Pierce) cocktail) for 20 min on ice with repeated mixing. Nuclei 
and unbroken cells were sedimented by centrifugation (3,000g, 15 min at 4 °C) and 400 μl of 
the supernatant transferred to a new tube. Antibody to PLC-1, control IgG or buffer (for a 
control sample) was added at a 1:50 ratio, and the samples were rotated for 1 h at 4 °C. We 
added 50 μl of a 1:1 slurry of protein A beads in lysis buffer and rotated the samples for 
another 2 h. The beads were then washed five times with a buffer that had the same 
composition as the lysis buffer but one-fifth the detergent. After the last wash we removed 
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20% of the samples and boiled them in SDS sample buffer. These fractions were later 
separated alongside total lysate corresponding to 1/10 of the input material on a 7.5% SDS-
PAGE gel and blotted with antibody to PLC-1 to check for efficient immunoprecipitation. 
The remaining 80% of the samples were taken up in two-dimensional PAGE buffer and 
separated on 7 cm NL pH 3-10 immobilized pH gradient (IPG) strips (Amersham) according 
to the manufacturer's protocol. Besides the anti-PLC-1 immunoprecipitate, the beads-only 
control and the control IgG (normal rabbit serum), we also separated total lysate 
corresponding to 1/10 of the input material on IPG strips of the same pH range. Separation in 
the second dimension was performed with 10% SDS-PAGE. The two-dimensional gels were 
blotted to nitrocellulose membrane and probed for coronin-1 and actin.
3.11. Immunoblot for coronin isoforms
Single positive thymocytes, double positive thymocytes and splenic T cells purified from 
wild-type (+/+) animals using MACS isolation kit (Miltenyi) were lysed in lysis buffer with 
protease inhibitors and the lysates were analyzed for total protein content by BCA assay. 
Equal protein amounts were loaded after denaturing with Laemmli buffer onto SDS-PAGE 
(10 %) and electrophoresed. The gel was transferred onto a nitrocellulose membrane and 
analyzed by Ponceau staining and incubated with anti-sera raised against the following 
KLHcrosslinked peptides (coronin 1; amino acid residues 5-20 (raised in rats), coronin 2;
amino acid residues 428-439, coronin 3; amino acid residues 419-430 and coronin 7; amino 
acid residues 910-922, all raised in New Zealand White rabbits). The membrane was 
incubated with corresponding HRP-tagged secondary antibodies and analyzed using enhanced 
chemiluminescence. (Experiments were performed together with Jayachandran R. and 
Combaluzier B.)
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3.12. RT-PCR for coronin isoforms
Total RNA was isolated from 5 × 106 single positive thymocytes, double positive thymocytes 
and splenic T cells purified from wild-type animals using MACS isolation kit (Miltenyi) 
using Qiagen RNA isolation kit in accordance with the manufacturer's protocol. RNA 
integrity was checked employing the RNA 6000 Nano Assay Kit (Agilent Technologies). 
Reverse transcription (RT) reactions were performed according to the manufacturer's protocol 
using 1 μg total RNA, SuperScript III reverse transcriptase (Invitrogen) and random 
hexanucleotide primers (Promega). Polymerase chain reactions using coronin-specific primers 
and cDNA templates from the RT reactions consisted of 30 cycles of 96 °C for 30 sec, 56 °C 
for 30 sec, and 72 °C for 60 sec. Primer sequences are listed below. (Experiments were 
performed together with Jayachandran R. and Combaluzier B.)
Coronin
isoforms
Forward Primer (FP)
Reverse Primer (RP)
Primer Sequence
1 FP 5'-AAACCACTTGGGACAGTGGCT-3' 
1 RP 5'-CATCCGGGCCCAGCGTCAGCA-3' 
2 FP 5'-GTGAGCGGTCA GGATGCTAATCCAA-3' 
2 RP 5'-TTCTCCCTGCTCCTTGACCAG-3' 
3 FP 5'-TTTGAGGGGAAGAACGCGGAC-3' 
3 RP 5'-AGTGTCTCCCTCTCTGCCCTC-3' 
4 FP 5'-CGACTAGGGAT TGTCCTCCA-3' 
4 RP 5'-GGTCAGGTGAGGTTTCTCCA-3' 
5 FP 5'-GATCCCCATCACCAAGAATG-3' 
5 RP 5'-GGCTGC CGTCTGTATTGAAG-3' 
6 FP 5'-GTGCTGGACATTGACTGGTG-3' 
6 RP 5'-TTGCTTGTGTCCATCTCCTG-3' 
7 FP 5'-GAGCTGCCAGTGGAGGTACT-3' 
7 RP 5'-GCAACTCATGAC AGCCAGTG-3' 
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3.13. Flow cytometric analysis and blood counts. 
Cell counts were determined for single cell suspensions of the indicated organs using a 
Neubauer chamber. Flow cytometry was carried out by staining the cells with the relevant 
monoclonal antibodies at saturating concentrations in PBS + 2 % FCS and analyzing them on 
a FACS Calibur (Becton- Dickinson). The following monoclonal antibodies and secondary 
reagents were obtained from BD Pharmingen: PE-labeled &-CD19 (clone 1D3), PE-labeled &-
B220 (clone RA3- 6B2), PE-labeled &-CD3 (clone 145-2C11), PE-labeled &-CD11b (clone 
M1/70), PE- or PECy7-labelled &-CD4 (clone RM4-5), PE-Cy7-labeled-&-CD25 (PL61), 
Biotinlabeled- &-CD44 (IM7), PE-Cy7-labeled-&-CD69 (H1.2F3), APC-labeled &-CD8a (53-
6.7), APC labeled &-CD62L (clone MEL-14), &-CD24 (M1/69) and PECy7-labelled 
Streptavidin. PElabeled &-CD8a (clone 53-6.7) was obtained from eBioScience. Biotin-
labeled antibodies against IgM (clone M41) and CD4 (clone RM4-5) were produced and 
labeled according to standard techniques. PE or APC labeled Annexin V and 7-AAD (BD 
Biosciences) was used according to the manufacturer’s protocol.
Peripheral blood was obtained by tail bleeding and cell counts as well as the hemoglobin
concentration were determined on an ADVIA hematology system (Bayer). For flow
cytometry, peripheral blood was subjected to erythrocyte lysis prior to staining and analysis
on a FACS Calibur (Experiments were performed together with Massner J. and Ceredig R.).
3.14. Immunohistology
Organs were embedded in OCT medium (Sakura Finetek), snapfrozen and 5-Am sections 
were cut with a cryostat. Sections were air-dried, acetone-fixed for 8 min and stored at -70 °C. 
Sections were then rehydrated and blocked in PBS/2 %BSA with 0.1 % NaN3 and 220 Ag/ml 
mouse IgG (Jackson ImmunoResearch Laboratories). Antibodies, diluted in PBS/2 % BSA, 
were added directly onto the sections and incubated for 60 min at room temperature in a wet 
chamber. Antibodies used were: Allophycocyanin (APC)-labeled anti-mouse CD4 (rat IgG2a, 
clone RM4-5) (Caltag Laboratories), fluorescein isothiocyanate (FITC)-labeled anti-mouse 
CD8 (rat IgG2a, clone 53-6.7) (BD Biosciences), fluorescein isothiocyanate (FITC)-labeled 
anti-mouse B220/CD45R (rat IgG2a, clone RA3-6B2) (BD Biosciences), R-Phycoerythrin 
- 143 - 
 
(PE)- labeled anti-mouse Thy1.2 / CD90.2 (mouse IgG2b, clone 5a-8) ( Caltag Laboratories)
and R-Phycoerythrin (PE)-labeled anti-mouse I-A' (mouse IgG2a, clone AF6-120.1) (BD
Biosciences). Sections were counterstained with DAPI (Serva) for 5 min. After washing the 
sections were mounted in Fluoromount (Southern Biotechnology Associates). Images were 
taken on a Zeiss Axioskop with an ORCA ER camera (Hamamatsu) and images were 
processed by using OPENLAB software (Improvision, Coventry, U.K.)
(Immunohistochemistry was performed by Blum C.).
3.15. Nuclear translocation of NF-B and NFAT. 
Wild-type as well as coronin 1-deficient splenic T cells were prepared as described for the 
signaling experiments. Cells were coated with anti-CD3 (10 Ag/ml) and anti-CD28 (5 Ag/ml) 
on ice or were left untreated as a control. After washing, T cell receptors were cross-linked by 
adding mouse-anti-hamster antibodies to a final concentration of 10 Ag/ml. Cells were 
incubated at 37° C in a water bath for 20 or 30 minutes and reactions were stopped by adding 
ice cold PBS/2 % FBS/ 0.05 % sodium azide. After washing, cells were incubated with Alexa 
Fluor-488 goat-anti-mouse on ice for 15 minutes to stain the TCR caps. Washed cells were 
fixed in 8% PFA for 20 minutes at room temperature and stained with rabbit anti-p65 or 
NFAT (both Santa Cruz). Nuclei were stained using DRAQ5. For quantization of nuclear
translocation of p65 or NFAT two times 100 cells were analyzed for both wild-type as well as 
coronin 1-deficient T cells from two independent experiments.
3.16. Preparation of CD4+ SP thymocytes, naïve T-cells and B-cells for 
survival and functional assays
Naïve T-cells were prepared from erythrocyte depleted splenic cell suspensions using the Pan 
T-cell isolation kit from Miltenyi supplemented with biotinylated antibodies against CD44 at 
a final concentration of 5μg/ml. Using this procedure we were able to isolate T-cell 
populations containing D2EF
	G+
-cells. In order to remove dead or apoptotic cells we 
passed cell suspensions at room temperature for 20 minutes at 800g over a cushion of 
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HISTOPAQUE-1077 and HISTOPAQUE-1119 (Sigma) mixed at a ratio of 11:3. Using this 
procedure we were able to recover naïve T-cell populations with D 2EF 
 +$"
 
""
(Annexin V, 7-AAD double negative).
For the isolation of CD4+ SP thymocytes we passed thymic single cell suspensions at room 
temperature for 20 minutes at 800g over a cushion of HISTOPAQUE-1077 and 
HISTOPAQUE-1119 mixed at a ratio of 11:3, depleted the remaining cell suspensions of 
CD8 expressing cells using anti-CD8 micro beads from Miltenyi according to the 
manufacturers protocol. In a next step we positively selected CD8 negative, CD4 positive 
cells using anti-CD4 micro beads from Miltenyi according to the manufacturers protocol. In 
order to remove dead or apoptotic cells we passed cell suspensions at room temperature for 20 
minutes at 800g over a cushion of HISTOPAQUE-1077 and HISTOPAQUE-1119 mixed at a 
ratio of 11:3. Using this procedure we were able to recover CD4 single positive thymic cell 
populations containing approximately 95% of CD4 positive cells which in addition were D
95% viable (Annexin V, 7-AAD double negative).
B-cells were isolated similar to naïve T-cells using anti-CD4, anti-CD8 and anti-CD11b micro 
beads (Miltenyi) to remove all non B-cells. Using this procedure we were able to recover 
CD19 positive splenic cells containing D2EF
019 positive cells which in addition were D
95% viable (Annexin V, 7-AAD double negative).
3.17. Transwell migration assay
For transwell migration cells were washed extensively with migration buffer: RPMI-1640 
supplemented with 0,1% tissue culture grade, lipid free BSA (Sigma) and L-glutamine. Cells 
were then added to the upper chamber of the migration setup in 100 μl of migration medium. 
500 μl of migration buffer containing the indicated stimuli at the indicated concentration were 
added to the lower wells. Migration was monitored after the indicated time span using a 
FACS Calibur or Neubauer chamber to quantitate migrated cell numbers. In experiments 
where wild type as well as coronin 1 deficient cells (express GFP) [251] where tested, we 
used mixtures of both cell types to minimize experimental variations by having exactly the 
same condition for both wild type as well as coronin 1 deficient cells. GFP was used to 
distinguish both cell types.
- 145 - 
 
3.18. Calcineurin activation
To measure calcineurin activity in naïve coronin 1 deficient or wild type T-cells untouched 
cells were isolated using the Pan T-cell isolation kit from Miltenyi supplemented with 
biotinylated antibodies against CD44 at a final concentration of 5 μg/ml. Cells were either 
stimulated for 15 minutes using anti-CD3, anti CD28 as well as secondary antibodies as stated 
for the calcium measurements or using PMA 50 nM/Ionomycin 200 nM. Upon stimulation 
cell lysis as well as calcineurin activity measurements were performed using a commercial kit 
(Calbiochem), according to the manufacturers protocol. Protein concentrations measurements 
were carried out using a commercial BCA protein assay kit (Pierce) according to the
manufacturers protocol.
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4. SUMMARY AND OUTLOOK
4.1. Part I
The first part of this thesis addressed the question of whether the F-actin cytoskeleton is 
important for store operated calcium entry (SOCE). We were able to show, that in Jurkat T 
cells stabilization or depolymerization of the actin cytoskeleton using actin modulating drugs 
both failed to affect calcium release activated calcium (CRAC) channel activation and 
calcium influx. These results lead us to conclude that rearrangement of the actin cytoskeleton 
is dispensable for SOCE in T cells. Consistent with a previous report, finding no effect of F-
actin modulation on SOCE in RBL cells, our data clearly disprove the long held idea that the 
actin cytoskeleton mediates coupling of intracellular calcium stores to plasma membrane 
calcium channels in lymphocytes.
These results improve our knowledge of calcium signaling in cells of the immunesystem and 
allow further refinement of the models we use to explain the molecular events underlying 
calcium signaling.
4.2. Part II
In the second part of this thesis the in vivo role of coronin 1 during T cell development was 
analyzed, as well as proliferation and T cell receptor (TCR) mediated signaling. We describe 
that coronin 1 is essential for the proliferation and survival of naive T cells in the periphery.
However when investigating T cell receptor downstream events, all analyzed signaling 
molecules, such as linker for activation of T cells (Lat) and SRC-homology-2-domain-
containing leukocyte protein of 76 kDa (SLP-76), down to phospholipase C  (PLC ),
were expressed to a similar extend as well as phosphorylated equally upon TCR ligation in 
both wild type and coronin 1 deficient T cells. In depth analysis of PLC  function, 
substrates and metabolites, revealed that coronin 1 exerts its function in naïve T cells by 
activating Ca2+ release from intracellular endoplasmatic reticulum (ER) calcium stores upon 
TCR triggering. We were further able to show that coronin 1 associates with PLC , thereby
being essential for the generation of the second messenger inositol-1,4,5- trisphosphate (IP3),
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which upon binding to IP3-receptors at the ER mediates the release of Ca2+ from ER calcium 
stores. The transient increase of cytosolic calcium caused by this release induces a second 
wave of calcium influx via SOCE channels in the plasma membrane. As a consequence of the 
elevated calcium concentrations the phosphatase calcineurin is activated and 
dephosphorylates the transcription factor, nuclear factor of activated T cells (NFAT) in the 
cytoplasm. Dephosphorylated NFAT translocated into the nucleus where it initiates gene 
transcription of genes such as the interleukin-2 (IL-2) gene. In line with the finding that in the 
absence of coronin 1 only weak IP3 and Ca2+ responses are generated both nuclear 
translocation of NFAT and IL-2 production were markedly decreased in coronin 1 deficient T 
cells.
The role defined here for coronin 1 in the generation of IP3 upon TCR triggering differs 
markedly from a recent report that coronin 1 is dispensable for TCR mediated signaling,
instead preventing F actin induced apoptosis. We describe however that in T cells from wild 
type and coronin 1 deficient mice, F-actin dynamics were normal in the absence of coronin 1
as analyzed by several independent morphological, biochemical and functional assays, 
including the analysis of TCR-mediated cell spreading.
We therefore conclude that coronin 1, rather than modulating the F-actin cytoskeleton in T 
cells, is involved in T cell receptor signaling in general and in particular in the regulation of 
PLC  mediated calcium release from internal stores.
The definition of coronin 1 as a regulator of PLC  and calcium signaling in T cells opens a 
new and unexpected field of research and possibilities with respect to the development of
novel compounds for the treatment of T cell mediated disorders of the immunesystem.
4.3. Part III
In the last part of this thesis we investigated the precise mechanism of T cell death, observed 
in coronin 1 deficient mice. We found that both naïve T cell survival as well as migration 
defects observed in coronin 1 deficient naïve T cells occurred as a result of defective PLC 
/calcium signaling and calcineurin activation. We were further able to demonstrate that 
cellular viability and the ability of T cells to migrate are intimately linked. When the viable 
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population of coronin 1 deficient naïve T cells was isolated, these cells neither displayed
elevated levels of spontaneous apoptosis nor a migration defect.
As a consequence of defective signaling and calcineurin activation in the absence of coronin 
1, Bcl-2 levels were found to be reduced, whereas caspase 3 was induced at high levels. These 
date are consistent with previous reports that calcineurin deficiency leads to specific defects in 
naïve T cells and a reduction in Bcl-2 protein levels [350]. Furthermore, the data presented
here provide, on a molecular level, an explanation for the diverse phenotypes such as 
migration and survival defects described for naïve T cells from coronin 1 deficient mice.
These data also demonstrate that phalloidin staining, which has been used to quantitate F-
actin levels in coronin 1 deficient T cells cannot be used to quantitate F-actin levels if coronin 
1 levels differ between cell populations, an effect that might be due to competition of coronin 
1 and phalloidin for spatially proximal binding sites. These findings are in agreement with a 
previous report demonstrating an essential role for coronin 1 in the activation and survival of 
pathogenic mycobacteria within host macrophages, but not F-actin regulation [251].
The definition of coronin 1 as an essential regulator of calcineurin mediated cellular viability 
in naïve T cells may allow a better understanding of leukocyte activation and homeostasis,
both of which are crucial to the understanding as well as treatment of autoimmune as well as 
lymphoproliferative diseases. In the future, the precise role of coronin 1 in different T cell 
subset as well as in different pathological conditions needs to be defined in order to further 
understand the differential roles of coronin 1 in T cell function as well as activation. Another 
aspect which might become important during viral and certain bacterial infection is the 
integrative effect of stimuli received via the TCR as well as other receptors such as the TLRs. 
Interestingly a recent publication describes that coronin 1 might act as a negative regulator of 
TLR signaling [371], implying that signaling input via TLRs could be significantly enhanced 
in the absence of coronin 1 and compensate for missing signals from the TCR as observed for 
/>

	 
"" [372-374]. Addressing these questions using the coronin 1 deficient 
mouse model may yield valuable insight into the involvement of coronin 1 in T cell regulation 
under physiological and pathological conditions. 
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6. ABBREVIATIONS
7-AAD 7-Aminoactinomycin
ABC ATP binding cassette
ADAP adhesion and degranulation promoting adaptor protein
ADCC Antibody-Dependent Cell-Mediated Cytotoxicity
AICD activation induced cell death 
&-CPM &-chain connecting peptide domain 
AP1 activator protein 1
2-APB 2-Aminoethoxydiphenyl Borate
APC antigen presenting cell
ARP2 actin-related protein 2 homologue
ARP3 actin-related protein 3 homologue
Bak Bcl-2 homologous antagonist/killer
Bax Bcl-2 associated X protein
Bcl B cell lymphoma 
BCR B cell receptor
BH-3-only Bcl-2-homology domain 3 only
Bid BH3 interacting domain death agonist
Bim BCL-2-interacting mediator of cell death
Ca2+ calcium
caspase cysteine aspartic acid proteases
CCL Chemokine (C-C motiv) ligand
CD cluster designation or cluster of differentiation
CDRs complementarily determining regions 
CDC42 cell-division cycle 42
CDI calcium dependent inactivation
CLIP class  associated invariant chain peptide
CaN calcineurin A
CRAC calcium release activated
cSMAC central SMAC
CTLA-4 cytotoxic T lymphocyte antigen 4
CytD Cytochalasin D
DAG diacylglycerol
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DC dendritic cell
DMSO Dimethylsulfoxid
DN double negative
DNA deoxyribonucleic acid
DP double positive
dSMAC distal SMAC
ER endoplasmic reticulum
ERK extracellular-signal-regulated kinase
FACS fluorescent activated cell sorter
F-actin filamentous actin
FasL Fas ligand
Fc fragment cristalizable
FoxP3 forkhead box P3
G-actin globular actin
GADS GRB2 related adaptor protein
GRB2 growth-factor-receptor-bound protein 2
ICAM1 intercellular adhesion molecule 1
IFN-  interferon-
IB inhibitor of NF-B
IL-2 interleukin 2
InsP3 nositol-1,4,5- trisphosphate
IP3 inositol-1,4,5- trisphosphate
IS immunological synapse
ISP immature single positive
ITAM immunoreceptors tyrosin-based activation motif 
ITIM immunoreceptors tyrosin-based inhibition motif 
ITK interleukin-2-inducible T-cell kinase
JAK Janus Kinase
JNK JUN amino-terminal kinase
JP Jasplakinolide
Jaspl Jasplakinolide
LAT linker for activation of T cells
LatB Latrunculin B
Lck Leukocyte-specific protein tyrosin kinase 
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LFA1 leukocyte function associated antigen 1 
LPS lipopolysaccharide
MIIC MHC class  compartment
Mcl-1 Myeloid cell leukemia sequence 1
MHC Major Histocompatibility Complex
m-3M3FBS N-(3-trifluromethylphenyl)-2,4,6-trimethylbenzenesulfonamide
NCK non-catalytic region of tyrosine kinase
NFAT Nuclear Factor of Activated T cells
NF-B nuclear factor-B
ORAI In greek mythology “Orai” are the keepers of the gates of heaven
PAMPs Pathogen-Associated Molecular Patterns
PH pleckstrin homology
PI3K phosphatidylinositol-3-kinase 
PiP2 phosphatidylinositol-4,5-bisphosphate
PIP3 phosphatidylinositol-3,4,5-trisphosphate 
PkC Protein kinase C
PLC phospholipase C
PMA phorbol-12-myristat-13-acetat
PRR pattern recognition receptors
pSMAC peripheral SMAC
PTEN phosphatase and tensin homologue
RAC Ras-related C3 botulinum toxin substrate 
RAG recombination-activation gene
RASGRP RAS guanyl-releasing protein
RBL rat basophile leukemia
SAM sterile alpha motif 
SCID severe combined immunodeficiency
SD standard deviation
SDF stromal cell derived factor
SDS sodium dodecyl sulfate
SERCA sarcoplasmic/endoplasmic reticulum calcium ATPase
SFKs Src family tyrosin kinases 
SH2 Src Homology 2 
SHIP SRC homology 2 (SH2)-domain-containing inositol-5-phosphatase
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SLP76 SRC-homology-2-domain-containing leukocyte protein of 76 kDa
SMACs supra-molecular activation complexes 
SOC store operated calcium
SOCE store operated calcium entry
SOCS-1 Suppressor of cytokine signaling-1
SOS son of sevenless homologue
SP single positive
STAT signal transducer and activator of transcription
STIM 1 stromal interaction molecule 1
TACO tryptophan aspartate containing coat protein
TCR T cell receptor
TLR Toll like receptor
TNF tumor necrosis factor
TPR Transient receptor potential
TREG regulatory T cells 
VAV1 vav1 guanine nucleotide exchange factor
WASP Wiskott-Aldrich syndrome protein
ZAP70 <-chain-associated protein kinase of 70 kDa
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